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Abstract 
The asymmetric outer membrane (OM) of a Gram-negative bacterium has many proteins 
embedded as β-barrel structures in it called outer membrane proteins (OMPs). The majority of 
these OMPs (porins) form non-selective channels across the OM to allow passive uptake of 
substrates. The treatment for infections caused by such bacteria mostly involves the 
administration of drugs/antibiotics, for which these porins play a very crucial role by providing 
an efficient (although not yet fully understood) route through their channel. The goal of this 
study is to study small-molecule permeation through the major porins, OmpU and OmpT, 
of Vibrio cholerae (the causative agent of cholera) for potential use of these proteins as the target 
for designing antibiotics or vaccines. Towards this project, we have succeeded in solving the 3D 
X-ray crystal structures of OmpU and OmpT as well as the structures of the major porins from 
Klebsiella pneumoniae (OmpK36) and Enterobacter cloacae (OmpE36, OmpE35).  
 
The proteins (OmpU/T, OmpE35/E36 and OmpK36) show the typical arrangement of 
porins with three β-barrel monomers arranged into a trimer. Each monomer displays 16 
antiparallel β-strands forming the hollow β-barrel formed by 8 long extracellular loops and 8 
short periplasmic turns. The latching loop L2 stabilises the trimer while loop L3 departs from the 
β-barrel fold and constricts the pore half-way through the channel. An unusual feature is 
observed in the channels of OmpU and OmpT that distinguishes them from other typical porins. 
In OmpU, the first 10 residues of N-terminus insert into the barrel and constrict the pore. In 
contrast, the structure of OmpT reveals that the extracellular loop L8 folds inwards to constrict 
the lumen of the channel. Such constriction elements not only reduce the pore sizes of OmpU 
and OmpT but may also dramatically affect the internal electrostatics of these channels, which is 
very important for small-molecule permeation. In addition, we also performed single channel 
electrophysiology experiments with OmpU and OmpT which revealed interesting features with 
the addition of carbapenems.  
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Chapter 1.  Introduction 
 
1.1. Gram-negative bacteria 
Bacteria are microscopic single-celled prokaryotes. These diverse microorganisms are 
ubiquitous in soil, freshwater, marine and as well as in extreme environments. The ability of 
bacteria to survive such harsh environmental conditions is owed in part to the rigid and 
multilayered structure of the bacterial cell envelope. The primary classification of bacteria into 
Gram-positive and Gram-negative organisms is based on the nature of this complex cell 
envelope.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Cell wall of Gram-negative bacteria.   
The schematic representation of cell wall architecture of Gram-negative bacteria, comprising an 
inner membrane (IM) of phospholipid (PL) bilayer, a peptidoglycan layer (PepG) in the middle 
and an asymmetric outer membrane (OM) composed of PL as the inner leaflet and 
lipopolysaccharide (LPS) in the outer leaflet. OMP; outer membrane protein, IMP; inner 
membrane protein. 
 
The simplest architecture of the bacterial cell wall is composed of a cell membrane and a 
peptidoglycan layer. Peptidoglycan (PepG) is composed of a carbohydrate backbone of 
alternating units of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid, that are 
crosslinked by pentapeptide side chains. Gram-negative bacteria possess a significantly thinner 
peptidoglycan layer than the multilayered thickened peptidoglycan of Gram-positive bacteria. 
3 
 
Gram staining is one of the simple diagnostic tools to differentiate between the two classes of 
bacteria and is based on the principle of intensive staining of the thickened peptidoglycan layer of 
Gram-positive bacteria. Gram-negative bacteria, on the other hand, because of thin peptidoglycan 
layer do not stain as much. However, the thickness of the peptidoglycan layer is not the only 
factor that differentiates the two primary classes of bacteria. One other major difference between 
these two is the presence of an outer membrane (OM) in Gram-negative bacteria. The cell wall of 
Gram-negative cells is thus composed of an inner membrane phospholipid bilayer, a thin PepG 
layer and an outer membrane, which is absent in the Gram-positive bacteria (Figure 1.1).  
 
1.1.1. The outer membrane 
The outer membrane is a crucial component of a Gram-negative bacterial cell that helps it 
to survive the harsh conditions of the environment. The loss of mechanical strength and durability 
to survive in hostile environments due to the absence of thickened peptidoglycan layer is 
compensated by presence of the OM in Gram-negative bacteria. The exclusive presence of the 
OM in Gram-negative bacterial walls allows the exchange of nutrients with the cell environment 
and disseminates the waste products into the external medium. At the same time, the OM also 
imparts restricted permeability to toxic compounds and thus serves as a protective barrier. The 
reason for being such a remarkable and efficient barrier lies in the composition of the OM.  
 
Like other biological membranes, the OM is also a lipid bilayer but is not entirely 
composed of phospholipids. The phospholipids are confined to the inner leaflet while glycolipids, 
widely known as lipopolysaccharide (LPS), are present in the outer leaflet of the OM. LPS, also 
known as endotoxin, is a complex biological entity of Gram-negative bacteria and contributes 
towards the asymmetric nature of the OM. The complex macromolecular structure of LPS present 
in the outermost region of Gram-negative cell wall plays a critical role in the barrier function of 
the OM (also see Section 1.1.2). The outer membrane proteins (OMPs) form channels across the 
membrane that allow the transport of solutes and hence make the OM selectively permeable. 
Each OMP spans the OM and its transmembrane segments either form specific or non-specific 
channels. These transmembrane channels serve as pathways between the interior of the cell and 
its environment, thereby helping the bacteria to function by allowing exchange of nutrients and 
waste in and out of the cell (also see section 1.2). Thus, the OM not only separates the external 
environment from a bacterial cell but also serves as an essential organelle for bacterial survival 
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by providing solute transport (through OMPs) while at the same time serving as a defence system 
against toxic compounds (via LPS).  
 
1.1.2.  Lipopolysaccharide structure  
Lipopolysaccharide (LPS) covers 90% surface of a Gram-negative bacterium cell 
(Rosenfeld and Shai 2006). It has been a subject of intense research for more than three decades 
that started with the characterisation of LPS (Luderitz et al., 1984, Wu and Health 1973) and 
identifying its location in the OM (Nikaido 2003, Kamio and Nikaido 1976). To date, several 
reviews exist that comprehensively describe the structure and biosynthesis of LPS (Raetz and 
Whitfield 2002, Wilkinson 1996). A typical LPS molecule essentially consists of three 
components, a hydrophobic lipid A, a hydrophilic core oligosaccharide chain and hydrophilic O 
antigen repeats forming a long polysaccharide chain (Figure 1.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1.2. Bacterial Lipopolysaccharide (LPS).  
(A) The chemical composition of LPS involves a membrane-anchored lipid A moiety, a core 
oligosaccharide unit (structurally classified into an inner and outer core) and an outermost O-
antigen polysaccharide. (B) The lipid A subunit is composed of glucosamine disaccharide sugars 
acylated by 3-hydroxymyristic acid chains.  
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Lipid A is the only lipophilic component of LPS which is embedded in the outer leaflet of 
the OM and is a dimer of phosphorylated N-acetylglucosamine sugars. The disaccharide 
backbone, composed of β-1’,6-linked glucosamine sugar moiety, is attached to four primary 3-
hydroxyacyl chains at positions 2, 3, 2’ and 3’; and two phosphates at both sugar ends at 
positions 1 and 4’ (Figure 1.2 B). In Escherichia coli, two of these fatty acyl chains (on the 1’ 
sugar) are further acylated on their hydroxyl groups by secondary acyl chains (like lauric acid or 
myristic acid) via forming ‘acyloxylacyl’ bonds. As a result, E. coli LPS is considered to contain 
mainly hexa-acylated lipid A. Lipid A is the most conserved component of LPS but the acylation 
pattern of the lipid A moiety of LPS varies among different Gram-negative bacteria. For instance, 
Yersinia pestis has been shown to synthesise tetra-acylated and hexa-acylated lipid-A based on 
the temperature of the external environment (Montminy et al., 2006). Likewise, tetra- and penta-
acylated lipid A has been reported for Porphyromonas gingivalis, another Gram-negative 
pathogen (Herath et al., 2013).  
 
The oligosaccharides of the core region are located on the surface of bacterial cells and 
are sub-divided into two domains: an inner core and an outer core (Figure 1.2 A). Typically 
composed of short chains of Kdo (3-deoxy-D-manno-oct-2-ulosonic acid) and Hep (L-glycero-D-
manno-heptose) sugars, the inner core oligosaccharide connects to the lipid A disaccharide unit. 
Kdo is the highly conserved entity of the LPS core region (Wang and Quinn 2010). Structurally 
more diverse than the inner core, the outer core oligosaccharide mostly contains heptose and 
hexose (D-glucose and D-galactose) sugars and makes a link with the O-antigenic repeats of LPS.   
 
The outermost and least conserved component of LPS is the O-antigen polysaccharide 
unit. The repeating oligosaccharide unit of O-antigen is generally composed of two to six sugars 
(mostly heptoses and hexoses). The length of O-antigen may vary from species to species among 
Gram-negative bacteria, up to a maximum of 40 repeat units forming smooth-type LPS (S-LPS; 
Lerouge and Vanderleyden 2002). The rough-type (R-LPS) LPS is devoid of O-antigen chain, for 
instance E. coli K-12 strain is unable to synthesise the O-chain and produces R-LPS (Stevenson 
et al., 1994).  
 
LPS forms a large macromolecule and the weight of an average LPS monomer is around 
10 kDa – 20 kDa (Magalhaes et al., 2007), but depending on the number of O-chain repeating 
units, the molar mass may vary from 2.5 kDa (lacking O-Ag repeats) to 70 kDa (extremely long 
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O-Ag repeats). LPS possess a few other crucial features (Nikaido 2003) that contribute in 
providing defence against the influx of hydrophilic and hydrophobic compounds. These features 
include; a) rigid lipid interior of LPS layer due to the low fluid texture of its fatty acyl 
component, b) thermal stabilisation of LPS molecules by mediating strong ionic interactions 
between the negatively charged phosphates (of LPS) and the divalent cations (Mg
+2
 and Ca
+2
) in 
the OM, and c) chemical structure stabilisation mediated through strong lateral interactions 
between the fatty acid chains within one LPS molecule or among neighbouring LPS molecules.  
 
LPS is also known as endotoxin because it acts as a strong stimulator of innate immunity 
in eukaryotic species including humans (Beutler and Rietshcel 2003). Lipid A, the most 
conserved unit of LPS, is responsible for triggering the endotoxin response in human cells 
(Loppnow et al., 1989 and Alexander and Ritschel 2001).  
 
1.2. Outer membrane proteins (OMPs) 
 
The proteins embedded in the inner membrane as well as outer membrane are collectively 
referred to as integral membrane proteins. Depending on their location in the membrane (OM or 
IM), integral membrane proteins are divided into outer membrane proteins (OMPs) and inner 
membrane proteins. Majority of the OMPs form membrane spanning anti-parallel β-stranded 
entities that are arranged into cylinder-like closed barrels across the OM. The transmembrane β-
strands of the barrel are connected by long loops present in the extracellular space and short turns 
facing the periplasmic region (Figure 1.3). In contrast to the OMPs, the inner membrane proteins 
of Gram-negative bacteria are present as transmembrane α-helical bundles in the IM (Dalbey et 
al., 2011). The transmembrane β-barrel motif is a characteristic architecture adopted by the 
OMPs, as has been demonstrated by numerous structures available in the protein data bank 
(PDB) since ≥ 25 years. However, there are few exceptions to the canonical trend seen in the β-
barrel structures of OMPs. For example, PorB in Corynebacterium glutamicum is an α-helical 
porin (Ziegler et al., 2008) and Wza, an OMP in E. coli, forms an α-helical barrel in the 
transmembrane region of OM (Dong et al., 2006).   
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Figure 1.3. General architecture of β-barrel OMPs.  
Schematic representation of the protein fold in OMPs showing (A) 8-stranded β-barrel for E. coli 
OmpA and (B) 16-stranded β-barrel for E. coli OmpF. The cartoon figures were made using 
PyMol (Schrodinger 2010) with the PDB codes 1BXW (OmpA; Pautsch and Schulz 1998) and 
2OMF (OmpF; Cowan et al., 1992). 
 
1.3. Import channels 
The OM of Gram-negative bacteria possess β-barrel channels acting as molecular filters 
for the influx of compounds. Although OMPs share a common secondary structural β-barrel 
motif, they vary depending on their functional roles in the membrane and show diversity in the 
oligomerised states and topology.  
 
1.3.1.   Passive channels: Non-specific Porins 
OMPs forming channels for the passive uptake of substrates are abundantly found in the 
OM. The outer membrane channels that allow passive uptake of ions or substrates are classified 
into two types depending on the specificity of the channel. The first category of passive channels 
are substrate-specific proteins that form channels that show specificity for the passage of 
substrate through the presence of a binding site (also see section 1.3.2). The second class of 
passive channels are known as general diffusion porins that do not discriminate between the 
substrates and allow the non-specific uptake of water-soluble, small solutes like nutrients and 
ions.    
 
The general porins are the major outer membrane proteins found in the OM of many 
Gram-negative bacteria, with ~10
5
 copies present per cell (Nikaido and Vaara 1985). The word 
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porin was proposed to indicate the non-specific nature of these channels (Nikaido 2003) and will 
continue to denote the same throughout this thesis. These non-specific diffusion channels exist as 
trimers in the OM and have a molecular weight of around 30-40 kDa per monomer. The porins 
form a molecular sieve for the access of small hydrophilic solutes with the size exclusion limit of 
~600 Da. Although classified as non-specific channels, porins do show some preference for either 
cations or anions.  
 
1.3.1.1.  Porin regulation  
The major porins of E. coli, OmpF and OmpC, have been extensively investigated for 
their expression and regulation in response to external stimuli. As a result, most of our 
understanding of porin regulation, expression and function comes from the information available 
for OmpF/C. Some examples of porin ortholog pairs from different Gram-negative species are 
OmpE35/OmpE36 (Enterobacter cloacae), OmpK35/OmpK36 (Klebsiella pneumoniae), 
Omp35/Omp36 (Enterobacter aerogenes), OmpS1/S2 (Salmonella enetrica), OmpF/OmpC 
(Yersinia pestis), PorA (Neisseria meningitidis), Omp32 (Comamonas acidovorans), 
OmpL/OmpH (Photobacterium profundum) and OmpU/OmpT (Vibrio cholerae). In a bacterial 
cell, porin regulation is controlled by various external stimuli including osmolarity, temperature, 
pH, oxygen starvation or stress. The environmental factors that play influential roles in the 
expression and regulation of porins are osmolarity, temperature, oxidative stress and pH.  
 
Osmolarity  
Bacteria, in general, employ a ‘two-component’ phosphotransfer signalling system for 
gene regulation in an adaptive response to external environment. The mechanism of this 
signalling system is based on the phosphate transfer from histidine (His) to aspartate (Asp) 
between its two components; a sensor kinase and response regulator (Pratt et al., 1996). Under 
osmotic pressure, the porin pair of E. coli (OmpF/C) is strictly regulated at the transcription level 
by the ‘two-component phosphorelay system’ which includes EnvZ as the ‘sensor’ and OmpR as 
the ‘response regulator’ (Mizuno 1998 and Pratt et al., 1996). In hyperosmotic medium, the 
osmosensor EnvZ gets autophosphorylated and phosphorylates OmpR. The phosphorylated 
OmpR binds to the ompC promoter region and increases OmpC expression. In contrast, hypo-
osmotic media induces binding of OmpR to ompF promoter which increases OmpF expression. 
Thus, the osmoregulation in E. coli involves reciprocal expression of its major porins; OmpF 
during low osmolarity and OmpC during high osmolarity.  Like E. coli, the reciprocal regulation 
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of porins in response to the osmolarity levels has also been seen in OmpF/C orthologs of E. 
aerogenes Omp35/36 (Bornet et al., 2004), K. pneumoniae OmpK35/K36 (Tsai et al., 2011) and 
OmpF/C of Salmonella marcescens (Begic and Worobec 2006) where the OmpF orthologs show 
increased expressions in hypo-osmotic environment and vice versa for OmpC orthologs.  
 
1.3.1.2.  Porin structure 
The initial X-ray crystallographic structures of general porins (in 1990s) were determined 
for a porin from Rhodobacter capsulatus (Weiss et al., 1991) and the major porin OmpF from E. 
coli (Cowan et al., 1992). The structure of another major porin from E. coli, OmpC, was solved 
much later (Basle et al., 2006), but its homolog OmpK36 from K. pneumoniae (Dutzler et al., 
1999) was solved only a few years after OmpF. Since then, there has been quite an increase in the 
number of porin structures available in the PDB. However, despite their prevalence in the OM, 
the protein database still lacks structural information on some of the major porins of several other 
Gram-negative pathogens.  
The two major porins of E. coli, OmpF and OmpC, are the designated archetypical members 
of the general porin family of Gram-negative bacteria. As elucidated by the architectural β-barrel 
fold of OmpF/C, porin structure is characterised by the following typical features: 
 
 β-barrel 
OmpF and OmpC channel is an ‘hour-glass’ shaped β-barrel formed by 16 antiparallel strands 
(Figure 1.4). The β-strands (β1 - β16) vary in their respective lengths, ranging from 5 residues in 
β6 of OmpF (8 in β7 of OmpC) to 16 residues in β16 of OmpF (and OmpC). The β-strands of the 
enclosed barrel are connected at their ends in the periplasmic and extracellular spaces. The 
residues bridging the β-strands at the periplasmic end are referred as ‘turns’ whereas those that 
connect at the extracellular end are termed as ‘loops’. The 16 stranded β-barrel is thus composed 
of 8 extracellular loops (L1-L8) and 8 periplasmic turns (T1-T8). The periplasmic turns are short 
and are typically composed of 2-4 residues, however the longest turn (T4) in OmpF/C structures 
contains 10 residues. The loops of extracellular space are comparatively very long and except L3, 
all are exposed (L1, L2, L4-L8) to the outside of the cell. The ones that are exposed to the cell 
exterior show a large variation in length. In OmpF/C structures, the length of the β-barrel along 
the channel axis is ~ 30 Å and the diameters of the elliptic cross-section of the barrel are 25 × 38 
Å (Rostovtseva et al., 2002).  
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Figure 1.4. Structure of OmpF.  
The figure displays the cartoon view from the OM plane (A) and extracellular side (B) for the 
homotrimer of E. coli OmpF. One of the monomers is shown in rainbow (N-terminus in blue to 
C-terminus in red) and other two in gray. (A) Each monomer is a 16-stranded β-barrel formed by 
8 extracellular loops and 8 periplasmic turns. (B) L3 loop folds inside the barrel and the latching 
loop L2 stabilises the trimer. (C) Schematic representation to show the ‘hour-glass’ shape of the 
channel. The cartoon shown is a crystallographic trimer, made using the PDB code 2OMF 
(OmpF; Cowan et al., 1992). 
 
 
 Salt bridged N- and C- termini 
Although the average length of transmembrane β-strands of OmpF/C lies between 11-12, 
strand β-16 includes 16 amino acids and stands out as the longest strand of the barrel. In addition, 
β-16 strand is formed of N- and C- terminal ends of the protein. The mature sequences of porins 
often initiate with alanine at the N-terminus and end with an aromatic residue at the C-terminus, 
with most common being phenylalanine (Phe) but in some cases tryptophan (Trp) may also be 
present. . In OmpF/C, the carboxylate oxygen of the terminal Phe makes ionic interaction (~ 2.6 
Å) with the α-amino nitrogen of Ala1 (Figure 1.5). The formation of a salt-bridge pair between 
the terminating ends of N- and C- termini is one of the characteristic features of porin structure 
(Nikaido 2003).  
 
 Amphipathic nature 
Any OM channel that transverses the lipid bilayer must maintain an amphipathic character in 
the membrane. In a porin channel, the extracellular loops and periplasmic turns contain 
hydrophilic residues but the β-strands show a significant amphipathicity. The transmembrane β-
strands contain alternating hydrophobic and hydrophilic residues. The hydrophobic residues 
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protrude outside the barrel into the hydrophobic core of the lipid bilayer. The hydrophilic 
residues of the β-strands, on the other hand, orient towards the interior of the channel where they 
interact with numerous water molecules, present inside the channel. Although the water-filled 
channels of porins contain abundant water molecules that are highly mobile, some of the waters 
remain fixed owing to their intricate connection with the polar residues via strong hydrogen 
bonding. One characteristic feature observed in porins is the presence of a ring of aromatic 
residues circling the barrel outside at two primary interfaces of the OM. The β-strands at the 
interfaces between the hydrophobic and polar parts of the OM are marked by either 
phenylalanine or tyrosine or tryptophan that form two ‘aromatic girdles’ outside the barrel 
(Galdiero et al., 2012). In fact, the terminal salt-linked aromatic residue of the C-terminus forms a 
part of the aromatic girdle at the OM-periplasm interface. The presence of aromatic girdles is not 
only limited to porins but have been observed in other OMPs as well.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. OmpF structural features.  
(A) The first residue, alanine (at N-terminus), and the terminal residue, phenylalanine (at C-
terminus), are salt bridged in the β-16 strand. (B) The eyelet region of OmpF monomer 
(extracellular view) is constricted by loop L3 that harbours negatively charged residues (Asp113 
and Glu117), placed opposite the positive charged residues of the barrel wall (Arg42, Arg82 and 
Arg132).  
 
 Pore-constriction: Loop L3 
One of the extracellular loops does not protrude out in the external medium but instead folds 
back inside the barrel to cause a constriction of the pore. Bridged between transmembrane strands 
β5 and β6, loop L3 is composed of more than 30 residues, making it the longest loop of all.  Loop 
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L3 folds inside the barrel such that the pore constriction is created almost in the middle of the 
barrel axis (Figure 1.5). The pore constriction by L3 is generally termed the ‘constriction region 
(CR)’ which forms a narrow elliptically shaped selectivity filter in OmpF with dimensions of 7 × 
13 Å (Yamashita et al., 2008) and solvent accessible area of 30–40 Å2 (Cowan et al, 1992; Varma 
et al, 2006). 
 
L3 is a hallmark for all porin channels and a crucial determinant of solute translocation. In 
OmpF, the two negatively charged residues of L3, Asp113 and Glu117, are placed opposite the 
positively charged residues of the barrel wall, Arg42, Arg82 and Arg132 (Figure 1.5). Such an 
organisation of the charged residues of the constriction region (CR) produces a local transverse 
electric field that, in the light of past and recent studies, is strongly believed to create the barrier 
that the permeating molecule has to overcome to translocate (Karshikoff et al., 1994, Acosta-
Gutierrez et al., 2016, also see section 1.4.3.).  
 
 Oligomerisation: Loop L2 
The porins exist as trimeric assemblies in the OM. Each of the three β-barrels of the porin 
trimer are tilted at an angle of 30°-60° and arranged around a central axis in the OM (Schulz 
2002). In the trimer, the extracellular loop L2 of one monomer latches over to the groove of an 
adjacent monomer and is involved in maintaining and stabilising the trimeric state of the porin. 
The latching loop L2 is negatively charged whereas the surface of the groove contains positive 
charged residues. As a result, L2 of one monomer makes several electrostatic interactions with 
the groove of an adjacent monomer and hence aids in stabilising the trimer. In OmpF, the 
oligomerised state is strongly stabilised by an inter-subunit salt bridge involving 4 H-bonds 
between Glu71 (of L2 in one monomer) and the guanidium head groups of Arg132* and Arg100* 
(groove residues of the adjacent monomer indicated by asterisks), and an intra-subunit H-bond 
between Asp74 and Ser70 (Phale et al., 1998). 
 
1.3.1.3.  Porin function: Solute transport  
The stress-induced activation of OmpC (and repression of OmpF) during increased 
extracellular osmolarity is explained by the channel size difference between the channels of two 
major porins of E. coli. The early diffusion studies of different compounds indicated that OmpC 
produced smaller-sized channels than OmpF (Nikaido and Rosenburg 1983). This was later 
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confirmed through their 3D X-ray crystal structures that revealed a slightly larger channel size for 
OmpF than OmpC (Cowan et al., 1992 and Basle et al., 2006), providing an explanation for the 
increased expression of OmpC under hypersmotic conditions. Because of its small channel size, 
OmpC minimises the influx of toxic products under hostile conditions or ions in high-osmolarity 
media.  
 
The liposome swelling assay (LSA) has proven to be a significant tool for determining the 
diffusion rates along with the selectivity of the porin channel (Figure 1.6). For the assay, 
multilamellar proteoliposomes are prepared in the presence of a non-permeating sugar (e.g. 
stachyose), of size above the exclusion limit of porins (≥ 600 Da). The molecule of interest is 
rapidly added to the liposome in an isotonic solution and the optical density of the mixture is 
measured to assess the permeability of the molecule (Figure 1.6). The assay provides a 
comparative rate for the diffusion of different sized solutes through one porin or different porin 
channels. The LSA diffusion studies with E. coli OmpF/C not only determined the size-exclusion 
limit of solutes but also demonstrated the preference of the channels for cationic molecules over 
the anionic counterparts (Nikaido and Rosenberg 1981 and Nikaido and Rosenberg 1983).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. Schematic representation of the liposome swelling assay.  
The substrate (or molecule) of interest is added to multilamellar liposomes (prepared in the 
presence of stachyose sugar; yellow circle). (A) If the molecule is unable to permeate through the 
porin channels, the optical density remains unchanged. (B) Upon permeation of the molecule, an 
osmotic gradient is created resulting in the influx of water molecules and swelling of the 
liposome. (C) Ultimately, water influx bursts the liposome and releases the sugar (stachyose), 
hence decreases the optical density. From Pages et al., 2008. 
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Electrophysiological techniques have been used for more than 30-40 years to study the 
functional aspects of pore-forming outer membrane proteins. Its contribution to understanding the 
nature of structure-function relationship in porins has been particularly significant. In lipid 
bilayer electrophysiology, the current traces through porins exhibit an open state allowing the 
passage of ions through their channels and may show the closing of the channel in three steps, 
also known as trimeric gating, where each step represents the closure of a monomer in the trimer. 
An important functional feature associated with their ion current traces as established by the 
initial lipid-bilayer studies of OmpF/C porins is the ohmic dependence, according to which the 
channel conductance is directly proportional to the applied voltage (Delcour 1997). 
Electrophysiology provided the first direct evidence of solute interaction with the channel in the 
form of discreet downward transitions in ion current traces. The zwitterionic molecules of various 
compounds induced current blocking events in the ion current traces of OmpF, implying the 
presence of low-affinity binding sites that may (or may not) result in the translocation through the 
porin channel (Danelon et al., 2006 and Mahendran et al., 2010).  
 
The characteristic folding of loop L3 inside the barrels of OmpF/C inspired several 
studies to determine the role played by L3 charged residues in solute translocation (also see 
section 1.5.1). The loop L3 certainly imposes the size exclusion limit on the solute for its 
translocation through porins, but its charged residues also contribute towards the effective charge 
inside the channel. Molecular dynamics simulations in combination with electrophysiology 
studies have also shown that the negatively charged residues of L3 along with the positively 
charged barrel wall create a transverse electric field at the constriction region which is strong 
enough to orient water molecules (Im and Roux 2002a, b) and charged dipolar molecules inside 
the channel (Bajaj et al., 2017 and Acosta-Gutierrez et al., 2015). The data from multiple single 
channel studies showed the mutants of key charged residues of the eyelet region affected the 
influx of solutes (Lou et al., 2011 and Bajaj et al., 2016). A report recently showed that the 
mutations of the charged residues inside the OmpC pore, apart from the CR, affected the 
permeation profiles of zwitterionic carbapenems (Bajaj et al., 2016).  These OmpC mutants with 
similar pore size (or ion-conductivity) posed altered internal electric fields which resulted in quite 
drastic variations in the flux of meropenem and imipenem molecules (Lou et al., 2011 and Bajaj 
et al., 2016).  
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The preference for the permeation of cations (over anions) is another factor that comes 
into play during ion diffusion through the porin channels. The selectivity of a channel is a 
measure of anion-cation permeability ratios as calculated by the Goldman-Hodgkin-Katz (GHK) 
equation (Hille 2001; see section 2.10.1.1) such that cation selectivity for a channel implies an 
effective anionic surface charge of the channel interior and vice versa for an anion selective 
channel (Alcaraz 2009). The intrinsic properties of the ions or the hydrophilic solute like the 
shape, size, charge and electromobility also play an important role during its diffusion through 
the channel. For example, in KCl solutions (when K
+
 and Cl
-
 have equal ion permeabilities in 
solution) OmpF channel shows weak selectivity for the monovalent cations (K
+
) that changes to 
anionic selectivity in solutions of multivalent cations (Alcaraz 2009). The observed anionic 
selectivity in the latter case may be due to the negative charge (over) compensation of the OmpF 
channel or the difference in the ionic mobilities of the counter-ions of the electrolyte (Alcaraz 
2009). Another factor determining the ion-diffusion process is the charged environment in the 
channel which is liable to be affected by the external pH. Low pH can cause protonation of acidic 
residues (in loop L3) of the OmpF channel that may result into an anion-selective channel 
(Nestorovich et al., 2003 and Aguilella-Arzo et al., 2007).  
Thus, solute translocation through a channel is not only dependent on its pore size but may be 
defined as interplay between the pore size, ionic selectivity and electrostatic properties of the 
channel. In addition, the overall electrostatic properties of the diffusing ion and the channel, 
collectively enact to achieve translocation.  
 
1.3.2.  Passive channels: Substrate-specific  
The substrate-specific channels, as the name indicates, shows specificity for the passive 
uptake of a particular substrate. Such passive uptake of the substrate is facilitated through the 
process of diffusion that in turn is dependent on concentration differences across the OM.  The 
substrate specific channels possess binding sites which aid the influx of a particular substrate that 
is not abundant in the cell exterior. As a result, substrate-specific channels can efficiently drive 
the diffusion of substrates which maintain low concentration gradients across the OM. 
 
In Enterobacteriaceae, LamB (or maltoporin) is an excellent example of a substrate-
specific protein from E. coli that was initially reported to transport disaccharide (maltose) or as 
polysaccharide (maltodextrin) sugars (Nikaido and Vaara 1985) but following structural evidence 
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of LamB bound to sucrose (Wang et al., 1997), it is since established as a carbohydrate-specific 
channel (Nikaido 2003).  ScrY (or sucrose channel) in Salmonella typhimurium is a LamB 
ortholog and a specific channel for many sugars (Forst et al., 1998). Except for few differences 
(Nikaido 2003), the two sugar-specific channels (LamB and ScrY) exhibit similar structural 
features. Both LamB and ScrY exist as trimers in the OM where each monomer is an 18-stranded 
β-barrel (Schirmer et al., 1995 and Forst et al., 1998). Both channels show characteristic folding 
of loop L3 inside the barrel that constricts the pore mid-way (Figure 1.7). The ‘greasy slide’ 
along the channel wall is created by 6 aromatic residues and forms binding sites for the pyranose 
rings of sugar to allow its passage (through hydrophobic and polar interactions) across the OM 
(Schirmer et al., 1995 and Forst et al., 1998).  
 
The OM channel devoted to uptake phosphates or phosphate bearing compounds in 
Enterobacteriaceae is PhoE. The phosphate-specific channels of PhoE from E. coli (Cowan et al., 
1992) function as trimers of 16-stranded β-barrels, with each barrel constricted inside by folding 
of loop L3. The specific-channels that are employed for the uptake of nucleosides and 
deoxynucleosides utilise the Tsx family of proteins in Gram-negative bacteria. Tsx is a 
monomeric 12-stranded β-barrel with a ‘key-shaped’ pore lined by 5 aromatic residues important 
for the substrate binding (Ye and Van den Berg 2004).  
 
 
 
 
 
 
 
 
Figure 1.7. Structure of LamB.  
The cartoon of a carbohydrate-specific channel of E. coli, LamB, forming a homotrimer in the 
OM. Each monomer is an 18-stranded β-barrel with loop L3 folded inside, constricting the 
channel. 
 
1.3.3.  Active OM transporters 
The high-molecular weight OMPs that utilise energy to translocate the substrates across 
the OM are classified as active OM transporters. TonB-dependent transporters (TBTDs) form 
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gated channels to mediate active transport of very large substrates like iron-siderophore 
complexes, vitamins etc. The interior of TBTDs β-barrel is capped with an N-terminal plug and 
the transport of compounds through TBTDs is dependent on a complex of three inner membrane 
proteins (TonB-ExbB-ExdD) and derives its energy from the proton-motive force (Gumbart et 
al., 2007 and Schauer et al., 2008). The iron uptake is the most-studied system in E. coli for 
which FhuA (Ferguson et al., 1998 and Locher et al., 1998) and FepA (Buchanan et al., 1999) 
serve as classic examples of TBTDs by forming dedicated pathways for the transport of iron-
siderophore complex (FhuA: ferrichrome, FepA: entrobactin). As shown through crystallography, 
these two proteins form 22-stranded β-barrel with a globular N-terminal plug domain and 
exemplify the architectural fold of TBTDs (Figure 1.8). TBTDs solved to date show this same 
architectural domain (Noinaj et al., 2010). The most common mechanism believed to cause the 
translocation of the substrate involves a ‘pulling’ effect, exerted by the periplasmic domain, of 
TonB protein (anchored to the IM) on the TonB box of the plug domain (Devanathan and Postle 
2007 and Shultis et al., 2006). It is speculated that TonB mediated pull somehow delocalises the 
plug causing its release from the barrel (Ma et al., 2007) or possibly a conformational change 
(Pawelek et al., 2006) that facilitates the substrate-transport. Apart from the ones involved in 
iron-transport, other TBTDs that function for the uptake of nickel (Schauer et al., 2007), Vitamin 
B12 (Cherezov et al., 2006), disaccharides (sucrose: Blanvillain et al., 2007) or polysaccharides 
(SusC: Reeves et al., 1996), colicins (Buchanan et al., 2007 and Devanathan at al., 2007) have 
also been identified.   
 
 
 
 
 
 
 
 
 
Figure 1.8. Structure of FhuA.  
The X-ray structure of FhuA in E. coli is shown as a rainbow cartoon (N-terminus in blue to C-
terminus in red). It is formed by 22 antiparallel β-strands forming the transmembrane barrel while 
the first 160 residues of N-terminus function as the plug domain inside the barrel. The cartoon 
figures were made using PyMol (Schrodinger 2010) with the PDB codes 1BY3.  
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1.4. Export channels 
The impermeable bilayer of Gram-negative bacteria must provide a route for the 
expulsion of toxic or waste compounds, a task that is well accomplished by outer-membrane 
export channels as a part of the efflux pumps.  Efflux pumps enact as a defence weapon for 
Gram-negative pathogens against toxic compounds such as antibiotics and thus are one of the 
major causes of multi-drug antibiotic resistance. Of all multi-drug efflux systems, RND 
(Resistance-Nodulation-Division) family of transporters form tripartite complexes across the cell 
wall of Gram-negatives, traversing the OM and the inner membrane. RND transporters utilise the 
electrochemical potential of protons, i.e., the proton motive force (PMF), to drive the substrate-
transport processes (Yamaguchi et al. 2015). RNDs are composed of three essential components: 
an ABC-type transporter (ABC) in the inner membrane, a Membrane Fusion Protein (MFP) 
spanning the periplasmic region and an Outer Membrane Factor (OMF) localised in the OM 
(Zgurskaya et al., 2011). The proteins of OM that are involved in the efflux systems belong to 
Outer membrane Efflux Protein (OEP) family. TolC protein is one such OEP in E. coli that 
functions as an OMF channel in complex with different types of efflux systems (Federici et al., 
2005). TolC presents a unique 140 Å long structure that extends from the OM to the periplasm 
and contrasts with the typical β-barrels of OMPs (Koronakis et al., 2000). The first domain of 
TolC is a trimer of 12-stranded β-barrel, constituted by the oligomerisation of three protomers, 
each contributing 1/3
rd
 of the β-barrel domain.  The second and third domains of TolC, 
comprising α-helical and mixed α/β motifs respectively, extend into the periplasmic space. OprM 
in Pseudomonas aeruginosa (Koronakis et al., 2000) and VceE in Vibrio cholerae (Akama et al., 
2004) are TolC-like OEPs that form OM channels (or OMF) for multi-drug efflux systems in 
other bacteria.  
 
1.5.  Exploitation of porins for antibiotic permeation 
Multidrug resistance in Gram-negative pathogenesis is an impending global threat. The 
Gram-negative pathogens from the extended-spectrum β-lactamase (ESBL) producing 
Enterobacteriaceae family account for an enormous subset of multi-drug resistance, a majority of 
which include E. coli, Vibrio cholerae, Salmonella spp., Shigella spp., Enterobacter spp., 
Enterococcus spp. and Klebsiella spp. (Paterson et al., 2005). The efficiency of multi-drug-
resistance in Gram-negative bacteria is particularly owed to three main factors (Pages et al., 
2008) : a) Influx: the inability of the drug to efficiently and quickly cross the OM, b) Periplasmic 
enzymes, the presence of bacterial β-lactamases that immediately degrade the antibiotic 
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molecules that reach the periplasm and render them inactive before traversing the IM, and c) 
Efflux, the export of drug molecules via multidrug efflux pumps.  
 
The first line of defence in Gram-negative bacteria is provided by its asymmetric outer 
membrane bilayer which restricts the influx of antibiotics. For an antibiotic to be effective, it 
must cross the OM efficiently. Hydrophobic antibiotics like macrolides and rifamycins utilise the 
lipid-mediated pathway whereas hydrophilic antibiotics like β-lactams are transported inside the 
cell by the porin channels of the OM (Delcour 2009). Some other compounds like tetracycline 
and quinolones utilise both lipid-mediated and porin-mediated pathways for the transport across 
the OM (Delcour 2009).  
 
1.5.1.   Porin-mediated pathway for drug translocation 
The β-lactams and fluoroquinolones are the most commonly used antibacterial agents 
against the majority of infections. The evidence for the interaction of porin channels with the β-
lactams like penicllins (Danelon et al., 2006 and Mahendran et al., 2010), cepahalosporins 
(Mahendran et al., 2010), carbapenems (Bajaj et al., 2016 and Bodrenko et al., 2015) and 
fluoroquinolones (Mahendran et al., 2010 and Bodrenko et al., 2015) have been mostly provided 
through single channel electrophysiology. An early study showed the transient current blocking 
events in the OmpF ion-traces upon the addition of zwitterionic molecules of ampicillin and 
amoxicillin but not in the presence of mono-anionic (piperacillin) or di-anionic (carbenicillin) 
compounds (Danelon et al., 2006). Based on the liposome diffusion data (Yoshimura and Niakido 
1985) and molecular simulation studies (Danelon et al., 2006), it was proposed that the 
zwitterionic molecules produce current blocking events because they are able to interact with the 
residues of the constriction region (CR) and as a result possess high diffusion rates in comparison 
to anionic molecules.  
 
Molecular dynamics simulations in combination with electrophysiology and liposome 
swelling data also provide experimental evidence for the porin-antibiotic interaction. These 
studies have demonstrated that mutations of the charged residues inside the channel affect the 
flux of β-lactams (Delcour 2009). The mutated key charged residues of the OmpF constriction 
eyelet, like D113N (or R132A), were shown to exhibit more channel-closing events with 
ampicillin than the wild type, implying its high susceptibility for the influx of antibiotic as seen 
in the liposome assays (Hajjar et al., 2010). Molecular modelling studies have demonstrated 
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D113A mutants of OmpF to be increasingly susceptible to ampicillin, ceftozidine and ceftazidime 
(Vidal et al., 2005) because these OmpF mutants will let pass such molecules. In contrast to 
mutating charged residues, several earlier studies have also shown that mutations of uncharged 
residues in the channel may also affect the influx of substrates with respect to the wild type 
(Delcour 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9. OmpF bound to antibiotics.  
The crystal structures of OmpF bound to ampicillin (A) and carbenicllin (B) are shown in cartoon 
(left panels) and surface views (right panels). The middle panels show the OmpF residues making 
interactions with the bound antibiotic. From Ziervogel and Roux, 2012 (PDB codes 4GCP and 
4GCQ). 
 
X-ray crystallography provided the molecular evidence for the porin-mediated pathway 
for zwitterionic antibiotics. The binding sites of ampicillin, carbenicllin and ertapenem were 
revealed in recent reported crystal structures of OmpF (Ziervogel and Roux 2013). The ampicillin 
zwitterion was observed bound just above the constriction zone, aligned perpendicular to the 
diffusion axis and explaining the reason for causing current blockages in the OmpF channel 
(Figure 1.9). Carbenicllin was observed close to the barrel wall bound weakly in the periplasmic 
vestibule region (Figure 1.9) and oriented in a direction parallel to the diffusion axis such that its 
binding in the channel does not occlude the pore. However, the B-factor values of ampicillin and 
carbenicllin were ~25% higher than the neighboring protein residues (Ziervogel and Roux 2012), 
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which suggests low occupation of the bound molecules and possibly, their multiple 
conformations inside the OmpF channel. 
 
1.5.2.   Porin-mediated antibiotic resistance 
Since many antibiotics utilise a porin-mediated pathway for translocation, the bacterial 
resistance in multiple cases is linked to the functional modulation or loss of porins. E. coli, 
Enterobacter spp. and Klebsiella spp. are examples that have shown antibiotic resistance due to 
the reduced influx of the compounds through porins (Pages et al., 2008). The porin-linked 
resistance mechanisms in gram-negative bacteria may involve loss of porin function or loss of its 
copy number due to altered expression (Figure 1.10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10. Porin-mediated mechanisms of bacterial resistance.  
The schematic representation of a Gram-negative cell with β-lactams shown as blue circles and 
porin trimers as pink cylinders in the OM. The straight arrows represent the uptake of β-lactams; 
thickness reflecting the level of penetration and curved arrows indicate the failure to permeate the 
OM through porins. From Pages et al, 2008. 
 
The loss of porin function may involve some mutations that can affect the permeability of 
the porin channels. For example, clinical isolates of Enterobacter aerogenes were characterised 
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with a G112D mutation in Omp36 porin that provides the bacterium high levels of β-lactam 
resistance (Domenech-Sanchez et al., 1999). Similarly, the multidrug resistant species of 
Neisseria gonorrhoeae were found to have multiple mutations in the loop L3 of PorA 
(Domenech-Sanchez et al., 1999).  
 
Porins can alternatively have varied expression profiles during antibiotic attack that may 
confer resistance. As observed for the altered porin regulation induced by osmotic pressure or 
acidic pH (also see section 1.4.1), the antibiotic stress may involve transcriptional repression of 
the porin channels with wide pore sizes and instead activate the expression of narrow-sized 
porins. For example, tetracycline causes an increase in the micF levels that repress OmpR 
mediated expression of OmpF channel and activates OmpC expression (Viveiros et al., 2007). 
Likewise, the porin-null strain of K. pneumoniae expresses OmpK37 porin and has drastically 
reduced susceptibility to β-lactams as compared to the wild type strain that expresses OmpK35 
and OmpK36 porins (Pages et al., 2008).  
 
1.6.  The Gram-negative pathogens of this project 
 
1.6.1.  Vibrio cholerae 
V. cholerae is a motile rod-shaped pathogen from the Vibrionaceae family of Gram-
negative bacteria and resides in marine or aquatic environments. The pathogen enters the human 
gut through ingestion of contaminated food or water resources and colonises the mucosal surface 
of the small intestine. After colonisation, the pathogen releases cholera toxin that is responsible 
for causing the severe intestinal infection in humans known as cholera.  
 
1.6.1.1. Overview of Cholera as a disease 
Cholera infection involves an acute diarrhoea characterised by profuse watery stool 
leading to rapid dehydration in the patient. The infection accompanies vomiting and acidosis in 
the patient. In majority of the cases, the failure of detecting the infection in time results in death. 
The infection is spread easily and rapidly in areas of poor treatment of sewage, inadequate 
sanitation facilities, improper hygienic conditions and contaminated water resources (ponds and 
lakes). According to the Centres for Disease Control and Prevention (CDC), sub-Saharan Africa 
(Ethiopia, Nigeria, Tanzania, Kenya) is the prime region affected with majority of cholera cases 
and with outbreaks each year from 2001-2012 (Figure 1.11). Southeast Asia is the foremost 
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region to have the largest population at risk for cholera, of which the nations with more than 
100,000 cases annually include India and Bangladesh (Ali et al., 2015; Figure 1.11). Cholera has 
very recently (2017) caught the world’s attention again through the recent and ‘unprecedented’ 
epidemic in Yemen causing more than 100,000 cases according to the WHO and UNICEF. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11. Cholera cases reported to WHO by continent from 1989-2016.  
From the World Health Organisation (WHO) 2017. 
 
Rehydration and antibiotics are the two primary methods for the treatment of cholera. 
Rehydration therapy involves extensive intake of fluids and salts to restore the loss of 
dehydration in the human body. The rehydration is often accompanied by antibiotic therapy to 
reduce the illness and control the dehydration in the patients. Tetracyclines and quinolones are 
widely employed during the infection to control the severity of the symptoms. From tetracyclines, 
doxycycline is most important antibiotic provided to infected adults and azithromycin for 
pregnant women (or children). According to WHO, the global efforts to control the resurgence of 
cholera have also included the development of effective oral cholera vaccines that have been 
successfully used in various outbreaks and humanitarian emergencies. 
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1.6.1.2.     OMPs of Vibrio cholerae  
Seven major outer membrane proteins have been reported in V. cholerae that include the 
45 kDa maltoporin OmpS (like LamB of E. coli), 25 kDa immunogenic protein OmpV, 35 kDa 
OmpA-like protein, 27 kDa trypsin-resistant OmpX (Simonet et al., 2003) and 22 kDa heat 
modifiable OmpW (Nandi et al., 2005). The other two major outer membrane proteins of V. 
cholerae, OmpU and OmpT, form hydrophilic non-specific channels across the OM and are thus 
classified as porins. The proteins OmpU and OmpT are the most-studied OMPs of V. cholerae 
and the literature investigating their expression, regulation and function dates back more than 30 
years. The preliminary characterisation of OmpU/T proteins as non-specific porins was 
performed using liposome swelling assays (Chakarbarti et al., 1996).  
 
The proteins OmpU/T of V. cholerae are regulated by a transmembrane DNA-binding 
protein, ToxR. Being localised in the inner membrane, ToxR comprises a cytoplasmic domain 
and a periplasmic domain. The cytoplasmic domains of ToxR and OmpR (of E. coli) share 30% 
homology and thus ToxR belongs to OmpR family of transcriptional factors. ToxR has been 
shown to activate the expression of OmpU (Crawford et al., 1998) and repress the expression of 
OmpT (Miller et al., 1988 and Li et al., 2000). The porin regulator acts at the transcription level 
for the expression (of ompU) or repression (of ompT) by binding to the upstream regions of their 
promoters (Crawford et al., 1998 and Li et al., 2000). To activate the ompU promoter, ToxR 
binds to the upstream region and through co-operative binding (protein-protein interaction) 
interacts with other ToxR proteins (Crawford et al., 1998). For OmpT repression, ToxR binds 
upstream of the ompT promoter and represses its activation by interfering with the interaction 
between the activator(s) and RNA polymerase (Li et al., 2000). ToxR-mediated reciprocal 
regulation of OmpU/T porins is thus similar to OmpR-mediated regulation of OmpF/C porins in 
E. coli (also see section 1.4.1) except for the phosphosignalling mechanism which is absent in the 
porin regulation of V. cholerae. Apart from porin regulation, ToxR with the help of other 
membrane proteins like, ToxS, TcpP and TcpH, activates the expression of a transcriptional 
activator ToxT (Li et al., 2000). The expression of ToxT is required for the expression of 
virulence factors of V. cholerae: cholera toxin (CT), toxin co-regulated pilus (TCP) and accessory 
colonisation factor (ACF) (Li et al., 2000 and Klose 2007). Hence, ToxR plays a prime role in the 
virulence properties of V. cholerae by directly regulating porin expression and indirectly 
regulating the virulence genes expression.  
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The effect of bile on the V. cholerae cells was first demonstrated by Provenzano et al., 
2000 who reported reduced growth rates for the toxR mutant strains of V. cholerae in the 
presence of the bile component deoxycholate (Provenzano et al., 2000). The study demonstrated 
bile-induced activation of OmpU implying bile-resistant property of OmpU (in OmpT null 
background) while OmpT expression (in OmpU null background) proved deleterious for the 
expression of virulence factors in vitro (Provenzano and Klose 2000). Another study showed that 
the presence of bile did not affect the antibiotic flux in V. cholerae cells expressing only OmpU 
but that flux was reduced (~70%) in cells expressing only OmpT (Wibbenmeyer et al., 2002). 
These studies indicated different behaviours of OmpU/T channels in response to bile but direct 
evidence of a bile effect on V. cholerae was provided through the single channel studies of 
OmpU and OmpT with deoxycholate (Duret and Delcour 2006). The deoxycholate clearly 
induced channel-blocking single-step closures (SSC) in the ion-current traces of OmpT but did 
not affect the ion current traces of OmpU (Duret and Delcour 2006). This illustrates the 
interaction of deoxycholate with OmpT which in turn could imply that OmpT allows the 
permeation of bile components (like deoxycholate). In contrast, bile may not permeate through 
OmpU porin and as a result, OmpU plays a protective role in the virulence and survival of V. 
cholerae cells in the small intestine of humans where bile is the principal component of the 
intestinal fluid (Wibbenmeyer et al., 2002).  
 
1.6.1.3.     Antibiotic resistance in Vibrio cholerae  
The past 10-15 years have seen a significant increase in the number of drug-resistant 
strains of V. cholerae, reported worldwide. The resistance against antibacterial compounds is 
very broad and ranges from penicillins, fluoroquinolones, macrolides, aminoglycosides to 
tetracyclines (Kitaoka et al., 2011). The antibiotic resistance in V. cholerae has been elaborated in 
a review by Kitaoka et al., 2011 and is linked to several intrinsic mechanisms of the bacteria that 
involve spontaneous mutations, presence of active multi-drug efflux pumps and through the 
transmission of mobile genetic elements or conjugative plasmids. However, porin-mediated 
resistance in V. cholerae has not been observed yet. 
 
1.6.2.  Enterobacter cloacae and Klebsiella pneumoniae 
The Enterobacteriaceae family of Gram-negative bacteria includes two common 
nosocomial pathogens, namely Enterobacter cloacae and Klebsiella pneumoniae. Both are 
facultative anaerobes that are ubiquitous in nature. E. cloacae is present in the intestinal tract of 
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humans (and animals) and causes opportunistic infections of urinary tract, septic arthritis, 
respiratory and abdominal systems. K. pneumoniae is also an opportunistic pathogen that resides 
in the human intestine and is responsible for causing pneumonia, meningitis and other infections 
in blood, urinary tract or wounds. The outbreaks caused by E. cloacae and K. pneumoniae have 
also been reported in hospital surgical units and neonatal units (Pages et al., 2008). Most of the 
multidrug resistant (MDR) clinical isolates of E. cloacae and K. pneumoniae have been isolated 
with extended spectrum β-lactamases (ESBL) and carbapenemases.  In fact after E. coli, E. 
cloacae and K. pneumoniae are the two most notorious Enterobacteriaceae species that are 
responsible for causing nosocomial infections and hence are included in the list of ESKAPE 
pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumanii, Pseudomonas aeruginosa, and Enterobacter spp) (Rice 2009). 
 
The major porins present in E. cloacae are OmpE35 and OmpE36 (previously 
characterised as F and D proteins, Lee et al., 1992) and are considered structural and functional 
homologs of OmpF and OmpC respectively, of E. coli. The porins OmpE35/E36 have been 
minimally investigated for the effect of antibiotics (Lee et al., 2012) and scarce experimental data 
exists to show that carbapenem resistant strains of E. cloacae lack porins (Raimondi et al., 1991). 
However, MDR strains of Enterobacter aerogenes have been reported in several studies to have 
altered expression profiles of porins (Omp35 and Omp36; Davin-Regli and Pages 2015).  
 
In K. pneumoniae, OmpK35 and OmpK36 are the two major porins present in the OM 
and are homologs of E. coli OmpF and OmpC (Doménech-Sánchez et al., 2003 and Alberti et al., 
1995). There have been a significant number of studies linking the antibiotic resistance in K. 
pneumoniae to the deficiency of OmpK35/K36 porins (Zhang et al., 2014, Tsai et al., 2011 and 
Shin et al., 2011). However, quite recently a report assessed the diffusion properties of OmpK35 
and OmpK36 porins with β-lactams (Sugawara et al. 2016). The report concluded that one of 
resistance mechanisms in K. pneumoniae may involve altered porin expression profile (i.e. 
downregulation of OmpK35 and upregulation of narrow channels of OmpK36 to restrict the drug 
influx) (Sugawara et al. 2016). 
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1.7.  Aims of the project 
 
The PhD is affiliated to the ‘ND4BB’ (New Drugs for Bad Bugs) initiative undertaken by 
the Innovative Medicines Initiative (IMI). IMI is a partnership between the European Union 
(represented by the European Commission) and the European pharmaceutical industry 
(represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). 
The current PhD project is a part of ‘TRANSLOCATION’, a component of the ND4BB platform 
that is aimed to determine the antibiotic influx/efflux mechanisms through outer membrane 
proteins of Gram-negative pathogens in order to aid in drug discovery strategies.  
 
In order to contribute towards the understanding of antibiotic permeation mechanism 
through the porins of Gram-negative bacteria, the major porins from three different Gram-
negative pathogens were targeted for the study. These include Vibrio cholerae porins OmpU and 
OmpT (and their mutants OmpUΔN and OmpTΔL8), Enterobacter cloacae porins OmpE35 and 
OmpE36 and Klebsiella pneumoniae porin OmpK36. The target proteins were recombinantly 
expressed in E. coli and purified in high amounts (Chapter 3). The 3D structures of the proteins 
were determined through crystallisation and X-ray diffraction (Chapter 4). In addition, we 
performed electrophysiological studies to study the effect of antibiotics on OmpU/T porins 
(Chapter 5).  For comparing the antibiotic permeation through the diffusion channels, different 
in vitro assays such as the liposome swelling and disc-diffusion assays were conducted with 
OmpU/T, OmpE35/E36 and OmpK35/K36 proteins in the presence of different antibiotics 
(Chapter 5).  
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Chapter 2. Materials and Methods 
 
2.1. Molecular Biology Reagents  
2.1.1.  Chemical suppliers 
All chemicals and molecular biology reagents were purchased from Sigma Aldrich or 
Thermo Fischer Scientific, unless stated otherwise. The amino acids were purchased from 
Formedium, while the antibiotics were purchased from Carbosynth Limited and Melford 
Laboratories Limited. The detergents used for the research were purchased from Anatrace. The 
enzymes and DNA/gel extraction kits were purchased from New England Biolabs (NEB) and 
Qiagen respectively.  
 
2.1.2.  Buffers and solutions 
The buffers of HEPES and Tris were made in deionized water from HEPES acid powder 
and Trizma base powder respectively. The pH values of the HEPES-based buffers were adjusted 
using sodium hydroxide (NaOH) or potassium hydroxide (KOH), while Tris-based buffers were 
pH adjusted with hydrochloric acid (HCl). All the buffers and reagents were made in deionized 
water. 
 
2.1.3.  Growth media 
All the bacterial cultures were grown in Luria Broth liquid media (LB broth; composition 
given in Table 2.1) and LB solid media, prepared with 1.5% agar, was used for overnight 
incubation of bacterial cells. For Selenomethionine-substituted protein expression, LeMasters-
Richards (LR) medium (mixture of buffer and salts) was used for the bacterial growth 
(components of LR buffer and LR salts are listed in Table 2.1). Depending on the type of plasmid 
construct used, the antibiotic solutions of Ampicillin (100 µg/ml) and Kanamycin (50 µg/ml) 
were added to growth media whenever required. The stock solutions of antibiotics (Amp: 100 
mg/ml and Kan: 50 mg/ml) were stored at -20°C for a month and diluted 1:1000 in the media, 
whenever required. 
 
2.2. Bacterial strains and vectors 
A list of bacterial strains and plasmid vectors used in the study are detailed in Table 2.2 and 
Table 2.3 respectively.  
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Table 2.1. Growth media composition and description for use in the study. 
Growth Medium Components (per litre) Description  
Luria-Bertani (LB)  25 g LB granules as supplied (Sigma-
Aldrich; Composition: 10 g/L 
Tryptone, 5 g/L Yeast Extract, 5 g/L 
NaCl 
Rich media for E. coli. 
Dissolved in H2O and pH 
adjusted to 7.2 with 
NaOH. Autoclaved before 
use. 
LeMasters-Richards 
(LR) media 
LR salts 
(100X per 
litre) 
167.5 g (NH4)2SO4 
30 g MgSO4.H2O 
300 mg FeSO4.7H2O 
1 ml conc. H2SO4 
Minimal media for 
producing Seleno-
methionine-substituted 
protein by inhibition of the 
methionine biosynthesis 
pathway in E.coli (Van 
Duyne et al., 1993) 
Salts and media 
autoclaved separately. The 
Glucose and salts added 
immediately before 
inoculation. 
LR buffer 
(per litre) 
24 g KH2PO4 
1 g NaOH 
0.25-3 g glycerol (5-6 
ml of a 50% w/v 
solution) 
100X  
AA stock 
(filter 
sterilized and 
stored at 4°C) 
5 g each of: 
Lys/Phe/Thr 
2.5 g each of : 
Leu/Ile/Val 
0.06% w/v seleno-
methionine 
2×YT (MgSO4) 
media 
16 g Tryptone 
10 g Yeast extract 
5 g NaCl 
2 mM MgSO4 
Nutrient-rich media for E. 
coli growth, containing 
double the concentration 
of yeast extract compared 
to LB media. 
Magnesium supplemented 
in the media increases the 
cell biomass (Webb 1949) 
 
 
Table 2.2. List of E.coli strains used for the study 
 
Bacterial 
strain 
Genotype Source Description 
DH5α fhuA2 Δ(argF-lacZ)U169 
phoA Φ80Δ (lacZ)M15 
gyrA96 recA1 relA1 endA1 
thi-1 hsdR17 
New England 
Biolabs 
(NEB) 
General strain of E. coli 
routinely used for cloning 
(Hanahan 1983). 
Bl21(DE3) F
-
 dcm ompT hsdS(rB- mB-) 
gal (DE3) 
 
 
Van den 
Berg lab 
(Newcastle 
University, 
UK) 
Optimised for protein 
expression using a T7 
promoter. Routinely used to 
over-express recombinant 
proteins (Studier and Moffat 
1986). 
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omp8 Bl21 
(DE3) 
Bl21(DE3), ΔlamB ompF: 
:Tn5 ΔompA ΔompC 
Lab of 
Mathias 
Winterhalter 
(Jacobs 
University, 
Bremen) 
Porin deletion strain of E. 
coli. Lacks major porins 
OmpF and OmpC, in addition 
to other OMPs like OmpA 
and LamB (Prilipov et al., 
1998) 
  
 
Table 2.3. List of the plasmids used in the study 
 
Plasmid 
Size 
(kbp) 
Supplier Description 
pBAD24 4.5 
Van den Berg 
lab (Newcastle 
Univeristy, UK) 
Bacterial expression vector with pBAD promoter 
under tight regulation by arabinose operon 
(araBAD). Ampicillin resistance. (Guzman et al., 
1995) 
pET28a 5.4 Novagen 
T7 promoter, lac operator, laciq, multiple cloning 
site with integrated N- and C- termnial 6×His-tag. 
Kanamycin resistance. 
 
 
2.3. Cloning 
The targeted protein genes were cloned into pBAD24 plasmid for membrane expression 
using NcoI and XbaI restriction sites.  Nucleotide sequences of target protein without the signal 
sequences were cloned into pET28a plasmid for inclusion body expression using NcoI and XhoI 
restriction sites. For cloning in pET28a, an additional glycine (Gly) residue was added between 
the NcoI restriction site (CCATGG) and the start codon.  
 
2.3.1.  Polymerase Chain Reaction (PCR) 
The nucleotide sequences of the target proteins were amplified using PCR (Mullis et al., 
1986).  The primers of 20-30 base pair length were designed using the 5’ and 3’ of the target 
DNA sequence and manufactured from Eurofins genomics (Wolverhampton, UK). For primer 
design, the online tool software ‘Oligo Calc 
(http://biotools.nubic.northwestern.edu/OligoCalc.html)’ was used to ensure the proper melting 
temperature (Tm ≥ 50°C) and avoid self- or cross -complementarity of the primers. Following the 
first two steps in PCR, i.e. denaturation and primer annealing, the final step of target DNA 
amplification was achieved using a thermostable DNA polymerase that synthesises and extends 
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the new DNA complementary strands based on the source template. The online software of NEB 
Tm calculator was used to get an estimate of the annealing temperature (Ta) required for the PCR. 
 
2.3.1.1.  Standard PCR 
The standard PCR mixture was prepared on ice and comprised of the reagents listed in 
Table 2.4. The conditions for a standard PCR reaction used in a thermocycler are described in 
Table 2.5.  
 
Table 2.4. Reagents used in a standard PCR 
Reagents (stock) 
Volume used from the stocks 
(Amount per reaction) 
Forward primer (10 µM) 2.5 µl ( 0.5 µM) 
Reverse primer (10 µM) 2.5 µl (0.5 µM) 
deoxy nucleotide triphosphates (dNTPs; 10mM) 1 µl (200 µM) 
Target DNA template 2 µl (50-100 ng) 
PCR Buffer (5×) 10 µl (1×) 
Phusion polymerase 0.5 µl (0.5 units) 
Autoclaved H2O 31.5 µl 
Total volume 50 µl 
 
Table 2.5. Conditions used for standard PCR 
 
Step Temperature (ᴼC) Duration Number of cycles 
Initial Denaturation 98 5 minutes 1 
Denaturation 98 10 seconds 25 
Annealing* 55 - 65 30 seconds 25 
Amplification
ᵻ
 72 40 seconds 25 
Final Extension 72 4 minutes 1 
*Annealing temperature can be varied depending on the melting point of primers used. 
ᵻ 
The extension rate for phusion polymerase is 45 seconds per kilo-basepair (kbp). Hence, 40 seconds was used for 
the amplification of sequences below 1 kbp.   
 
The amplified DNA products from standard PCR were analysed by agarose gel (also see section 
2.3.2).  
 
2.3.1.2. PCR for Site directed mutagenesis (SDM) 
Site directed mutagenesis (SDM) is an in vitro technique that uses custom-designed primers 
to create selected single or multiple amino-acid mutations (insertions or deletions) in a double-
stranded DNA plasmid. The Q5 Site-Directed Mutagenesis kit (Q5 kit) from NEB was used to 
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create deletion or insertion constructs of target sequences via SDM. In this study, site directed 
mutagenesis was used to create: 
 
 N-terminus deletion construct (Δ10 amino acids) of pBAD24 OmpU (OmpU ΔN)  
 Loop deletion construct (Δ16 amino acids) of pBAD OmpT (OmpT ΔL8)  
The protocol for Q5 site-directed mutagenesis involved the following two steps. 
Step 1 The initial step was to amplify the targeted gene sequence with the custom designed 
primers (flanking the DNA region to be deleted/inserted). The PCR was done using standard PCR 
methodology (Table 2.5) with the reagents listed in Table 2.6. Since the amplified regions were 
approximately around 6 kbp, the amplification time was set to 3.5 minutes based on the extension 
rate of Q5 Hot Start High-Fidelity DNA polymerase (~20-30 kbp/second). 
 
Table 2.6. PCR reagents for SDM  
Reagents (stock) 
Volume used from the stock 
(amount used) 
Q5 Hot Start High-Fidelity Master Mix 
(2×) 
12.5 μl (1×) 
Forward primer (10 μM) 1.25 μl (0.5 μM) 
Reverse primer (10 μM) 1.25 μl (0.5 μM) 
Template DNA (25 ng/μl) 1 μl (25 ng) 
Autoclaved H2O 9 μl 
Total Volume 25 μl 
 
Step 2 The amplified DNA product was incubated with a unique enzyme mix containing a 
kinase (K), a ligase (L) and DpnI (D), hence referred to as KLD treatment. These enzymes allow 
for rapid circularization of the PCR product and removal of the template DNA. Table 2.7 shows 
the reagents used for KLD treatment. The KLD mix was kept for incubation at room temperature 
(RT) for 5 minutes, followed by the transformation of the competent cells. 
 
Table 2.7. KLD treatment for SDM 
 
Reagents Volume used from the stock 
PCR product 1 μl 
KLD Reaction Buffer (2×) 5 μl (1×) 
KLD enzyme mix (10×) 1 μl (1×) 
Autoclaved H2O 3 μl 
Total volume 10 μl 
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2.3.2.  Agarose gel electrophoresis 
The quality and size of a target polynucleotide (from PCR or DNA isolation and 
purification methods) was analysed using agarose gel electrophoresis. 1 % (w/v) agarose gels 
were prepared by mixing DNA-grade agarose powder with 1× TAE (Tris-Acetate-EDTA; 40 mM 
Tris, 20 mM acetic acid, 1 mM EDTA) buffer and the mixture was boiled until the agarose 
dissolved completely. Upon cooling, the SYBR Safe DNA stain (1 in 10,000 dilution) was added 
to the agarose solution to aid in DNA visualisation during electrophoresis. The mixture was 
poured in a gel mould casting tray and a comb was placed at one end to produce wells for loading 
DNA samples.  For the preparation of DNA samples, 1× DNA loading dye (6× dye stock from 
NEB) was added to the desired amount (10 ng – 1 µg) of target DNA. To estimate the size of the 
samples, 1 µl of 1 kb DNA ladder (500 µg/ml, solubilised in sample buffer) was used as the 
marker and run along the samples. The gel was submerged in 1× TAE buffer and ran at 100 V for 
40-50 minutes (depending on the size of DNA).   
 
The DNA samples on the agarose gel was visualised and photographed through a Bio-Rad 
Gel Doc EZ Imager (Image Lab/ PC Windows software).  
 
2.3.3.  Purification of PCR products from agarose gel 
The PCR products were run on the agarose gel and the amplified DNA was carefully 
excised from the gel using a sharp scalpel by visualising under a UV transilluminator. The 
extraction of DNA from the agarose gel slices was performed using QIAquick Gel Extraction Kit 
(Qiagen) and the steps were followed according to the kit’s protocol. The agarose gel slices were 
initially solubilised in a buffer and incubated at 55ᴼC for 10 minutes. The mixture was then 
applied to a column with silica membrane that absorbed DNA in high salt conditions. Impurities 
like primers, enzymes, nucleotides, salts etc. are removed with ethanol wash. The pure DNA was 
finally eluted in autoclaved MilliQ water (pH 7.0, 20 – 30 µl per PCR reaction) and stored at -
20°C until further required.  
 
2.3.4.  Restriction digestion 
The insert (DNA) and vector are digested with selected restriction enzymes. For insert 
digestion, 1-3 µg of the target DNA was mixed with High-Fidelity restriction enzymes (1 unit per 
µg of DNA) in the presence of 1× fast digest reaction buffer (ThermoFisher Scientific). Likewise 
for vector digest, plasmid (~1 µg) was added to the mix containing High-Fidelity restriction 
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enzymes and 1× fast digest reaction buffer. The reaction mixture volume was made up to 50 µl 
with autoclaved milliQ (MQ) water and incubated for 1-2 hours at 37°C.  
 
Post-restriction digestion, the plasmid and DNA inserts were purified using the Qiaquick 
PCR Purification Kit (Qiagen). According to the kit’s protocol, the digests were mixed with a 
binding buffer and subsequently applied to a silica column that entraps the nucleic acids to the 
silica membrane under high salt conditions of the buffer. The impurities were washed away using 
ethanol but the DNA was eluted in 20 - 30 µl autoclaved MQ water. 
 
2.3.5.  Ligation of the plasmid and DNA insert 
The plasmid and the DNA insert, digested with compatible endonucleases, were mixed at 
a molar ratio of 3:1 (insert: vector) using Equation 1 (50 ng of vector was used as the standard 
amount). For ligation, 1× T4 DNA ligase buffer and T4 DNA ligase enzyme were added to the 
plasmid and DNA mix. Ligation reactions using reagents from the Rapid DNA Ligation kit 
(Thermo Fisher Scientific) were mixed in 200 μl PCR tubes. The ligation mixture was made up to 
a volume of 20 µl and incubated at 22 ᴼC for 15 – 30 minutes. Post-incubation, 5-7 µl of the 
ligation mixture was transformed into DH5α E. coli competent cells.  
 
 
                                                         
Equation 1: Calculating molar ratio of insert to vector DNA 
 
2.3.6.  DNA Transformation in E. coli competent cells 
For cloning purposes, chemical competent cells of E. coli DH5α were transformed with 
the target DNA.  
Preparation of competent cells   A single bacterial colony was picked from a LB agar plate to 
inoculate 3 ml of LB starter culture and incubated at 37ᴼC overnight. A volume of 0.2 % of this 
culture was used to inoculate 100 ml LB media.  The 100 ml preculture was placed in an 
incubator 37ᴼC and shaken at 150 rpm for 2-3 hours till the optical density (OD) of the bacterial 
cells (recorded at 600 nm in a UV-Vis spectrophotometer) reached 0.3 – 0.5.  
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Electrocompetent cells The cells were incubated on ice for 20 minutes. Incubation on ice 
was followed by harvesting at 4000 rpm for 10 minutes at 4ᴼC. The cell pellet obtained 
was washed with 50 ml chilled (at 4 ᴼC) 10 % glycerol. The washed cells were again spun 
down at 4000 rpm for 10 minutes at 4 ᴼC. Following washing of the subsequent cell pellet 
with 25 ml 10 % glycerol (at 4 ᴼC), the cells were spun down again (as above). Finally, 
the cell pellet was suspended in 2 ml of chilled 10 % glycerol.  
 
Chemical competent cells The cells were incubated on ice for 10 minutes and centrifuged 
at 4000 rpm for 10 minutes at 4ᴼC in sterile tubes. The cell pellet was suspended in 20 ml 
ice-cold 0.1 M CaCl2 followed by incubation on ice for 20 minutes. The cells were again 
spun down at 4000 rpm for 10 minutes at 4ᴼC and the subsequent cell pellet was finally 
suspended in 5 ml of ice-cold 0.1 M CaCl2. 
 
The suspended solution of competent bacterial cells was aliquoted (50 – 100 µl) in 1.5 ml 
eppendorf tubes and flash-frozen with liquid nitrogen before storing in -80ᴼC. DH5α strain of E. 
coli cells were prepared chemically competent and used for transformation in cloning purposes 
whereas omp8 or BL21 (DE3) strain of E. coli cells were prepared electrochemically competent 
to be used for transformation during expression purposes. 
Transformation For transformation, 10-20 ng of DNA (or 5-7 µl from the ligation mix) was 
added to 25-50 µl of the chemical competent DH5α cells of E. coli and placed on ice for 15-20 
minutes. The cells were then given a heat shock at 42°C for 45 seconds and placed back on ice 
for 5 minutes prior to mixing with 900 µl of LB media. The mixture was incubated at 37°C for 
the revival of the transformed cells. After 45 minutes, the bacterial cells from the suspension 
were plated on LB agar.  
 
2.3.7.   Plating of bacteria 
For the preparation of LB-agar plates and bacterial plating, the work area was sterilised by 
cleaning the bench with ethanol and a bunsen flame was kept on throughout. To prepare the agar-
medium plates, 1.5 g of LB-agar powder was added per 100 ml water and sterilised by 
autoclaving. The selected antibiotic solution (also see section 2.1.3) was added to the autoclaved 
LB-agar media just before pouring into sterile petri dishes. The LB-agar plates were stored at -
20°C for 1 month. 
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The LB-agar plate was incubated at 37°C for 15-20 minutes prior to bacterial plating.  A 
glass rod was moulded into a spreader using the heat flame. Approximately, 150 µl of bacterial 
suspension was pipetted on the LB-agar plate. For plating, the spreader was dipped into 70% 
ethanol, passed through the flame for few seconds and then used for spreading the bacterial cells 
uniformly through the plate. The agar-plate was incubated at 37°C overnight for bacterial cell 
growth. 
 
2.3.8.  Screening of the recombinant plasmids: Colony PCR 
The colonies obtained next day after bacterial plating were screened for positive clones 
using colony PCR. Around 10-15 colonies were picked at random, one at a time, using a sterile 
tip and patched at the inside bottom of a PCR tube. This was followed by streaking a small patch 
by the tip on a LB-agar plate (Amp
r
/Kan
r
). The LB-agar plate was incubated at 37°C overnight, 
to be used later for growing small-scale cultures of the positive clones.  
For one PCR reaction, 6.5 µl of 2× EmeraldAmp® PCR Master Mix was added to the 
PCR tube, along with 0.2 µM of the universal primers (T7 Fwd/Rev for pET28a and pBAD 
Fwd/Rev for pBAD24b). The reaction volume for each PCR tube was made to 13 µl with 
sterilised MQ water. The colony patched at the bottom of each PCR tube acted as a DNA 
template for the synthesis and amplification of the insert DNA. The amplification time for the 
PCR reaction was set according to the extension rate of Emerald enzyme (1 kb per minute). The 
conditions for the colony PCR reaction were same as described section 2.3.1.1 and Table 2.4.   
The results of the cloning were analysed via agarose gel electrophoresis.  
 
2.3.9.  DNA isolation from small-scale cultures 
The recombinant plasmid DNA from the LB-agar plates (streaked during colony PCR; 
also see section 2.3.7) was isolated from small-scale cultures. Whenever required, the stocks of 
vectors and recombinant plasmid constructs were prepared by DNA transformation, bacterial 
plating followed by DNA isolation and purification from small scale cultures. 
 
A sterile tip was used to transfer a single colony from LB-agar plate to 10 ml of LB-media 
containing 1:1000 dilution of Amp (100 mg/ml) or Kan (50 mg/ml) antibiotic stock. The 
inoculated media was shaken at 180 rpm overnight (16-18 hours) at 37°C. The cells were spun 
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down the following day by centrifuging at 4000 rpm for 10 minutes. The supernatant was 
discarded while the cell pellet was processed to isolate DNA using the QIAprep Spin Miniprep 
Kit (QIAGEN). The manufacturer’s protocol was followed for the plasmid/DNA isolation. 
Finally, the eluted DNA (in MQ) was stored at -20°C. 
 
2.3.10.  DNA quantification  
DNA estimation was carried out using nanodrop method by NanodropLite 
Spectrophotometer (Thermo Scientific). 1 µl of autoclaved MQ water was used for blanking 
before measuring the absorbance of 1 µl target DNA sample at 260 nm. 
 
2.3.11.  Automated DNA Sequencing 
The final confirmation of the recombinant plasmid constructs was carried out through 
automated DNA sequencing. Two positive DNA clones (100 ng/µl) for each recombinant 
construct were sent to Eurofins Genomics. The sequencing of each cloned plasmid was carried 
out in both forward and reverse directions, using universal primers (T7 and pBAD primers for 
pET28a and pBAD24 constructs respectively).  
 
BLAST was used to check sequencing results by comparing the sequences of the cloned 
genes with those in KEGG or UniProt databases (Table 2.11).  
 
2.4. Expression and purification of recombinant proteins 
The target proteins were expressed in the outer membrane (OM) of the bacterial cells by 
using E. coli cells of Omp8 strain for large-scale growth. Omp8 is a porin deletion strain of E. 
coli (Kan
r
) that lacks the major OMPs of the bacterium like OmpA, LamB, OmpF and OmpC. 
Whenever required, the proteins were also expressed as inclusion bodies (IBs) in Bl21 DE3 cells 
of E. coli to increase the yield.  
 
2.4.1.  Transformation of DNA in electro-competent cells 
For expression purposes, the recombinant plasmid DNA was electroporated into 
competent cells of E. coli expression strain Bl21 (DE3) or Omp8 (also see section 2.3.6). An 
amount of 1-2 ng of DNA was electroporated into 50 µl electro-competent Omp8 cells (porin 
deletion strain) or Bl21 DE3 cells of E. coli in a Micropulse Electroporator at a pulse of 2500 V 
voltage, 25 µF capacitance. The electroporated cells were immediately transferred to 750 µl of 
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pre-warmed LB broth in a sterile eppendorf tube and revived at 37ᴼC.  After 1 hour, 150 µl of the 
cells were plated on LB-agar plates (Amp
r
/Kan
r
) and incubated at 37ᴼC overnight (also see 
section 2.3.7). 
 
2.4.2.  Overexpression of target proteins 
The large-scale overexpression of proteins required 8-10 litres of growth media for an 
optimum yield (≥ 5-10 mg). The details for the expression and growth conditions of the proteins 
used in the study are described in Table 2.8. 
 
2.4.2.1.  Standard method for overexpression of proteins  
The single cell colonies of E. coli transformed with desired recombinant plasmid were 
used to inoculate pre-cultures of LB media. Using 1% v/v inoculum size conditions, a starter 
culture of 10 ml LB broth (Amp
r
/Kan
r
), grown at 37ᴼC for 16-18 hours, was used for the 
inoculation per litre LB media (Amp
r
/Kan
r
) in 2-litre conical flasks.   
 
 For large-scale expression, the inoculated media was incubated at 37°C whilst 
continuously shaking at 180 rpm. The cells were allowed to grow past the lag phase until the 
beginning of exponential phase which was carefully monitored by measuring optical cell density 
(OD600) using a UV-Vis spectrophotometer (Eppendorf BioSpectrometer kinetic). The amount of 
time required to achieve the exponential phase varied depending on the E. coli strain used for 
growth (2-3 hours for Bl21 DE3 and 4-5 hours for Omp8). At an OD600 of 0.5-0.6, the target 
proteins were expressed by adding a specific inducer to the growth media. The pBAD24-cloned 
constructs were induced with 0.1 % w/v arabinose while pET28a cloned constructs were induced 
with 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG). Post-induction, the cells were grown 
for 3 hours at 37°C or for 5 hours at 30°C. The final cell OD was typically around 1-1.5 (or 
above) and the bacterial cells were spun down by centrifugation (Avanti J-26 XP Centrifuge, 
Beckman Coulter Inc.) at 5000 rpm for 20 minutes at 4°C.  
 
2.4.2.2.  Overexpression trials of Seleno-methionine substituted protein 
The method for expressing Seleno-methionine (SeMet) substituted protein is based on the 
inhibition of the methionine biosynthesis pathway protocol for E. coli (Van Duyne et al., 1993). 
The seleno-methionine substituted protein was expressed using LeMasters-Richards (LR) media 
that comprises 2 components: LR buffer and LR salts (Table 2.1). A single colony from the LB-
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agar plate was used to inoculate 2-3 ml LB media. This starter culture was grown for 6-8 hours at 
37°C till the OD reached around 0.8. It was then transferred to 100 ml of LR preculture which 
was grown at 37°C for 16-18 hours at 200 rpm. For 1 % v/v inoculation, 10 ml of LR preculture 
was used to inoculate 1 L of LR media (usually required 6-8 L of media for good yield). The LR 
media was grown at 37°C with continuous shaking at 150 rpm. Anywhere between an OD of 0.5 
to 1.0, 0.01% v/v of 100× amino acid stock (100× AA; Table 2.1) was added to the cells to shut 
down methionine biosynthesis and incorporate seleno-methionine. Half an hour later, the 
induction step was done using 1 mM IPTG (for pET-cloned constructs) to express the protein 
overnight at 30°C at 150 rpm. 
 
 
Table 2.8. Expression conditions of recombinant proteins.  
The table enlists the cloning vectors, E. coli strains used for expression and growth conditions for 
all the proteins of this study.   
 
Protein 
Expression as (E. 
coli strain) 
Plasmid 
Antibiotic 
added 
Induction 
Temperature 
(Time post-
induction) 
OmpE35 OMP (Omp8) pBAD24 Ampicillin Arabinose 37°C (3 hours) 
OmpE36 OMP (Omp8) pBAD24 Ampicillin Arabinose 37°C (3 hours) 
OmpK36 OMP (Omp8) pBAD24 Ampicillin Arabinose 37°C (3 hours) 
OmpU OMP (Omp8) pBAD24 Ampicillin Arabinose 37°C (3 hours) 
OmpUΔN OMP (Omp8) pBAD24 Ampicillin Arabinose 30°C (5 hours) 
OmpUΔN IB (Bl21(DE3)) pET28a Kanamycin IPTG 37°C (3 hours) 
OmpT OMP (Omp8) pBAD24 Ampicillin Arabinose 30°C (5 hours) 
OmpT IB (Bl21(DE3)) pET28a Kanamycin IPTG 37°C (3 hours) 
OmpT (6×His) OMP (Omp8) pBAD24 Ampicillin Arabinose 37°C (3 hours) 
OmpT (Se-Met) OMP (Omp8) pET28a Kanamycin IPTG 37°C (3 hours) 
OmpTΔL8 IB (Bl21(DE3)) pET28a Kanamycin IPTG 37°C (3 hours) 
 
 
2.4.3.  Outer membrane protein extraction 
The following subsections describe the extraction strategies employed for the isolation of 
proteins expressed in the outer membrane (OM) or expressed as the inclusion bodies (IBs).  The 
list of buffers used during OMP extraction from OM or solubilisation of IBs are listed in Table 
2.9. 
 
40 
 
2.4.3.1.  Extraction of OM-expressed proteins 
The cell pellet was resuspended in Tris-saline buffer (20 mM Tris HCl and 300 mM 
NaCl, pH 8.0) and lysed with a cell disrupter (0.75 kW; Constant Systems; one pass at 23 kpsi) at 
4°C. After lysis, the cells were ultracentrifuged at 42,000 rpm (Beckman Coulter Inc.) using a 45 
Ti rotor for 45 min at 4°C. The resulting membrane pellet was extracted twice with 0.5% N-
lauroylsarcosine (sarkosyl) detergent (in 20 mM HEPES, pH 7.5; Table 2.9) to solubilise the 
inner membrane fraction followed by ultracentrifugation (45 Ti rotor) at 42,000 rpm for 30 
minutes at 4°C. The inner membrane fraction obtained in the form of supernatant was removed 
while the cell pellet containing outer membrane (OM) fraction was resuspended in 50 ml of 1% 
lauryldimethylamine-oxide (LDAO) buffer (10 mM HEPES, 50 mM NaCl, pH 7.5; Table 2.9). 
The LDAO suspension was kept for constant stirring overnight at 4 °C to solubilise the targeted 
outer membrane protein. Next day, the LDAO extract was ultracentrifuged using a 70 Ti rotor 
(Beckman) at 50,000 rpm at 4°C for 30 minutes. The supernatant containing the solubilised outer 
membrane protein was collected while the pellet was discarded.  
 
2.4.3.2.  Solubilisation of IB-expressed proteins 
The bacterial cells expressing the inclusion bodies (IBs) were harvested by centrifuging at 
5000 rpm for 20 minutes and lysed using the cell disrupter (as described in section 2.4.3.1). The 
inclusion bodies were collected in the form a cell pellet by ultracentrifugation at a low speed of 
10,000 rpm for 20 minutes (at room temperature). 1% Triton, solubilised in an Inclusion Body 
(IB) buffer (50 mM NaCl and 10 mM HEPES, pH 7.5; Table 2.9), was used to remove residual 
membranes from IB pellet. Following ultracentrifugation at 10,000 rpm for 10 minutes (at RT), 
residual membrane fraction was removed in the form of supernatant while the IBs were obtained 
in the form of cell pellet. The pellet was washed twice in the IB buffer to remove any residual 
Triton, each step followed by centrifuging at 10,000 rpm for 10 minutes. Cells were re-suspended 
in 8 M Urea (in IB buffer; Table 2.9) and continuously stirred at RT to solubilise and denature the 
target protein overnight. The urea extract was then subjected to ultracentrifugation at 50,000 for 
30 minutes (at RT) and the supernatant containing the denatured protein was added drop-wise to 
1% LDAO in IB buffer such that urea concentration was 10-fold diluted in the resulting solution. 
The protein was allowed to fold in vitro by constantly stirring at RT for 2-3 days and was finally 
applied to an ion-exchange column for purification.  
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2.4.4.  Purification of recombinant proteins 
Protein purification was carried out using ion-exchange chromatography for tag-less 
proteins (IEX) and immobilised metal affinity chromatography (IMAC) for his-tagged proteins. 
In addition, the protein purification steps typically employed two rounds of size exclusion 
chromatography (SEC). Whenever required, a second IEX followed by SEC was used at the end 
stages of purification to increase protein purity or for exchange purposes (crystallisation). The list 
of buffers used during elution and purification are listed in Table 2.9. 
 
2.4.4.1.  Purification by Anion-Exchange chromatography (IEX) 
The isoelectric points (pI) of the proteins, used in the study, ranged between 3.5– 4.5. The 
use of purification buffers at pH 7.5 rendered negative charge to the proteins and as a result, a 
positively charged anion-exchanger was applied for protein purification. Elution of tag-less 
proteins isolated from IBs was performed using gravity-flow anion-exchange columns and 
proteins isolated from OM were subjected to pre-packed anion-exchangers (from GE Healthcare).  
 
Gravity-flow columns 
The LDAO extracts isolated from the inclusion bodies were subjected to gravity-flow 
columns prepared using 10 ml of Q-Sepharose Fast Flow resin (GE Healthcare). The columns 
were initially charged with 2-3 CV (column volume) of high salt IEX Buffer B solution and then 
equilibrated by running 5-10 CV of low salt IEX Buffer A (Table 2.9). The LDAO extract was 
filtered using a 0.45 µm MF-Millipore membrane filter (Merck) before loading on the 
equilibrated anion-exchange column. The flow-through was discarded and the column was 
washed with 10 CV of IEX Buffer A (in 0.1 % LDAO). The elution of the protein was done by 
passing 2-3 CV of IEX Buffer B (in 0.1% LDAO) through the column and the flow-through was 
collected in a 15 ml falcon tube.  
 
Pre-packed HiTrap Q columns 
To elute the proteins isolated from the membrane fractions, the LDAO extracts were 
loaded on pre-packed HiTrap-Q HP (5 ml, GE Healthcare) columns and the protein separation 
was monitored using an AKTA protein purification system (ÄKTA FPLC from GE Healthcare). 
HiTrap Q equilibration was done by passing 15 CV of IEX Buffer A after charging the column 
with 5 CV of IEX Buffer B. The column was loaded with filtered LDAO extracts, washed with 
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10 CV of IEX Buffer A and eluted with a gradual increase in salt gradient (150 mM to 1 M of 
NaCl over 5 CV).  
 
Pre-packed Resource Q and MonoQ columns 
The impure OMP extracts were subjected to another anion exchanger, Resource Q (6 ml 
volume, GE Healthcare) column. The column was first charged with 2 CV of IEX Buffer B and 
then equilibrated with 5 CV of IEX Buffer A. After elution through HiTrap-Q HP column, the 
sample was buffer exchanged (see section 2.4.6) to low salt buffer before applying to Resource Q 
column.  The column was washed with 10 CV IEX Buffer A and target protein was separated 
with a salt gradient using IEX Buffer B (150 mM to 1 M of NaCl over length of 10 CV).  
 
Some of the protein samples required additional strategies to get rid of stubborn 
impurities which were not removed through SEC purification columns.  For such samples, the 
protein fractions obtained from the SEC runs, were further subjected to another anion exchange 
column (Mono Q 10/100 GL; GE Healthcare) using the AKTA system. The column equilibration 
and protein elution was done as described previously (see section 2.4.4.1) in 0.1% LDAO using 
IEX Buffers A and B (Table 2.9). The protein eluted in high salt buffer was either subjected to 
another SEC column (in C8E4 buffer) or buffer exchanged (see section 2.4.6) to C8E4 buffer 
(Table 2.9) for crystallisation.  
 
The protein separation and fraction collection was monitored through Unicorn software 
on an AKTA FPLC.  The eluates from the peak fractions of HiTrap Q and Resource Q columns 
were collected and assessed using SDS-PAGE (see section 2.4.7) to pool the purest fractions for 
further purification. 
  
 2.4.4.2.  Elution by Immobilised Metal Affinity chromatography (IMAC) 
  The protein expressed with the histidine-tag (six His residues) was eluted using 
immobilised metal affinity chromatography (IMAC). The gravity-flow columns were prepared 
using 10 ml of chelating Sepharose Fast Flow IMAC resin (GE Healthcare). The IMAC media 
was charged with Ni
+2
 ions by passing 2 CV of 0.1 M NiCl2 solution through the column and 
equilibrated with 10 CV of IMAC buffer solution (Table 2.9) in 0.1% LDAO. The protein extract 
isolated from the cell fractions was subjected to Ni
+2 
charged IMAC column. The column was 
washed with 15 CV of 25 mM imidazole (Imidazole buffer: 50 mM NaCl, 10 mM HEPES, pH 
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7.5 and 0.1% LDAO; Table 2.9). For protein elution, 3 CV of 250 mM imidazole (in Imidazole 
buffer; Table 2.9) was passed through the column. The eluates were collected in 50 ml falcon 
tubes for purification by size-exclusion chromatography (SEC). 
  
Table 2.9. Buffers used during protein extraction, elution and purification.  
 
2.4.4.3.  Purification by Size Exclusion chromatography (SEC)  
The protein samples were concentrated by centrifuging (also see section 2.4.5) to an 
appropriate volume (≤ 5 ml) for purification through size-exclusion chromatography (SEC) 
columns using FPLC. Depending on the protein amount and molecular weight, three types of 
SEC prep grade (PG) columns (GE Healthcare) were used for protein purification: HiLoad 
Buffer 
Name 
Buffer Composition Use pH Detergent 
OMP extraction from OM 
Tris-
saline 
buffer 
150 mM Tris HCl, 300 mM 
NaCl 
Cell lysis and cell pellet 
resuspension 
8.0 - 
Sarkosyl 
buffer 
20 mM HEPES 
Solubilise inner 
membrane proteins 
7.5 0.5% Sarkosyl 
LDAO 
buffer 
10 mM HEPES, 50 mM 
NaCl 
Solubilise OMP from IB 7.5 1% LDAO 
OMP extraction from IB 
Triton-IB 
buffer 
50 mM NaCl,10 mM HEPES 
Solubilise membrane 
proteins (IB wash) 
7.5 1% Triton 
Anion-exchange chromatography (IEX) 
IEX 
Buffer A 
150 mM NaCl, 10 mM 
HEPES 
Column Equilibration 7.5 0.1% LDAO 
IEX 
Buffer B 
1 M NaCl, 10 mM HEPES Elution 7.5 0.1% LDAO 
Immobilised metal affinity chromatography (IMAC) 
IMAC 
buffer 
20 mM Tris, 300 mM 
NaCl,10 mM HEPES 
Column Equilibration 7.5 0.1% LDAO 
Imidazole 
buffer 
20 mM Tris, 300 mM NaCl 
NaCl,10 mM HEPES 
Washing/Elution 7.5 
25 /250 (mM) 
imidazole 
Size-exclusion chromatography (SEC) 
SEC 
buffer 
100 mM NaCl, 10 mM 
HEPES 
Column Equilibration 
and Elution 
7.5 0.1% LDAO 
C8E4 
buffer 
100 mM NaCl, 10 mM 
HEPES 
Final purification (for 
crystallisation) + 
exchange 
7.5 0.45% C8E4 
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16/600 Superdex 200 PG column (120 ml), HiLoad 26/600 Superdex 200 PG column (320 ml) 
and Superdex 200 PG 10/300 GL analytical column (24 ml). The columns were equilibrated 
with 0.05 % LDAO in SEC buffer (10 mM HEPES, 100 mM NaCl, pH 7.5; Table 2.9). For 120 
ml column, the protein sample in a 5 ml tubing loop was injected into the column using a 
syringe and the protein fractions were collected in volume of 3 ml in falcon tubes using a 
fraction collector. A typical purification involved one round of SEC column (mostly in 0.05% 
LDAO) to isolate the purest fractions of the protein (impure fractions required two rounds of 
purification through SEC).  
 
The final step of protein purification was done through SEC column equilibrated in 
C8E4 buffer (Table 2.9) containing 0.45% C8E4 for crystallisation. The purity of the peak 
fractions was assessed using SDS-PAGE (see section 2.4.7), following which the purest protein 
samples were pooled together and typically concentrated to 10-15 mg/ml (see section 2.4.5), 
flash-frozen in LN2 and stored at -80°C.   
 
2.4.5.   Protein concentration  
  The concentration of protein samples was achieved using Amicon Ultra-15 Centrifugal 
Devices (molecular weight cut-off size of 50 kDa or 100 kDa). The samples were spun at 4000 
rpm at 4°C until a required volume was obtained. To inject the samples for SEC, the protein 
sample was concentrated to less than 5 ml (typically around 3 ml) volume. For C8E4 purified 
fractions, the protein was concentrated down to 10-15 mg/ml and aliquoted in ~100 µl fractions 
in eppendorf tubes for storage at -80°C.  
 
2.4.6.  Buffer exchange 
The Amicon Ultra-15 Centrifugal Devices (molecular weight cut-off size of 100 KDa) 
were also used to exchange protein buffer. The sample was centrifuged at 4000 rpm at 4°C until 
the volume was reduced to 1 ml. The tube was filled with 15 ml of desired buffer and centrifuged 
again at 4000 rpm till the volume was reduced to 1 ml. The process was repeated at least twice to 
achieve buffer exchange.  
 
2.4.7.  SDS-PAGE for protein analysis 
The quantity, purity and size of proteins were visualised through sodium-dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE). The apparatus and reagents for SDS-PAGE 
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were purchased from ThermoFischer Scientific. The protein samples (in the form of LDAO 
extracts, purified OMP fractions etc.) were loaded on the NuPAGE 4-12% Bis-Tris Plus Gels. 
Due to heat modifiable nature of OMPs (Beher et al., 1980), the proteins were loaded as boiled 
(B) and non-boiled (UB) samples on the SDS-PAGE.  A volume of 15 µl was used for loading 
each sample prepared in 4X Bolt™ LDS sample buffer along with prestained protein 
ladder (10 - 250 kDa). The samples were boiled for  5-10 minutes at 100°C prior to 
loading. The apparatus was assembled using XCell SureLock™ Mini-Cell 
Electrophoresis System (ThermoFischer Scientific) the SDS-gels were run at 165 V for 70-
80 minutes.  
 
After the run, the gel cassette was disassembled to wash the gels in distilled water by 
microwaving for 1 minute followed by shaking for 3 minutes. This step was repeated at least 
three times to get rid of any residual SDS that can inhibit effective staining of the gel. The gel 
was finally stained in coomassie stain (0.01 % Coomassie Blue R-250, 10% ethanol, 30 mM 
HCl) for 20 minutes and destained overnight in distilled water. The pictures of the SDS-PAGE 
gels were taken through a Bio-Rad Gel Doc EZ Imager (Image Lab/ PC Windows software). 
 
2.4.8.   Native PAGE for protein analysis 
The Native PAGE reagents were purchased from ThermoFisher Scientific. The samples 
for the Native PAGE were made of volume 10 µl (each), prepared with 1% n-Dodecyl β-D-
maltoside (DDM), 1× Native PAGE sample buffer and 0.25% Native PAGE G-250 additive. The 
NativePAGE 4-16% Bis-Tris Protein Gels were used with the Native PAGE Anode Buffer (1×) 
and Native PAGE Dark Blue Cathode Buffer (1×) which were prepared following the 
manufacturer’s protocol. The samples were run at 165 V for 100 minutes using the XCell 
SureLock™ Mini-Cell electrophoresis tank. 
 
After the run, the gel was transferred to 100 ml fixing solution (40 % methanol, 10 % 
acetic acid), microwaved for 45 seconds and incubated on an orbital shaker for 15 minutes. This 
process was repeated twice before the gel was removed from the fix solution and placed in 100 
ml Destain Solution (8 % Acetic acid). The gel was incubated overnight to remove the excess 
stain and photographed next day using Bio-Rad Gel Doc EZ Imager (Image Lab/ PC Windows 
software). 
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2.5. Determination of protein concentration 
2.5.1.   Bicinchoninic acid assay (BCA) method  
The Pierce BCA Protein Assay Kit (ThermoFisher Scientific) was used to estimate the 
protein concentration. The BCA working reagent (WR) was prepared by mixing two reagents of 
the BCA assay kit in a ratio of 50:1 (Reagent A: Reagent B). 500 µl of WR was added to 10 µl of 
the protein sample and incubated with a slight shaking at 37°C for 45 minutes. Post-incubation, 
the samples were measured at 562 nm in the spectrophotometer, since BCA-Cu
+
 complex 
exhibits strong linear absorbance at this particular wavelength with increasing protein 
concentrations. BSA protein standards (2 µg, 4 µg and 8 µg) were used to compare and calculate 
the concentration of the target protein sample. 
 
2.5.2.  UV absorption method 
Another method of protein concentration was via absorption at 280 nm wavelength in the 
NanoDrop 2000 benchtop spectrophotometer (Thermo Fisher Scientific). The absorbance values 
(ɛ0.1%) of 0.1 % (=1g/L) solutions measured in a 1 cm cuvette were obtained by entering the 
specific amino acid sequence of the expressed protein into the ProtParam tool (Table 2.11). 
Equation 2 was used to calculate protein concentration in mg/ml using A280 nm.   
 
               
  
  
            
Equation 2 – Calculating concentration of a protein solution in mg/ml. 
A = absorbance at 280 nm, 
ɛ0.1%= 0.1% extinction coefficient 
 
2.6. Crystallisation 
The process of crystallisation completes by achieving a special phase equilibrium between 
a protein-rich phase (in the form of a well-ordered crystal) and a saturated protein solution. 
 
2.6.1.  Crystal screens  
Frozen aliquots of protein were thawed at room temperature for setting up initial screens 
by the sitting-drop method. Three commercial membrane crystallisation screens from Molecular 
Dimensions: MemGold1 (MG1; Newstead et al., 2008), MemGold2 (MG2; Parker and Newstead 
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2012) and Morpheus (Gorrec et al., 2015) were used for the initial screening. An automated 
Mosquito crystallisation robot (TTP Labtech) was employed to set up the screens in MRC 96-
well crystallisation plates (Molecular Dimensions). 75-80 µl of screen conditions were manually 
pipetted into the reservoir wells of 96-well plate. The robot was used to dispense 200 nl + 200 nl 
and 200 nl + 150 nl of protein + reservoir solution in the two sample wells. The screen plates 
were incubated at 20°C and checked periodically for the growth of protein crystals.  
 
2.6.2.  Optimisation of crystal hits 
The initial crystal hits were manually optimised using two types of vapour diffusion 
method: sitting-drop and hanging-drop. For crystal optimisation, the original hit condition with 
required pH was fine screened as follows.  
 
2.6.2.1.  Vapour diffusion using hanging-drop method 
VDX 24-well hanging drop plates (Hampton Research) were used for setting up hanging-
drops of the protein sample. The crystallisation cocktail, with varying PEG amount (± 10%), was 
pipetted into the reservoir wells (500 µl) such that a precipitant gradient was set up across an 
entire row of the plate for the same condition. For each well, the protein was mixed with its 
reservoir solution as two drops in volumes of 1 + 1 µl and 1.5 + 1 µl, respectively. The drops 
were placed on 18 × 0.22 mm or 22 × 0.22 mm siliconised glass cover slides (Hampton 
Research) and placed upside down by inverting the slides on the top of individual wells.  The 
grease was applied on the raised rims of the wells to seal the drops. The plates were stored at 
20°C and checked periodically. 
 
2.6.2.2.  Vapour diffusion using the sitting-drop method 
Intelli-Plate 48-3 well plates from Art Robbins Instruments (Hampton Research) were 
used to set up sitting drops for crystal optimisation. The crystallisation cocktail, with varying 
PEG amounts, was pipetted into the reservoir wells (200 µl) similar to as described above 
(section 2.6.2.1). The protein was mixed with its reservoir solution in volumes of 1 + 1 µl and 1.5 
+ 1 µl, respectively, in the drop wells. The drops were sealed by applying transparent scotch tape 
across the rows of 48-well plates. The optimised plates were stored at 20°C and checked 
periodically.  
 
 
48 
 
2.6.2.3.  Co-crystallisation trials with antibiotics 
The antibiotic solutions were prepared using the desired concentration of antibiotic 
dissolved in buffer solution (in 10 mM HEPES, 100 mM NaCl, pH 7.5). The antibiotic 
concentration for the co-crystallisation trials were varied from 0.1 M to 0.5 M. Co-crystallisation 
of proteins with antibiotics was enforced in crystal-optimised conditions via two independent 
approaches using either hanging-drop or sitting drop method (sections 2.6.2.1 and 2.6.2.2). One 
method was to incubate protein and the antibiotic solution for an hour at room temperature or 4°C 
prior to setting up the crystal drops. A second approach adopted was to mix protein sample with 
the antibiotic solution and dilute to 1 ml (using buffer solution 10 mM HEPES, 100 mM NaCl, 
pH 7.5). The mixture was incubated at room temperature for 30 minutes and then concentrated 
together at 4°C (4000 rpm; section 2.4.5) to the original volume. The co-concentrated protein-
antibiotic mix was used to set crystal drops and the plates were stored at 20°C. Sometimes, the 
pre-formed protein crystal (or crystals) were soaked in a 1-2 µl drop of the antibiotic solution for 
overnight (or a few hours depending on crystal stability) before crystal harvesting.  
 
2.6.2.4.  Heavy-atom incorporation 
Different heavy atoms (HAs) [Platinum (Pt), Lead (Pb), Iridium (Ir) and Osmium (Os)] 
were procured from Hampton Research in the form of powder [Potassium tetrachloroplatinate- 
K2PtCl4, Lead acetate trihydrate- Pb(CH3COO)2.3H2O, Potassium hexachloroiridate- K2IrCl6, 
and Potassium osmate dehydrate- K2OsO4.2H2O]. HA was dissolved in the mother liquor to 2-10 
mM and 1-2 µl drops of HA solution was mixed with the protein crystal drop. The selected 
crystals were picked using suitable-sized loops and transferred to HA solution. After few hours of 
incubation (1-2 hours), the crystals were backsoaked into the mother liquor before harvesting 
using appropriate cryoprotection (see section 2.7). 
 
2.7. Crystal harvesting  
Unless the crystallisation condition contained more than 25% of PEG 400 as the 
precipitant, the selected crystals were cryoprotected (Teng 1990) prior to harvesting. A default 
cryoprotectant solution is composed of 200 µl of optimised condition with 20% glycerol and 
0.4% C8E4 detergent. The crystals were dipped in 1-2 µl of cryoprotectant solution for a few 
seconds just before the harvest. The optimum size crystals were harvested using suitably sized 
loops (Hampton Research). The crystals were immediately flash-frozen by transferring to the 
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liquid nitrogen and stored in dewars (filled with liquid N2) prior to shipment to Diamond Light 
Source (DLS). 
 
2.8. X-ray diffraction and structure determination 
X-ray diffraction data of crystals was processed as follows.  
 
2.8.1.  In-house screening of crystals for diffraction 
Protein crystals were first screened through in-house X-ray diffraction. Crystals were 
mounted on a copper anode Rigaku MSC microfocus generator and data was collected on Raxis 
IV
++
 image plate detector. Two diffraction images per crystal were collected, at relative phi 
angles of 0° and 90° and were indexed in iMOSFLM (Leslie, 2006). Crystals were ranked based 
upon diffraction pattern and resolution, and accordingly, the best ones were sent to DLS. 
 
2.8.2.  Diffraction dataset collection  
Datasets were collected at Diamond Light Source (DLS, Didcot, Oxfordshire, UK) by Dr. 
Arnaud Baslé. Among the five automated beamlines of Diamond (I02, I03, I04, I04-1 and I24) 
used for macromolecular crystallography, the available beamline was used for the diffraction of 
the crystals. For data collection, the crystal was rotated around a single axis by small increments 
(~ 0.1°) while exposed to X-rays and diffraction images were collected for each increment using 
fast readout and shutter-less operation of the Pilatus detector (Broennimann et al, 2006). 
 
2.8.2.1.  Single-wavelength anomalous diffraction (SAD) 
Single-wavelength anomalous diffraction (SAD) data was collected for Se-Met 
substituted protein (Se-Met OmpT) and heavy-atom incorporated protein crystals (HA-
incorporated-OmpT).  The heavy atoms in the protein crystal act as anomalous scatterers and 
provide important phase information for structure determination (Hendrickson 2014). A 
fluorescence scan was performed to determine the maximum wavelength for SAD data 
collection. The optimal wavelength values for the absorption edges of other heavy atoms was 
identified online using the Heavy-atom-choices webpage 
(http://xray0.princeton.edu/~phil/Facility/heavyatompick.html). Based on the fluroscence scan, 
peak wavelengths chosen for different heavy atoms were: 0.9792 Å for selemium (Se; 12.658 eV 
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and K absorption edge), 1.072 Å for platinum (Pt; 11.564 eV and L-III absorption edge) and 
1.1055 Å for iridium (Ir; 11.2152 eV and L-III absorption edge). 
 
2.8.3.   Data processing  
The data indexing was performed by XDS (Kabsch 2010. For data scaling and reduction, 
Aimless (Evans and Murshudov 2013) within CCP4 (Winn et al., 2011) was used. Typically, 5% 
of the data reflections were kept unmerged (as Rfree; during scaling and merging of the data) for 
computing statistics during model refinement (Brünger 1992). During scaling, the quality of the 
data was assessed based on different factors like reliability or R-factor (Rmerge/Rpim), signal to 
noise ratio (I/σI), correlation coefficient (CC1/2), and completeness. Whenever required, scaled 
data from the xia2 pipeline (Winter 2010), an automated system for X-ray data processing, were 
directly used for molecular replacement.  
 
2.8.3.1.  Phase information by Molecular Replacement (MR) 
Molecular replacement is a phasing technique used only when a search model, with a 
crystal structure available in the PDB, is structurally similar to the target molecule. As a result, 
the phases calculated from the search model are used to estimate the phases for the unknown 
structure of target molecule. In general, the search model should have more than 20-25% of 
sequence identity with the target molecule in order to be used for molecular replacement. 
To solve the structure of target proteins in this study, molecular replacement was done 
using either MolRep (Vagin and Teplyakov 1997) or PHASER (McCoy et al., 2007) within 
CCP4i (Winn et al., 2011) or PHENIX (Adams et al., 2010). In MolRep, the potential solutions 
were monitored by observing the ‘contrast score’, followed by manual inspection of cell 
symmetry and packing in COOT (Emsley and Cowtan 2004). In PHASER, the LLG (log-
likelihood gain) values of rotation and translation search functions are used to compute the ‘Z 
score’ to identify a definite solution, followed by manual inspection of the solution in COOT for 
any symmetry clashes. Table 2.10 enlists the structures of recombinant proteins solved by 
molecular replacement method in this study.  
2.8.3.2. Phase information by Experimental phasing 
The anomalous scattering caused by the HA atoms (in OmpT-HA and Se-Met OmpT 
crystals) was used to derive the phase information required for experimental phasing. SAD data 
were auto-processed by SHELX C/D/E (Sheldrick 2008) pipeline using a graphical user interface, 
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hkl2map (Pape and Schneider 2004). SHELX program sets up files and calculates the estimated 
substructure structure factor amplitude (FA) (shelxc), finds heavy atoms (shelxd; Sheldrick, 2010) 
and modifies the density (shelxe; Thorn and Sheldrick 2015) to obtain the electron density map. 
The solution output is judged on the basis of best CFOM value (≥ 35 for a good SAD solution), 
CC for partial structure against native data (if available) and manual inspection in COOT.  
 
Table 2.10. List of structures solved by molecular replacement with search models and 
sequence identity to the target.  
 
Another program applied to determine the phases and build an initial model was by using 
AutoSol (Terwilliger et al., 2009), an experimental phasing pipeline in PHENIX. The input data 
files were either provided as premerged .sca or .mtz files (after scaling in Aimless). The SAD 
data obtained from the diffraction of Se-Met substituted OmpT and HA-incorporated OmpT 
crystals was used for attempts to solve the structure via experimental phasing.  
 
2.8.4.  Model building, refinement and validation 
The electron density maps obtained from the molecular replacement were improved 
manually by model building in COOT (Emsley and Cowtan 2004) followed by refinement cycles 
in Refmac5 (Murshudov et al., 1997) within CCP4i or by Phenix.Refine (Afonine et al., 2012) in 
PHENIX. Electron density maps for model building are combination of: 2Fo-Fc (density map, 
weighted towards experimental data) and Fo-Fc (difference map) where Fo are the structure 
Structures Search Model 
Sequence 
identity 
MR 
method 
OmpE35 2ZFG (OmpF of E. coli) 80% MolRep 
OmpE36 2J1N (OmpC of E. coli) 66% MolRep 
OmpK36 
2OSM (OmpK36 of K. 
pneumoniae) 
94% MolRep 
OmpU 3UPG (OmpF of S. typhi) 26% PHASER 
OmpUΔN OmpU (this study) 99% MolRep 
OmpT-monomer; IB 
expressed 
OmpU (this study) 19% PHASER 
OmpT-trimer; IB expressed 
OmpT-monomer; IB expressed 
(this study) 
100% MolRep 
OmpT; OM expressed 
OmpT-monomer; IB expressed 
(this study) 
100% PHASER 
OmpTΔL8 
OmpT-monomer; IB expressed 
(this study) 
99% PHASER 
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factors observed from the diffraction pattern and Fc are the structure factors calculated from the 
model. Simulated annealing was used to generate an omit map in PHENIX (with starting 
temperature of 1000K). The reliability of the model (R-factor) was assessed by comparing the 
measured amplitudes with those calculated from the model (Rfree for unmerged data reflections 
and Rwork for the working model). Models were validated using COOT validation parameters and 
the online validation software program, MOLPROBITY (Chen et al., 2010) to check the 
geometry and Ramachandran outliers in addition to clashes.  
2.9. Antibiotic binding and transport assays 
In vitro uptake of antibiotics (see Appendix Figure 4) through the target OMPs was 
performed using disc-diffusion assays, bacterial growth rates and liposome swelling assays, 
described below.  
 
2.9.1.  Disc diffusion assay 
The recombinant constructs of the target proteins were electroporated in omp8 competent 
cells (see section 2.3.6). The single colonies were used to inoculate small-scale LB media 
cultures (3 ml per target protein) and incubated at 37°C overnight (16-18 hours). For each 
protein, the bacterial cells were diluted to 0.3-0.4 OD using sterilised LB media. The omp8 cells 
were transformed with an empty pBAD24 plasmid and used as a negative control for the assay 
(referred to as pBAD). 200 µl of diluted cell sample was plated on pre-warmed LB-agar plates 
(Amp
r
 + 0.01 % Arabinose) using a glass spreader (see section 2.3.7). The plates were incubated 
at room temperature for 2 hours or for 1 hour at 37°C. For the assay, drops of 25 µl antibiotic 
solution (8 mg/ml) were pipetted on the filter discs (12 mm size) and left at room temperature to 
dry for 2-3 hours. Three discs were placed per LB-plate (spread with bacterial cells) and 
incubated at 37°C. Next day, the plates were assessed to calculate the radii of zone of lysis for 
each target protein and compare with that of a negative control. The radii were calculated with 
the help of a ruler for each individual measurement.  
 
2.9.2.  Bacterial growth assay 
The overnight bacterial cultures of target proteins in 3 ml LB-media (see above section 
2.9.1) were diluted to 0.3-0.4 OD and aliquoted in wells of a microplate reader. Sterilised LB 
media (Amp
r
), 0.01 % arabinose and desired antibiotic solution (with varying concentration) 
were added to the wells. Each well (150 µl volume) of the microplate was aliquoted with 75 µl 
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cells + 65 µl LB-media + 5 µl of arabinose + 5 µl of antibiotic solution. The omp8 cells were also 
transformed with an empty pBAD24 plasmid and used as a negative control for the assay 
(referred to as pBAD). The microplate was placed in a plate reader to incubate by continuous 
shaking 180 rpm for 16 hours at 37°C. The cell OD was measured every 20 min during the 
incubation by the plate reader. After 16-hour incubation, the growth rates of the cells expressing 
the target protein were assessed in the presence of different concentrations of antibiotics and 
compared with the cell growth of negative control. 
  
2.9.3.  Liposome swelling assay (LSA) 
The liposome suspension mixture was prepared by mixing 100 mg egg 
phosphatidycholine (solubilised in 25 mg/ml in chloroform; Avanti Polar Lipids) and 2.3 mg 
dihexadecyl phosphate (dissolved in 1 ml of chloroform). For each protein, 100 µl from the 
liposome suspension was aliquoted in glass tubes and vacuum dried for 2 hours. The thin dried 
lipid layer was then suspended in 100 µl water along with the addition of protein, such that all 
proteins have the same millimolar amount in each experiment set-up. This mixture was sonicated 
for 2 min before leaving for drying overnight in a dessicator. The control liposome mixture was 
prepared by adding buffer without protein into the liposome suspension. The next day, 200 µl of 
12 mM of stachyose solution (in 10mM HEPES, pH 7.5) was added to the overnight dried 
proteolipid film and pipetted gently before proceeding to the swelling assay. For each assay, 5 µl 
of proteoliposome mixture was added to 100 µl of substrate solution (8-15 mM depending on the 
empirical, iso-osmotic concentrations of these substrates that show no change in the optical 
density values when measured with the control liposomes) and mixed rapidly before measuring 
the optical density at 400 nm for 60 secs at a 5 sec interval. The swelling assay rate for glycine 
permeation through OmpF of E. coli was taken as 100% (as reference). To ensure equimolar 
amounts of proteins, 15 µg for a protein with a molecular weight of 25 kDa was set as the 
standard to calculate the amounts of all proteins needed for the assays. 
 
2.10.  Electrophysiology 
The biophysical characterisation of proteins was performed using lipid bilayer 
electrophysiology via single-channel or multi-channel experiments. In this study, the proteins of 
Vibrio cholerae (OmpU, OmpT, OmpUΔN and OmpTΔL8) were characterised through 
electrophysiology experiments. 
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2.10.1.  Multichannel bilayer experiments 
The multichannel bilayer experiments were used to compute conductance and ion-
selectivity of the target OMPs.  
2.10.1.1.  Ion-selectivity experiments  
The ion-selectivity measurements were done as described elsewhere (Benz et al., 1985). 
The instrumentation consisted of a Teflon cuvette partitioned in the middle by a thin wall 
containing a 2 mm
2 
small hole. The two chambers of the cuvette were each filled with 5 ml of salt 
solution (mostly buffered in 10 mM HEPES, pH 7.0) and dipped in calomel electrodes (Metrohm, 
Herisau, Switzerland), one connected to an amplifier and the other to an electrometer (Keithley 
427) to monitor current. 10 mg/ml DPhPC (diphytanoylphosphatidylcholine) in n-decane butanol 
was used for prepainting while 20 mg/ml DPhPC (in chloroform) was used to form the black 
lipid bilayer across the hole using a teflon loop. At a constant voltage of 20 mV, upon forming 
stable bilayer, a certain amount of protein was added to increase the conductance up to 100-200-
fold so as to allow the insertion of multiple channels (100-200). High molar salt solution (3 M 
NaCl, 10 mM HEPES, pH 7.0) was then added to create a desired salt gradient and the zero-
membrane potentials were measured from the connected electrometer. The study with the low 
salt gradient involved 0.01 M KCl in bath solution to achieve 10-fold KCl concentration with the 
stepwise addition of high molar salt. Likewise, the high salt gradient measurement was done by 
achieving 10-fold concentration of 0.1 M KCl (in bath solution). The resting membrane potential 
(Vm) was calculated using the Goldmann-Hodgkin-Katz equation (Equation 3).  
 
  Vm = RT   ln (Pcation [cation]o + Panion [anion]i) 
             F        (Pcation[cation]i + Panion [anion]o)  
Equation 3 – Goldmann-Hodgkin-Katz equation. 
Vm = Resting membrane potential, R = universal gas constant (8.314 J.K
-1
.mol
-1
) 
T = temperature in Kelvin (K = °C + 273.15), F = Faraday's constant (96485 C.mol
-1
) 
Pcation/Panion = relative membrane permeability of cation/anion 
[cation]o/[anion]o = concentration of cation/anion in the extracellular medium 
[cation]i/[anion]i = concentration of cation/anion in the intracellular medium 
 
2.10.1.2.  Conductance measurements 
To compute the conductance of target proteins, the instrumentation for multichannel was 
set up in a similar manner as described above (section 2.10.1.1). The lipid bilayer experiments 
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were carried out in 1 M KCl buffer solution (10 mM HEPES. pH 7.5). A certain concentration of 
protein (5 µl of 10
7
/10
8
 dilution of 10 mg/ml protein stock) was added to both sides (cis and 
trans) of the membrane and 20 mV potential was applied through the attached electrodes. The 
gradual increase in the channel insertions induced stepwise increase in the conductance which 
was printed on a chart. The steps indicating the conductance increase were manually counted off 
the chart and plotted to calculate the average conductance (at least 80-100 channels).  
 
2.10.2.  Single channel experiments 
All single channel measurements were done with a 25 µm thick Teflon film partitioning a 
cuvette, where each formed chamber contained 10 mM HEPES buffer with 1 M KCl at pH 7.0 
(unless stated otherwise). The Teflon film was pierced with a 75 µm wide aperture that was used 
for forming a lipid bilayer from n-pentane solution of 5 mg/ml diphytanoylphosphatidylcholine 
(DPhPC, Avanti Polar lipids). The electrodes of Ag/AgCl (World Precision Instruments, 
Sarasota) were used to measure current, with one electrode grounded (at the cis side of the 
membrane) and the other electrode (at the trans side of membrane) connected to an amplifier 
(200B Axopatch, Axon Instruments, CA). To ensure the insertion of a single channel, a very low 
concentration of protein (1-2 µl of 10
-6
 – 10-7 dilution of 10 mg/ml protein stock) was added to 
the cis side of the chamber. The voltages were applied with an Axopatch™ 200B Patch Clamp 
amplifier and data was captured using Axon Digidata 1440 digitizer. Sampling frequency of 50 
kHz was used for all measurements with a low-pass Bessel filter cut-off applied at 10 kHz. 
Acquisition and analysis of the data was done using Clampex and Clampfit software respectively 
(Axon Instruments, CA).  
 
2.10.4.  Antibiotic interaction studies 
The instrumentation for studying antibiotic interaction was set up as described for the 
single channel experiments (section 2.10.2). Antibiotic solutions (with varying concentrations of 
up to 10 mM) were added at cis- and trans- sides of the membrane to analyse antibiotic-porin 
interaction.  
 
In order to calculate the binding constant values (K; Equation 3), transient current 
blocking events were analysed to derive values for kon (association rate constant) and koff 
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(dissociation rate constant). The number of binding events per second divided by the 
concentration (of the added substrate) gives kon , while koff is derived from the inverse of the 
residence time τ, which in turn is calculated by an exponential fit of the dwell time histogram. 
  
   
    
 
Equation 3: Binding constant. Where K=binding constant (M
-1
) 
kon (M
-1
 s
-1
) is association rate constant, koff  (s
-1
) is dissociation rate constant. 
 
2.11. Bioinformatics 
Bioinformatics tools used in this study are listed below in Table 2.11. 
Table 2.11. List of Bioinformatic tools used for the study.  
Provided with the website links and description of use.  
Bionformatic tool Source Description 
Genetic 
and 
Proteomic 
tools 
BLAST https://blast.nc
bi.nlm.nih.gov
/ 
 
Basic Local Alignment Search Tool (BLAST; 
Altschul et al., 1990). Finds proteins with 
conserved regions (homologues). The query 
sequence (protein or nucleotide) is compared to a 
database of non-redundant sequences. 
KEGG http://www.ge
nome.jp/kegg/ 
 
Kyoto Encyclopedia of Genes and Genomes 
(KEGG; Kanehisa et al., 2000). Used for 
searching DNA/protein sequences and 
organisation of proteins within the genome. 
UniProt http://www.un
iprot.org/ 
 
A vast database providing comprehensive 
sequence and functional information of proteins. 
Protein 
Parameters 
ExPASy 
ProtParam 
http://web.exp
asy.org/protpa
ram/ 
 
Calculates e.g. molecular weight, isoelectric 
point and extinction coefficient for the input 
protein sequence. 
ExPASy 
Translate 
http://web.exp
asy.org/transla
te/ 
 
Translates the DNA nucleotide sequence to 
amino acid sequence. Useful for analysing 
sequencing results for recombinant constructs. 
Primer 
Design 
OligoCalc http://biotools.
nubic.northwe
stern.edu/Olig
oCalc.html 
 
(Kibbe 2007) Calculates oligonucleotide 
parameters (melting temp, G/C content etc.) 
based on DNA sequence. Useful for primer 
designing. 
NEBcutter 
V2.0 
http://nc2.neb.
com/NEBcutt
er2/ 
 
(Vincze et al., 2003) Helps in locating restriction 
enzyme sites within a DNA sequence, provided 
as input. 
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Alignment Clustal 
Omega 
https://www.e
bi.ac.uk/Tools
/msa/clustalo/ 
 
(Sievers et al., 2011). Tool provided by EMBL-
EBI. Used for multiple sequence alignment of 
protein sequences. 
Structural 
data 
Molprobity http://molprob
ity.biochem.d
uke.edu/ 
 
Online validation tool for checking the 
refinement parameters of protein structure 
models. (Chen et al., 2010) 
Diffraction 
Anisotropy 
server 
https://service
s.mbi.ucla.edu
/anisoscale/ 
 
An online tool for performing ellipsoidal 
truncation and anisotropic scaling for the 
diffraction data (Strong et al., 2006) 
CCP4 online https://www.c
cp4.ac.uk/ccp
4online/ 
Collaborative Computational Project No. 4 
(CCP4) is a software suite for Macromolecular 
X-Ray Crystallography. Used for automated 
molecular replacement (MR) pipelines for data 
processing. 
RCSB-PDB 
PDBe 
https://www.r
csb.org/pdb/ 
https://www.e
bi.ac.uk/pdbe/ 
 
Database of protein structures. Structures from 
this study were deposited to PDBe. 
 
 
2.12. Statistical Analysis and Data Presentation 
The following statistical analysis has been applied for calculating and presenting the data (as 
described in Chapter 5): 
 Disc-diffusion assay (discussed in section 5.2): For each molecule, three independent 
measurements were used to calculate the mean and the standard deviation. To present the 
data, a column-graph (Figure 5.1) was plotted using the mean values and the error bars 
represent the standard deviation of the data set.  
 Liposome swelling assay (discussed in section 5.4):  For each substrate, triplicate values 
were recorded in every experiment. Three such experiments were performed to produce a 
total of nine values which were then used to calculate the mean and the standard 
deviation. The mean values were plotted to present the data in a column-graph (Figures 
5.5 and 5.18), with the error bars corresponding to the standard deviation.  
 Multichannel conductance (discussed in section 5.6): The data presented in the column-
graph (Figure 5.8) was plotted using the mean of three values, each recorded from three 
independent experiments.  
 Ion-selectivity (discussed in section 5.7): The data presented in the scatter-graph (Figures 
5.9 and 5.10) was plotted using the mean of three values, each recorded from three 
independent experiments and the error bars represent the standard-deviation of the data 
set. 
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Chapter 3 Recombinant expression of OMPs in E. coli 
3.1 Introduction 
OmpF and OmpC in E. coli are two typical diffusion porins representing a structural as 
well as functional paradigm for Gram-negative porins. This chapter describes the isolation and 
purification of major porins from 3 notorious gram-negative pathogens: OmpE35/E36 (from 
Enterobacter cloacae), OmpK36 (from Klebsiella pneumoniae) and OmpU/T (from Vibrio 
cholerae) in E. coli as the recombinant host. The other major porin of Klebsiella pneumoniae, 
OmpK35, was structurally characterised by another member of the lab (also see section 5.1).  As 
a result of interesting findings for the structures of OmpU and OmpT (as discussed in section 
4.1), two additional mutants; OmpUΔN and OmpTΔL8, were also constructed and expressed in 
E. coli. In order to target these recombinant OMPs (OmpE35/E36/K36, OmpU/UΔN and OmpT) 
to E. coli OM, each of their signal peptides were swapped with the signal sequence of OmpA 
(OMP in E. coli). Since the membrane expression of OmpT and OmpUΔN produced low yields 
of the sample with poor purity (as discussed in sections 3.4 and 3.5), both OMPs (and 
OmpTΔL8) were alternatively expressed as IBs. For transformation (of pBAD24 cloned 
constructs) we have used a porin-deficient strain of E. coli, referred to as omp8 (BL21), which 
lacks ompF, ompC, ompA, lamB and phoE. The pET28 cloned constructs (designed for IB 
expression) were electroporated in E. coli Bl21 (DE3) cells. To check the expression of an OMP, 
the overexpression trials were usually done with 2 litres of LB media (unless stated otherwise) 
prior to large scale harvest (that employed 10-12 litres growth media).  
 
In E. coli OmpF/C porins, β-barrel structure is characterised by a salt bridge between α-
amino group and the C-terminal carboxylate. This precludes the use of terminal tags for protein 
purification given the presumed structure similarities between OmpF/C and OMPs of this study.  
Hence, all tag-less OMPs were purified by anion-exchange chromatography (IEX) and size 
exclusion chromatography (SEC) (also see sections 2.4.4.1 and 2.4.4.3). Except for histidine 
tagged OmpT (with a 6× his-tag in one of the predicted loops of OmpT), which was purified by 
immobilised metal affinity chromatography (IMAC) and SEC (also see sections 2.4.4.2 and 
2.4.4.3). To assess the purity and integrity of the purified OMPs, the samples were analysed on 
SDS-PAGE as boiled (B) and non-boiled (NB) samples. 
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Detergents (or surfactants) are normally used to extract the membrane proteins from the 
membrane fraction. Sarkosyl, an anionic detergent, plays a unique role in the separation of the IM 
and OM fractions. Since in low ionic strength buffer the density of sarkosyl resembles that of the 
LPS-phospholipid layer, treatment with sarkosyl followed by centrifugation solubilises and 
removes IM-bound proteins. For the extraction and purification of OMPs, the most common 
detergent used was lauryldimethylamine N-oxide (LDAO) except for some cases, where milder 
detergents such as n-decyl-β-D-maltopyranoside (DM) and n-dodecyl-β-D-maltopyranoside 
(DDM) were employed for OM extraction purposes (see section 3.5.3). We have used octyl 
tetraethylene glycol ether (C8E4) for our final protein stocks, since this has been a successful 
detergent for the crystallisation of β-barrel membrane proteins.   
 
3.2. Overexpression and purification of OmpE35, OmpE36 and OmpK36  
The genomic DNA of Enterobacter cloacae (ATCC 13047) and Klebsiella pneumoniae 
(ATCC 43816) were obtained from Basilea Pharmaceutica Limited, Basel Switzerland. The 
genes of OmpE35, OmpE36 and OmpK36 were amplified using the genomic DNA (of E. cloacae 
and K. pneumoniae) as the template in the Polymerase Chain Reaction (PCR) (Figure 3.1). 
Primers designed using the N- and C- terminus of ompE35, ompE36 and ompK36, were used to 
amplify the gene sequences and successfully cloned into pBAD24 plasmid using the restriction 
sites NcoI and XbaI (Figure 3.1).  
 
 
 
 
 
 
 
 
 
Figure 3.1 PCR and cloning of OmpE35/E36 and OmpK36.  
DNA gel image showing (A) PCR amplified genes of OmpE35, OmpE36 and OmpK36 (using 
genomic DNA as the template) and (B) amplified products of pBAD cloned constructs of 
OmpE35/E36 and OmpK36 using colony PCR. L represents the molecular weight marker. 
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The pBAD24-cloned OmpE35/E36/K36 constructs were electroporated in the competent 
cells of E. coli omp8 (Bl21) strain and the OMPs (OmpE35, OmpE36 and OmpK36) were 
overexpressed (Table 2.8 and section 2.4.2.1) and extracted from the membrane fraction (section 
2.4.3.1). The proteins were separated by IEX (section 2.4.4.1) with a salt gradient from 50 mM to 
1 M over 20 column volumes (CV) using Resource Q (Figure 3.2 A, B and C).  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. Purification of OmpE35, OmpE36 and OmpK36 by IEX and SEC.  
The elution of OmpE35 (A), OmpE36 (B) and OmpK36 (C) through Resource Q with the salt 
gradient (y axis: 50 mM – 1 M NaCl) shown in blue. The GF peak obtained in 0.45% C8E4 for 
OmpE35 (D), OmpE36 (E) and OmpK36 (F) eluted at ~65 ml. For each protein, the peak 
fractions were pooled and analysed by SDS-PAGE (indicated by arrows) as non-boiled (Lane 
NB) and boiled (Lane B) samples.  
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The purification of OmpE35/E36/K36 was done by SEC (section 2.4.4.3) using 120 ml 
S200 GF (Superdex 200 PG gel-filtration) column in 0.05% LDAO followed by second round of 
SEC purification in 0.45 % C8E4 (Figure 3.2 D, E and F).  C8E4 peak fractions of OmpE35, 
OmpE36 and OmpK36 were pooled and analysed by SDS-PAGE to assess the purity of the 
proteins (Figure 3.2). Post-visualisation of protein bands by Coomassie blue staining, the proteins 
were subjected the crystallisation trials (section 4.2). The typical yields of OmpE35 and OmpK36 
were 4-5 mg of protein per litre of cells, while the yield for OmpE36 was ~12 mg of protein per 
litre of cells.  
 
3.3. Overexpression and purification of OmpU  
A synthetic gene for the mature part ompU (V. cholerae OmpU Uniprot id K08720) and 
the signal sequence of E. coli OmpA was obtained from Eurofins Genomics and cloned into 
pBAD24 plasmid using NcoI/XbaI restriction enzymes. The bacterial colonies containing pBAD-
OmpU constructs were screened by colony PCR (section 2.3.8 and Figure 3.3) and confirmed by 
DNA sequencing.    
 
 
 
 
 
 
 
 
 
Figure 3.3. Screening of bacterial colonies with pBAD-OmpU plasmid by colony PCR.  
DNA gel image showing amplification of ompU (insert, ~1 kbp) cloned in pBAD24 with 3 
positive clones (indicated by arrow in lanes 3, 4 and 5) and 2 negative clones (1 and 2; estimated 
size is  ~1 kbp).  L represents the molecular weight marker. 
 
The pBAD24-OmpU construct was transformed into omp8 (Bl21) competent cells and the 
protein was overexpressed at 37°C for 3 hours after induction with 0.1% arabinose (also 
described in section 2.4.2.1). OmpU was eluted by IEX using a salt gradient (50 mM – 1 M NaCl 
over 20 CV) on Resource Q column (Figure 3.4 A). OmpU purification by SEC was first carried 
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out in 0.05% LDAO and then in 0.45% C8E4 (Figure 3.4 B). The chromatogram in Figure 3.4 B 
shows the main peak of OmpU at ~75 ml (in 120 ml GF column) which indicates the elution of 
monomer. The quality of purified OmpU was analysed on SDS-PAGE (Figure 3.4 C). The 
overall yield of OmpU was ~1 mg of protein per litre of cells and the pure protein was 
concentrated to 10 mg/ml for crystallisation (as described in section 2.4.5).  
 
 
 
 
 
 
 
 
 
Figure 3.4. Elution and Purification of OmpU.  
(A) Resource-Q chromatogram of OmpU showing elution in a high salt gradient as represented 
by linearly increasing conductance (in blue). (B) GF chromatogram showing the final purification 
step of OmpU in 0.45% C8E4 column with a peak at ~75 ml. (C) Coomassie stained SDS-PAGE 
gel showing contents of GF peak fractions (Lane NB: non-boiled and Lane B: boiled). The 
arrows of SDS-PAGE indicate the bands of OmpU (~38 kDa). 
 
3.4.  Overexpression and purification of OmpUΔN 
The first 30 nucleotides from the N-terminus of the mature ompU were deleted by site-
directed mutagenesis (SDM; section 2.3.1.2) using OmpU-pBAD24 plasmid as the template. As a 
result, ompUΔN sequence optimised with signal sequence of E. coli OmpA was cloned into 
pBAD24 using NcoI and XbaI restriction sites and omp8 (Bl21) cells were transformed with the 
recombinant OmpUΔN-pBAD24 construct. Figure 3.5 shows the DNA gel image for the 
screening of clones containing OmpUΔN-pBAD24. 
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Figure 3.5. Screening of clones with pBAD24-OmpUΔN recombinant plasmid.  
DNA gel image showing amplification of ompUΔN (insert, ~1.2 kbp) cloned in pBAD24 
plasmid. Except for lane 1, the other 6 clones are positive (lane 2- lane 7; indicated by arrow). 
 
 
 
 
 
 
 
 
 
Figure 3.6. Purification of membrane-expressed OmpUΔN  
(A) The elution peak of OmpUΔN through HiTrap-Q in high salt gradient (conductance in blue) 
was analysed on SDS-PAGE (as boiled; B). (B) The S200 chromatogram showing OmpUΔN 
peak at 70 ml and the peak fractions were loaded as non-boiled (Lane NB) and boiled (Lane B) 
samples on SDS-PAGE. The arrows of SDS-PAGE indicate the bands of OmpUΔN (~37 kDa). 
 
OmpUΔN was expressed at 37°C for 3 hours post-induction with arabinose and extracted 
from the OM (as described in sections 2.4.2.1 and 2.4.3.1). A shallow salt gradient (50 mM – 0.5 
M NaCl over 10 CV) was applied to purify OmpUΔN by IEX (section 2.4.4.1) using HiTrap-Q 
(Figure 3.6 A). On SDS-PAGE, the eluted fractions showed low expression of OmpUΔN and 
high levels of impurities (Figure 3.6. A). To remove the excess impurity, the protein was purified 
through S200 GF column in 0.05 % LDAO and subsequent fractions of OmpUΔN peak were 
subjected to MonoQ. OmpUΔN was purified using a salt gradient (50 mM – 0.5 M NaCl over 30 
CV) and the peak fractions through MonoQ column were loaded on S200 GF column for the final 
step of purification in 0.45 % C8E4 (Figure 3.6. B). Extensive purification carried out for 
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OmpUΔN resulted in big losses of the protein and as a result, its final yield was extremely low 
(~0.2 mg per litre of cells). In addition, the purity levels of purified OM-expressed OmpUΔN 
were imperfect for crystallisation (Figure 3.6 B). Despite these concerns the protein was used for 
crystallisation trials (Chapter 4).  
 
The problem of membrane expression of OmpUΔN was solved by expression as IBs. 
ompUΔN was cloned into pET28a plasmid using NcoI and XhoI restriction sites without the 
signal peptide. Following overexpression trials of OmpUΔN (as described in section 2.4.2.1 and 
Table 2.8) and protein isolation by solubilisation of IBs, OmpUΔN was folded in vitro by 
continuously stirring in IB buffer containing 1% LDAO (also see section 2.4.3.2) at room 
temperature (RT). A salt gradient was used to elute OmpUΔN through gravity flow anion-
exchange (see section 2.4.4.1). The SDS-PAGE gel of OmpUΔN OM extract (Figure 3.7 B; Lane 
1) showed high expression levels of the IB-expressed OmpUΔN as compared to the membrane 
expressed OmpUΔN (Figure 3.6 A). A two-step purification was performed by SEC, first in 0.05 
% LDAO followed by 0.45 % C8E4 (Figure 3.7 A). The C8E4 GF peak was analysed by SDS-
PAGE (Figure 3.7 B; Lanes 2 and 3). Typical yields of IB-expressed OmpUΔN were 5-6 mg of 
protein per litre of cells.  
 
 
 
 
 
 
 
 
Figure 3.7. Purification of OmpUΔN from Inclusion Bodies.  
(A) The S200 GF-chromatogram of OmpUΔN purification in 0.45 % C8E4. (B) Coomassie 
stained SDS-PAGE gel showing the contents of the OM extract (Lane 1) and GF peak fractions 
(Lane 2: non-boiled and Lane 3: boiled). The arrows indicate the DNA band for OmpUΔN (~37 
kDa). 
 
3.5. Overexpression and purification of OmpT  
The DNA sequence of Vibrio cholerae OmpT (Uniprot id K10940) was synthesised by 
Eurofins Genomics. ompT was directly excised from the obtained plasmid constructs using 
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restriction digestion and cloned into the desired vector. The overexpression of OmpT was 
extremely challenging because of very low expression. Thus, for isolating the purest fractions of 
OmpT, several different methodologies had to be adopted that are detailed in this section. 
 
3.5.1.  Overexpression trials of OmpT  
The ompT gene sequence was cloned into pBAD24 plasmid using NcoI/XbaI restriction 
sites (Figure 3.8).  
 
 
 
 
 
 
 
 
 
Figure 3.8. Screening of pBAD24-OmpT plasmid constructs.  
DNA gel image showing amplification of ompT (insert, ~1.1 kbp) cloned in pBAD24. Lanes 2, 4 
and 5 display the clones with pBAD24-OmpT recombinant plasmid (indicated by arrow). 
 
The pBAD24-OmpT construct was electroporated into omp8 (Bl21) competent cells and 
overexpression of OmpT was done in similar manner as described earlier (in section 2.4.2.1 and 
Table 2.8). OmpT was isolated from the membrane fraction using a high salt gradient (50 mM – 1 
M NaCl over 20 CV) through HiTrap Q (Figure 3.9 A). The OmpT peak fractions were subjected 
to SEC in 0.05 % LDAO for purification (Figure 3.9 B). The GF peak fractions, as assessed by 
SDS-PAGE, showed strong contamination (Figure 3.9 C). Moreover, since average yield of 
membrane-expressed OmpT was extremely low (~ 0.1 mg per litre of cells), we varied different 
growth conditions (like growth media and temperature) to boost the expression of OmpT.   
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Figure 3.9 Membrane expression of OmpT (cloned in pBAD24 plasmid). 
(A) OmpT elution from HiTrap-Q column using high salt gradient. (B) The S200 GF 
chromatogram showing OmpT peak at ~ 75 ml (in 0.05% LDAO). (C) Coomassie stained SDS-
PAGE gel showing contents of GF peak fractions (Lane NB: non-boiled and Lane B: boiled). The 
arrows of SDS-PAGE indicate the bands of OmpUΔN (~37 kDa). 
 
A particular observation made for the membrane expression of OmpT was low cell OD 
after 3 hours of induction (0.6 - 0.7) which indicated toxicity. On the other hand, under similar 
conditions, the membrane expression of OmpU resulted in an OD of 1.0 - 1.2 post-induction. In 
order to promote the extended growth phase of OmpT-expressed cells, a nutritionally enriched 
media (2×YT) media was used in combination with MgSO4 (Table 2.1) that enhances the 
bacterial cell growth. The overexpression trials of OmpT in MgSO4 supplemented 2×YT media 
were done at 37°C (for 3 hours), 30°C (for 5 hours) and 18°C (for overnight) (Figure 3.10 C). A 
few reports have implicated the role of environmental conditions such as high osmolarity or 
minimal media in affecting the expression of OmpT in V. cholerae (Li et al., 2002). Subsequent 
steps were taken to improve the protein expression by varying the composition of growth media. 
The overexpression trials of OmpT were performed in LR minimal media at two different 
temperatures (30°C or 37°C) (Figure 3.10 A). In addition, the expression trials were also carried 
out in high osmolarity conditions using LB media supplemented with different NaCl 
concentrations; 0.125 M and 0.225 M (Figure 3.10 B). The expression trials with media 
supplemented with 0.125 M NaCl was done in 3 different batches and cells were harvested at 
different time-points post induction (1, 2 or 3 hours) to ensure accumulation of healthy cells and 
avoid toxicity (Figure 3.10 B).  
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Figure 3.10. Expression checks of OmpT under different growth conditions.  
(A) SDS-PAGE of IEX eluates (boiled) of OmpT grown in LR minimal media and expressed at 
30°C (Lane 1) and 37°C (Lane 2); OmpT expressed at 37°C in LB media was run as control 
(Lane 3). (B) SDS-PAGE of boiled OM extracts of OmpT grown in LB media with no 
supplement (Lane 1; control), supplemented with 0.125 M NaCl [Lane 2; 3 hours induction, Lane 
3; 2 hours induction and Lane 4; 1-hour induction) and supplemented with 0.225 M NaCl (Lane 
5; 3 hours induction). (C) SDS-PAGE of boiled OM extracts of OmpT grown in 2×YT media 
(with MgSO4) expressed at 37°C for 3 hours (Lane 1), 30°C for 5 hours (Lane 2) and 18°C for 
overnight (Lane 3). The arrows indicate the bands of OmpT (~40 kDa). 
 
The SDS-PAGE of the OM extracts from different overexpression trials (Figure 3.10) 
indicated low membrane expression of OmpT with poor purity levels.  
 
3.5.2.  Large scale expression of OmpT  
Despite the low yield for the membrane expression of OmpT (~0.1 mg of protein per litre 
of cells), we expressed OmpT on a large scale to obtain sufficient amount of protein for 
crystallisation. The plasmid construct pBAD24-OmpT was electroporated in omp8 (Bl21) cells 
and OmpT was expressed in 50 litres LB media (Amp
r
) in 5 different batches (10 litres each) at 
37°C for 3 hours. For each batch, the OM extracts were subjected to HiTrap-Q chromatography 
and the protein was further purified by SEC (in 0.05 % LDAO) and Mono-Q (50 mM-0.5 M 
NaCl over 30 CV). The peak fractions of OmpT of the 5 Mono-Q batches were pooled together 
prior to the final purification by SEC in 0.45 % C8E4 (Figure 3.11 A). A total of 4 mg of OmpT 
was obtained from the large-scale expression of 50 litres. SDS-PAGE in Figure 3.11 B shows the 
non-boiled and boiled samples of purified OmpT (from C8E4 GF peak) used for crystallisation.  
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Figure 3.11. Purification of OmpT from large scale expression (50 litres).  
(A) OmpT peak at 72 ml through SEC purification in 0.45% C8E4. (B) Coomassie stained SDS-
PAGE gel showing contents of GF peak fractions (Lane NB: non-boiled and Lane B: boiled). The 
arrow on SDS-PAGE indicate the bands of OmpT (~40 kDa). 
 
3.5.3.  Overexpression and purification trials of His-tag OmpT  
OmpT produced from the expression of 50 litres allowed us to set up 150-200 screen 
conditions for crystallisation and optimise some of the hit conditions. One of the screen 
conditions yielded just one crystal of decent size (further discussed in sections 4.3 and 4.8). The 
protein crystallisation was perhaps hindered by the persistent presence of impurities in the 
membrane isolated fractions of OmpT, as seen in the SDS-PAGE gels (Fig. 3.11). To improve the 
efficiency of OmpT purification, a histidine tag was incorporated in the ompT sequence.  
 
 
 
 
 
 
 
 
 
Figure 3.12. Screening of pBAD24 his-OmpT plasmid constructs.  
DNA gel image showing amplification of histidine-tagged ompT (insert, ~1.2 kbp) cloned in 
pBAD24. Lanes 2, 3 and 4 display the positive clones with pBAD24 his-OmpT recombinant 
plasmid (indicated by arrow). 
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According to OmpT structure prediction (by online software program BOCTOPUS 
(Hayat and Elofsson 2012), the histidine tag was incorporated in one of its predicted extracellular 
loops (L6) such that the insertion might not interfere the (expected) trimeric form of OmpT. 
Thus, histidine-tagged ompT was synthesised from Eurofins with the 6× His tag between Thr260 
and Gly261 of mature OmpT. His-tag ompT was cloned in pBAD24 using NcoI/XbaI restriction 
sites and His-OmpT pBAD24 constructs were confirmed by colony PCR (Figure 3.12). 
 
His-OmpT pBAD24 construct was transformed in DE3 cells (Bl21) of E. coli (healthier 
strain as compared to slow growing omp8 strain). The overexpression trials for his-OmpT were 
done similarly to the previous section (section 3.5.2). Histidine-tagged protein was isolated from 
the membrane fraction by IMAC (section 2.4.4.3). His-OmpT was further purified by SEC in 
0.05 % LDAO. During purification, the protein peak was very close to the void volume of the GF 
column (Figure 3.13 A) suggesting aggregation of his-OmpT. The identity of his-OmpT was 
assessed by loading the GF fractions of both peaks on SDS-PAGE (Figure 3.13. B). 
 
 
 
 
 
 
 
 
 
Figure 3.13. Purification of his-OmpT (cloned in pBAD24).  
(A) S200 GF (120 ml) chromatogram for the purification of his-tag OmpT shows peak 1 at ~ 55 
ml and peak 2 (at ~ 75 ml) implying a monomer. (B) Coomassie stained SDS-PAGE gel showing 
contents of GF peak fractions of peak 1 (Lane 1) and peak 2 (Lane 2). The arrows in the SDS-
PAGE indicate the bands of OmpT (~ 40 kDa). 
  
To solve the aggregation problem, different detergents (other than LDAO) were employed 
for the extraction and purification of his-OmpT. Towards this, 3 different detergents (1% DM, 
1% DDM or 1% OG + 0.5% LDAO) were used for the extraction (section 2.4.3.1). In addition, 
0.1% DDM (n-Dodecyl-β-D-Maltoside) was used in the purification buffers (instead of 0.05% 
LDAO) for the protein elution through Ni
+2
 affinity column and purification through 24 ml 
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analytical GF column (Superdex 200 PG 10/300 GL). The purification chromatograms in Figure 
3.14 show protein elution near the void volume of GF column (~ 9 ml), again suggesting 
aggregation of his-OmpT.  
 
 
 
 
 
 
 
 
Figure 3.14. Purification of his-OmpT (cloned in pBAD24).  
The chromatograms show the elution of his-OmpT in the void volume (~ 9 ml) of analytical GF 
after IMAC of the membrane fraction extracted in (A) 1% OG + 0.5% LDAO, (B) 1% DDM and 
(C) 1% DM. 
 
Imidazole (~ 250 mM) used to elute protein from the IMAC column could be a potential 
factor for the aggregation of his-tagged protein. Towards this, we employed alternate methods for 
the elution of his-tagged OmpT. One such method adopted the use 100 mM EDTA (instead of 
imidazole) to chelate the nickel ions of the column and strip off the metal and protein, which was 
immediately followed by buffer exchange to remove Ni-EDTA from the protein. Another method 
employed for elution of his-OmpT used low pH buffer (50 mM sodium acetate, 200 mM NaCl, 
pH 4.5) in order to protonate the histidines of OmpT and disrupt binding with the nickel ions of 
the column. For both elution strategies, the purification of his-OmpT through 24 ml analytical GF 
column displayed irregular peaks (Figure 3.15 A and B). Cobalt has a lower affinity for His and 
requires lower imidazole concentration for the protein elution than nickel. Hence, 50 mM 
imidazole was used to elute his-OmpT from a cobalt-charged IMAC column. The purification of 
his-tag OmpT by analytical GF produced a single sharp peak at ~ 13 ml (Figure 3.15 C) and 
showed no trace of aggregation. However, since the final yield of his-OmpT was very low (0.05 
mg protein per litre of cells), it was not pursued for large scale expression.  
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Figure 3.15. Purification of his-OmpT (cloned in pBAD24).  
Protein purification through 24 ml analytical GF column for his-tag OmpT, which was eluted 
using (A) EDTA, (B) low pH and (C) 50 mM imidazole in a Co
2+
 affinity column. 
 
 3.5.4.  Inclusion body expression of OmpT  
Since the membrane expression of OmpT (or his-OmpT) produced low yields of purified 
protein, we approached an alternative strategy of expression by forming inclusion bodies (IBs). 
ompT (without the signal peptide) was PCR amplified and subsequently cloned into pET28a 
expression vector using NcoI/XhoI restriction sites (Figure 3.16).  
 
 
 
 
 
 
 
 
Figure 3.16. Cloning of OmpT-pET28a recombinant plasmid.  
(A) DNA gel image showing digests of ompT insert (995 bp; Lane I, arrow indicated) and 
pET28a vector (5.3 kbp; Lane V) using NcoI/XhoI restriction enzymes. (B) DNA gel image for 
the screening of OmpT-pET28a constructs (positive clones) by colony PCR; Lanes 1-3 show 
positive clones (indicated by arrow). 
 
The omp8 (Bl21) and DE3 (Bl21) strains of E. coli cells were separately transformed with 
OmpT-pET28 construct. The overexpression trials followed by protein purification were done in 
a similar manner as described above for the IB expression of OmpUΔN (section 3.4; also see 
sections 2.4.2.1, 2.4.3.2 and Table 2.8). For the purification of OmpT, isolated from omp8 (Bl21) 
cells, some of the protein came out as an aggregated mass in the void volume (~ 45 ml) of SEC 
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(Figure 3.17 A). Surprisingly however, OmpT isolated from DE3 (Bl21) cells was purified as a 
single sharp peak (at 72 ml) and showed no trace of aggregation (Figure 3.17 B). Hence for large 
scale expression, IBs of OmpT (cloned in pET28a) were expressed in DE3 (Bl21) cells and the 
purified protein was obtained by performing two rounds of SEC (first in 0.05% LDAO and final 
in 0.45% C8E4). Typical yields obtained for OmpT (isolated from IBs) were 2-3 mg of protein per 
litre of cells and was used to set up the crystal drops (section 4.3).     
    
During initial crystallisation and optimisation, one of the crystals obtained for OmpT 
diffracted to ~2.0 Å. However, the structure of the protein could not be solved because of the 
unavailability of a good molecular replacement (MR) model for OmpT. Experimental phasing is 
another method (other than MR) that provides the solution for the phase problem and requires the 
anomalous scattering by a heavy atom (HA). Hence, OmpT was expressed to incorporate 
selenomethionine in its sequence and use selenium as the phasing marker (as described in the 
next section 3.5.5). 
 
 
 
 
 
 
 
 
Figure 3.17. Purification of OmpT expressed as inclusion bodies (IBs).  
(A) S200 GF chromatogram for purification of OmpT, isolated from IBs in omp8 (Bl21) cells; 
peak 1 in the void volume of GF column indicates protein aggregation (Lane 1 of SDS-PAGE; 
boiled) and peak 2 is OmpT monomer (Lane 2 of SDS-PAGE; boiled). (B) S200 GF 
chromatogram for purification of OmpT, isolated from IBs expressed in DE3 (Bl21) cells. A 
single sharp peak at 70 ml is present (on SDS-PAGE, Lane NB; non-boiled and Lane B; boiled). 
The arrows indicate OmpT (~ 40 kDa). 
 
 
3.5.5.   Overexpression of selenomethionine substituted of OmpT  
The use of selenium (Se; heavy atom) in methionine instead of sulphur forms the basis of 
anomalous diffraction (required for experimental phasing). In order to use Se as the phasing 
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marker, we overexpressed and purified SeMet-labelled OmpT (cloned in pET28a) as IBs from 
Bl21 (DE3) cells of E. coli (see section 2.4.2.2 and Table 2.8).  
 
 
 
 
 
 
 
 
 
Figure 3.18. Purification of selenomethionine substituted OmpT (SeMet OmpT).  
(A) S200 GF chromatogram showing a single sharp peak of SeMet OmpT (at ~ 70 ml). (B) 
Coomassie stained SDS-PAGE gel showing contents of pooled GF peak fractions (Lane NB: 
non-boiled and Lane B: boiled). The arrow indicates SeMet OmpT (~ 40 kDa). 
 
SeMet-OmpT (folded in vitro) was purified by IEX using a gravity flow anion-exchange 
column and further purified by SEC in 0.05% LDAO. A final round of S200 GF purification was 
done in 0.45% C8E4 (Figure 3.18 A). Elution of OmpT at 70 ml (in 120 ml GF column) 
corresponds to the monomeric form of Se-Met OmpT (Figure 3.18 B). Typical yields of Se-Met 
OmpT were 2 mg per litre of cells. 
 
3.6. Overexpression and purification of OmpTΔL8  
 
 
 
 
 
 
 
 
Figure 3.19. Cloning of OmpTΔL8-pET28a recombinant plasmid.  
DNA gel image for the screening of OmpTΔL8-pET28a constructs (ompTΔL8; ~ 1.0 bp) by 
colony PCR; Lanes 1-6 show positive clones (indicated by arrow). Lane C is the control showing 
ompT (~ 1.1 kbp). 
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Sixteen residues from loop L8 of OmpT (Thr294 - Thr309 in mature OmpT sequence) 
were deleted by Q5 site-directed mutagenesis kit (SDM) and replaced by one glycine residue to 
connect the strands (section 2.3.1.2). As a result, ompTΔL8 (L8 deletion mutant of ompT) was 
cloned into pET28a without the signal peptide using NcoI/XhoI restriction sites (Figure 3.19).  
 
OmpTΔL8-pET28a was electroporated into DE3 (Bl21) cells of E. coli. The protein 
overexpression as IBs was followed by isolating OmpTΔL8 through solubilisation of IBs (section 
2.4.3.2). Protein purification (section 2.4.4) was done by IEX using gravity flow anion-exchange 
column and by SEC in 0.05% LDAO and 0.45% C8E4 (Figure 3.20). The average yield of 
OmpTΔL8 was 4 mg of protein per litre of cells.  
 
 
 
 
 
 
 
 
 
 
Figure 3.20. Purification of OmpTΔL8.  
(A) The purification chromatogram of S200 GF column (120 ml) showing a single sharp peak at 
70 ml for OmpTΔL8. (B) Coomassie-stained SDS-PAGE gel showing contents of GF peak 
fractions (Lane NB: non-boiled and Lane B: boiled). The arrow indicates OmpTΔL8 (~ 38 kDa). 
 
3.7. Discussion 
The OmpF/C orthologs of E. cloacae (OmpE35, OmpE36) and K. pneumoniae (OmpK36) 
were recombinantly expressed in the OM in the porin deficient omp8 strain of E. coli. Despite 
considerable loss of proteins during the purification steps, the overall high expression levels of 
OmpE35/E36/K36 enabled us to obtain approximately ~ 2-3 mg of pure proteins per litre of cells 
which were used for crystallisation. On other hand, the membrane expression of V. cholerae 
porins, OmpU and OmpT was comparatively poor. Average yield of OmpU was approximately 1 
mg of protein per litre of cells while the yield for membrane-expressed OmpT was 5-fold less (~ 
0.2 mg per litre of cells). In addition, OmpT fractions isolated from the membrane contained 
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several impurities that were persistent despite multiple rounds of purification. The histidine tag 
employed to improve the efficiency of OmpT purification and get rid of the impurities instead 
resulted in protein aggregation due to imidazole. At last, IB-expression of OmpT produced pure 
protein with typical yield of 4 mg per litre of cells.  
 
The reports for the native expressions of OmpU and OmpT in the wild type strains of V. 
cholerae are available in plenty but data for the recombinant membrane expressions of these 
proteins is scarce (Khan et al., 2012). To our knowledge, this is the first study to describe the 
recombinant expression of OmpT in E. coli. The reasons for poor membrane expression levels of 
OmpT compared to OmpU in E. coli are not clear.  
 
The isolation of the N-terminal deletion mutant of OmpU, OmpUΔN, from E. coli OM 
was almost as challenging as for OmpT. The purified fractions of OM-expressed OmpUΔN 
displayed the presence of impurities and yielded an average amount of 0.2 mg of protein per litre 
of cells which is a little unexpected considering the comparatively high membrane expression 
levels achieved for OmpU (~ 1 mg/L). This suggests that deletion of the N-terminus may 
somehow be involved in the export or effective localisation of OmpU and might account for the 
poor membrane expression levels of OmpUΔN. Unfortunately, the studies providing evidence for 
the role of N-terminus in the export or localisation of the mature protein in the OM are limited. 
Nontheless, a few reports demonstrate the significance of N-terminus (Rasmussen and Silhavy 
1987 and Bosch et al., 1988) in efficiently exporting the mature protein precursor to the OM. 
Some other groups have shown the C-terminus to contain motifs that are required for the 
targeting of the proteins to the OM (Robert et al., 2006, Tommassen 2010 and Rollauer et al., 
2015). These studies suggest both N- and C- terminal ends contain essential information for the 
effective insertion of a protein in the OM. Thus, the deletion of N-terminus might have affected 
the export or insertion of OmpUΔN causing the decrease in its expression levels compared to 
wild type OmpU.  
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Chapter 4. Crystallisation and structure determination  
of OMPs using X-ray crystallography 
4.1. Introduction 
The structural paradigm for the typical general porins of Gram-negative bacteria is set by 
the two major general porins, OmpF (Cowan et al., 1992) and OmpC (Figure 4.1; Basle et al., 
2006) of E. coli which consist of a 16 stranded β-barrel formed by long extracellular loops and 
short periplasmic turns (also see section 1.3.1.2). In OmpF (and other porins), N- and C- terminal 
ends of the protein constitute the β-16 strand (Figure 4.1). Unlike E. coli OmpF/C, the structural 
data for Enterobacter cloacae porins (OmpE35 and OmpE36) are not available. The structure of 
OmpK36 porin of Klebsiella pneumoniae, however has been determined previously at a low 
resolution of 3.2 Å (Dutzler et al., 1999). With 1OSM as the PDB code, the OmpK36 trimer 
shows a 16 stranded β-barrel constricted by L3 loop for each monomer (Dutzler et al., 1999). In 
order to perform detailed structural analysis, we attempted to obtain a high resolution structure 
for OmpK36, in addition to determining the structures for OmpE35 and OmpE36.  
 
 
 
 
 
 
 
 
 
Figure 4.1. Structure of OmpC.  
The figure shows cartoon for OmpC monomer from the side (left panel) and extracellular 
environment (right panel). The constriction zone of OmpC comprises the acidic residues of loop 
L3 (Asp105 and Glu109) opposite the positive charged residues (Arg37, Arg74 and Arg124). The 
figures were made using PyMol (Schrödinger 2010) from PDB ID 2J1N (Basle et al., 2006). 
 
Vibrio cholerae OmpU and OmpT have been widely investigated over the past 10-15 
years at the genetic level (Crawford et al., 1998 and Li et al., 2000) but no structural data for 
these two proteins has been reported. Due to the implication of these OMPs in the virulence of V. 
cholerae (Wibbenmeyer et al., 2002, Merrell et al., 2001 and Provenzano and Klose 2000), the 
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structure determination of these two major porins might provide an insight into the pathogenesis 
of V. cholerae. Based on their homology to OmpF/C proteins, both proteins (OmpU and OmpT) 
are assumed to form water-filled channels across the OM (Chakrabarti et al., 1996) and based on 
the structure prediction programs, OmpU is speculated to be a 16-stranded β-barrel while OmpT 
might form a 14-stranded β-barrel (Duret and Delcour 2010). 
 
In the present study, MemGold and MemGold2 (Molecular Dimensions) are the two main 
crystal screens used for the crystallisation of the purified OMPs (as described in Chapter 3). 
Typical protein concentration used for setting up the crystal drops was 10 mg/ml (unless stated 
otherwise; also see sections 2.6 and 2.7). This chapter describes the high-resolution 3D structures 
of E. cloacae OmpE35 and OmpE36, K. pneumoniae OmpK36 and V. cholerae OmpU and 
OmpT (also see Table 2.10 and section 2.8). The structures of OmpU and OmpT revealed 
interesting constrictions inside their channels that led us to construct deletion mutants, OmpUΔN 
and OmpTΔL8 respectively. OmpUΔN has a deletion of the first 10 residues of the N-terminus of 
OmpU whereas in OmpTΔL8, 16 residues of loop L8 of OmpT are deleted (also see sections 3.4 
and 3.6).      
 
4.2. Crystallisation trials for OmpE35, OmpE36 and OmpK36 
 
The initial crystal screens of proteins were set up at concentrations of 10 mg/ml (for 
OmpE35), 24 mg/ml (for OmpE36) and 18 mg/ml (OmpK36) using a Mosquito crystallisation 
robot. The crystal hits obtained for each protein were optimised (see section 2.6.2) to obtain high 
quality crystals that were sent to DLS (Figure 4.2). Table 4.1 lists the conditions that generated 
the crystals diffracting to highest resolution for OmpE35, OmpE36 and OmpK36. 
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Table 4.1. Optimised crystal conditions.  
The optimised conditions of OmpE35/E36, OmpK36, OmpU/UΔN and OmpT/TΔL8 crystals 
diffracting to highest resolution at the synchrotron.   
 
 
Figure 4.2. Crystals formed by the OMPs.  
The figure shows pictures of the crystals for OmpE35 (A), OmpE36 (B), OmpK36 (C), OmpU 
(D), OmpUΔN (E), OmpT (F) and OmpTΔL8 (G) which were sent to DLS for X-ray diffraction 
data collection.  
Protein Expression Crystal Screen Crystal Condition 
OmpE35 OM-expressed MemGold2 0.2 M Ammonium sulfate, 0.05 M 
ADA, 13% w/v PEG 4000, pH 6.5 
OmpE36 OM-expressed MemGold2 0.4 M Ammonium sulfate, 0.1 M MES, 
10% w/v PEG 3350, pH 6.5 
OmpK36 OM-expressed MemGold2 0.08 M Magnesium acetate tetrahydrate, 
0.1 M Na citrate, 14% w/v 5000 PEG 
MME, pH 6.0 
OmpU OM-expressed MemGold2 0.2 M sodium acetate, 0.1 M MES, 28% 
w/v 400 PEG, pH 6.5 
OmpT OM-expressed MemGold 15% PEG 4000, 0.1 M sodium acetate, 
0.4 M ammonium thiocyanate, pH4.5 
OmpT IB-expressed MemGold 0.1 M sodium chloride, 0.1 M MES, 
33% v/v PEG 400, 4% v/v ethylene 
glycol, pH 6.5 
OmpUΔN IB-expressed MemGold 0.1 M sodium chloride, 0.05 M bicine, 
33% PEG 300, pH 9.0 
OmpTΔL8 IB-expressed MemGold2 0.05 magnesium acetate, 0.1 M glycine, 
32% PEG 400, pH 9.5 
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4.3. Crystallisation trials for OmpU/UΔN and OmpT/TΔL8 
Crystallisation for OmpU (OM-expressed) and OmpUΔN (IB-expressed) was done at 10 
mg/ml and the hits were optimised to produce big crystals using vapour diffusion (Figure 4.2). 
The crystal conditions of OmpU and OmpUΔN that diffracted to the highest resolution are listed 
in Table 4.1. The crystallisation for OM-expressed OmpUΔN proved difficult and produced no 
crystal hits primarily because of the poor quality of the purified protein fractions (as discussed in 
section 3.4). The total amount of protein obtained from large-scale culture of OM-expressed 
OmpT (see section 3.5.2) was adequate to set up the crystal screens (MG and MG2) at 8 mg/ml.  
One of the screen conditions (Table 4.1) generated a small crystal (~ 50 µM) which diffracted to 
3.2 Å at DLS. Attempts to optimise this condition didn’t generate any crystals. On the other hand, 
crystallisation of IB-expressed OmpT and OmpTΔL8 at 15 mg/ml produced multiple crystals 
(Figure 4.2), the best ones of which were sent to DLS (Table 4.1). 
 
4.4. Crystal structure of OmpE36 with bound LPS 
The structure of OmpE36 was solved by molecular replacement with E. coli OmpC as a 
search model [PDB code 2J1N and 66% sequence identity] using data to 1.45 Å resolution. Table 
4.2 lists the statistics of X-ray diffraction data and refinement of OmpE36.  
Table 4.2. X-ray diffraction and refinement statistics for OmpE36 
Values in parentheses refer to the highest resolution shell. 
*Rfree was computed as for Rwork using a test set (~5%) of randomly selected reflections that were omitted from the 
refinement 
Data collection Refinement statistics 
Beamline DLS I02 Resolution (Å) 48.92-1.45 
Wavelength (Å) 0.9796 Reflections (n) 529555 
Space group P21 Rwork/Rfree (%)* 15.2/17.8 
Cell dimensions 
(a,b,c), (α,β,ϒ) 
109.75, 123.26, 116.01 
90.00, 91.01, 90.00 
Atoms (n) Protein/solvent 
ligand/detergent 
16245/1910 
1239/231 
Molecules/AU 6 
B factors (Å
2
) Protein/solvent 
ligand/detergent 
17/30 
37/42 
Solvent content 
(%) 
65 
Rmsd bond lengths (Å) 
bond angles (ᴼ) 
0.0095 
1.5091 
Resolution (Å) 48.92-1.45 
Ramachandran plot (%) Most 
favoured/outliers 
95.5/0.6 
Completeness 99.6 (100) 
Redundancy 3.7 (3.7) 
I/ σ 8.0 (1.6) 
Rpim (%) 4.9 (46) 
CC (1/2) 0.98 (0.62) 
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The crystal was obtained in space group P21 and shows two trimers in the asymmetric unit 
(AU). Due to the high resolution of the data (higher than 2.0 Å), NCS restraints were not applied 
applied during refinement. The two trimers are stacked in a double layered head-to-head 
arrangement, with lattice contacts between the periplasmic ends of the β-barrels in the AU. 
OmpE36 showed a typical arrangement of 3 β-barrel monomers arranged into a trimer (Figure 
4.3 A). Each monomer displays 16 antiparallel strands (β1-β16) forming the hollow β-barrel, with 
8 long flexible loops (L1-L8) in the extracellular space and 8 short turns (T1-T8) in the 
periplasmic region (Figure 4.3 B). N- and C- terminal ends of OmpE36 barrel formed a salt-
bridge. The loop L2 of each monomer latches over to the top of adjacent monomer in each 
OmpE36 trimer. The stability of the trimer is owed to the electrostatic as well as hydrogen-
bonding interactions between the L2 loop and the groove of adjacent monomer. The typical CR 
of porins, caused by the folding of L3 loop inside the channel, is also observed in OmpE36 
monomer (Figure 4. 3 C). The loop L3 departs from the β-barrel fold and is extended along the 
inner side of the barrel wall, constricting the pore half-way through the channel. In addition and 
as seen for OmpF/C porins, loop L3 in OmpE36 harbours two negatively charged residues 
(Asp105 and Glu109) that are placed opposite the positively charged residues (Arg37, Arg74 and 
Arg124) lining the β-barrel wall (Figure 4.3 C). 
 
 
Figure 4.3. Structure of E. cloacae OmpE36.  
(A) The extracellular view of OmpE36 trimer with 3 β-barrel monomers bound to 4 LPS 
molecules at site A (LPS-A) and site B (LPS-B), with calcium ion shown as green sphere. (B) 
The rainbow cartoon of 16-stranded β-barrel of OmpE36 monomer displaying salt-bridged N- 
(blue) and C-terminus (red). (C) Constriction region of OmpE36 is formed by the charged 
residues present in loop L3 (Asp105 and Glu105) and the barrel wall (Arg37, Arg74 and 
Arg124).   
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The Fo-Fc difference map of refined OmpE36 showed electron density on the outer 
surface of barrel wall close to L4, L5 and L6 extracellular loops of every protein chain. After 
careful inspection, the electron density was found to be matching with lipopolysaccharide (LPS) 
which forms an integral part of the outer leaflet of the OM. So far, there is only one structure in 
the PDB that has reported LPS bound to an OMP (the siderophore TBDT FhuA of E. coli; 
Ferguson et al., 1998). OmpE36-LPS is thus the second structure to show the interaction of LPS 
with an OMP but is the first porin to show bound LPS. Each OmpE36 trimer shows the presence 
of 4 bound LPS molecules and since the AU consisted of 2 trimers, a total of 8 LPS molecules 
are found for OmpE36 structure (Figure 4.3 A). The crystal structure exhibits two different 
positions of LPS molecules; LPS-A corresponds to the site where LPS is bound in each groove 
between two monomers and LPS-B corresponds to an additional site on just one monomer per 
trimer (Figure 4.3 A). As a result, each trimer contains 3 LPS-A and 1 LPS-B molecule. The LPS 
molecule at site B (LPS-B) serves as a sandwich between the two symmetry-related protein 
molecules and explains why only one of the monomers (per trimer) is bound to 2 LPS molecules.   
 
The typical structure of LPS in gram-negative bacteria includes three main components: 
1) a hydrophobic lipid A, a short hydrophilic core oligosaccharide and a hydrophilic O-antigen 
(also see section 1.1.2 and Figure 1.2). In the OmpE36 structure (Figure 4.4), both LPS-A and 
LPS-B molecules show clear density for the glucosamine disaccharide unit (GlcNI and GlcNII) 
and the KDO residues (KDOI and KDOII) of lipid A moiety while in LPS-B (but not in LPS-A) 
the density extends beyond KDOII to reveal the linked manno-pyranose ring of heptose sugar 
GMH (L-glycero-D-manno-heptopyranose). The structure of FhuA-LPS complex showed 
hexaacylated lipid A (Ferguson et al., 1998) but in OmpE36 we observe heptaacylated lipid A for 
both LPS-A and LPS-B molecules. The two glucopyranose rings of lipid A disaccharide are each 
acylated at two positions by 3-hydroxymyristic acid residues (FTT), accounting for 4 FTT chains 
per disaccharide unit. Three of these FTT chains are further acylated on their hydroxyl groups 
either by lauric acid (DAO) or myristic acid (MYR) residues, generating heptaacylated lipid A 
for each LPS molecule which is quite interesting because heptaacylated LPS is thought to be 
uncommon in E. coli. 
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Figure 4.4. LPS bound to OmpE36.  
(A) The side view of OmpE36 trimeric structure shows the monomer (in gray) bound to 2 
molecules of LPS; LPS-A and LPS-B with one calcium ion (green sphere) between LPS-B and 
OmpE36. (B) Dotted box in A is zoomed in to show the triad H-bond formed between Arg213, 
LPS-A and LPS-B. Multiple interactions of OmpE36 residues with (C) LPS-A and (D) LPS-B 
molecules. (E) The bound calcium ion forms ionic interactions with the OmpE36 residues 
Asn250 and Asn239, and KdoII of LPS-B. The panels B and C show 2Fo-Fc map contoured at 
1.5σ. 
 
LPS-A and LPS-B are linked to each other via H-bonding between their fatty acyl chains 
and both molecules show multiple polar (ionic and H-bonds) interactions with OmpE36 residues 
(Table 4.3). In LPS-A (Figure 4.4 C), GlcNI forms H-bonds with the carboxylate oxygen of 
Asp174 while GlcNII shows H-bonding with the basic residues Lys198 and Arg213. The KDOI of 
LPS-A forms a single ionic interaction with Lys198 whereas KDOII shows interactions with 
residues Lys152, Glu159, Arg199 and Ser201. In LPS-B (Figure 4.4 D), Tyr238 H-bonds with 
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GlcNII and the two carboxylate oxygens of Glu215 interact with both GlcNI and GlcNII. Since 
KDOI of LPS-B is oriented away from the barrel wall of OmpE36, it does not interact with any 
protein residue but KDOII of LPS-B shows interactions with 2 asparagines; the side chain of 
Asn210 and α-carboxyl of Asn250. Interestingly, the crystal structure displays a strong electron 
density peak consistent with a metal atom between LPS-B and OmpE36 residues. Because of the 
high-resolution data (1.45 Å), we were able to rule out sodium (Na) and magnesium (Mg) 
through initial refinement runs by placing each metal atom one at a time. The calcium metal atom 
fitted perfectly with the evident density (Figure 4.4 E) which was further confirmed by a metal-
binding site validation server CheckMyMetal (Zheng et al., 2017). Since calcium ion was neither 
present in the expression/purification conditions nor in the crystallisation condition, its presence 
in OmpE36 structure suggests that it must have been co-purified from E. coli. 
 
Table 4.3. List of H-bond interactions between OmpE36 residues and LPS (A/B) molecules; 
and ionic interactions formed by calcium ion with LPS-B and protein residues.  
Residue of E36-C chain LPS atom (moiety) H-bond distance (Å) 
174 Asp, OH 2 GlcNI, O4 (LPS-A) 2.63 
174 Asp, OH 3 GlcNII, N2 (LPS-A) 2.82 
149 Tyr, OH 7 FTT, O3 (LPS-A) 2.69 
213 Arg, NH2 11 MYR, O1 (LPS-A) 3.56 
213 Arg, NH2 9 FTT, O2 (LPS-A) 3.6 
213 Arg, NH2 6 PO4, O3 (LPS-A) 2.78 
198 Lys, NH2 4 KDO, O1 (LPS-A) 2.84 
198 Lys, NH2 3 GlcNII, O4 (LPS-A) 3.6 
198 Lys, NH2 6 PO4, O1 (LPS-A) 2.8 
160 Asp, OH 5 KDO, O5 (LPS-A) 2.52 
199 Arg, O- 5 KDO, O8 (LPS-A) 2.86 
159 Glu, O- 5 KDO, O4 (LPS-A) 2.8 
152 Lys, NH2 5 KDO, O1 (LPS-A) 2.91 
152 Lys, NH2 5 KDO, O6 (LPS-A) 3.2 
152 Lys, NH2 5 KDO, O5 (LPS-A) 2.81 
201 Ser, NH 5 KDO, O7 (LPS-A) 2.99 
11 MYR, O1 (LPS-A) 7 FTT, O3 (LPS-B) 3.09 
213, Arg, NH 7 FTT, O3 (LPS-B) 3.58 
196, Ser, OG 7 FTT, O3(LPS-B) 2.9 
215, Glu, OH 9 FTT, O2 (LPS-B) 3.23 
215, Glu, OH 2 GlcNI, O4 (LPS-B) 2.41 
250, Asn, OH 5 KDO, O5 (LPS-B) 3.11 
217, Tyr, OH 9 FTT, O2 (LPS-B) 3.54 
239, Asn, NH 5 KDO, O1A (LPS-B) 2.79 
210, Asn, OH 5 KDO, O5 (LPS-B) 2.94 
215, Glu, OH 3 GlcNII, N2 (LPS-B) 3.14 
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236, Gln, NH 12 DAO, O1 (LPS-B) 3.31 
238, Tyr, OH 6 PO4, O3 (LPS-B) 2.64 
238, Tyr, OH 3 GlcNII, O4 (LPS-B) 3.58 
251, Lys, NH 6 PO4, O3 (LPS-B) 3.43 
Residue/LPS molecule Metal ion Ionic bond distance (Å) 
250, Asn, O- Calcium 2.36 
239, Asn, O- Calcium 2.49 
210, Asn, O- Calcium 2.35 
5, KDO, O7- (LPS-B) Calcium 2.59 
5, KDO, O1- (LPS-B) Calcium 2.46 
5, KDO, O5- (LPS-B) Calcium 2.45 
5, KDO, O6- (LPS-B) Calcium 2.59 
    *Abbreviations for the components in the molecules of LPS-A and LPS-B are listed in the Abbreviation Table.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. 2D diagram of LPS interactions with OmpE36 resdiues.  
The diagram depicts the interactions of LPS-A and LPS-B molecules with the protein residues 
and was generated using the online software program PoseView (Stierand and Rarey 2010). For 
the abbreviation of the LPS components, see the List of Abbreviations.  
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The ligands of the calcium ion are the side chains of Asn239 and Asn250 as well as the 
backbone carbonyl of Asn210 (Table 4.3). In addition, four functional groups on KdoII provide 
ligands to the calcium ion (Table 4.3). In this structure, the presence of calcium ion shows the 
important role played by metal ions in maintaining the binding of LPS to protein. An overview of 
the interactions between LPS-A/B and OmpE36 residues is presented in Figure 4.5 as a 2D-
structure diagram generated by PoseView (Stierand and Rarey 2010). 
 
The structure of the complex of OmpE36-LPS has been published recently in PNAS 
(Arunamanee et al., 2016). This paper discusses the high-affinity LPS binding sites in Gram-
negative bacterial porins (like OmpF). The paper not only shows the importance of the LPS-
binding site (LPS-B) in stabilising the OmpF trimer but also sheds a light on its essential role in 
the OM biogenesis of porins. 
4.5. Crystal structure of OmpE35 
 
Table 4.4. X-ray diffraction and refinement statistics for OmpE35. 
 
Values in the parentheses refer to the highest resolution shell. 
*Rfree was computed as for Rwork using a test set (~5%) of randomly selected reflections that were omitted from the 
refinement. 
 
Data collection Refinement statistics 
Beamline DLS I04-1 Resolution (Å) 45.8-2.3 
Wavelength (Å) 0.9282 Reflections (n) 70510 
Space group C2221 Rwork/Rfree (%)* 20.6/24.6 
Cell dimensions 
(a,b,c), (α,β,ϒ) 
137.55, 187.25, 122.96 
90.00, 90.00, 90.00 
Atoms (n) Protein/solvent 
ligand/detergent 
7736/188 
35/79 
Molecules/AU 3 
B factors (Å
2
) Protein/solvent 
ligand/detergent 
53/46 
67/61 
Solvent content 
(%) 
65 
Rmsd bond lengths (Å) 
bond angles (ᴼ) 
0.015 
1.405 
Resolution (Å) 46.81-2.30 
Ramachandran plot(%) Most 
favoured/outliers 
95.2/0.1 
Completeness 100 (99.9) 
Redundancy 7.6 (7.5) 
I/ σ 16 (1.4) 
Rpim (%) 3 (56) 
CC (1/2) 0.99 (0.63) 
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The crystals produced from the purified OmpE35 in this study diffracted to low resolution 
(≥ 3.0 Å). However, one of the colleagues from the lab was able to get good quality diffraction 
for OmpE35 crystals for a different batch of purified protein. The resolution achieved for the best 
diffracting crystal of OmpE35 was 2.3 Å with the space group C2221. The phase problem for 
OmpE35 was solved by molecular replacement using E. coli OmpF (PDB accession code 2ZFG; 
sequence identity 80%) as a search model. The X-ray diffraction data collection and refinement 
statistics are mentioned in Table 4.4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Structure of E. cloacae OmpE35.  
The cartoon views from the (A) extracellular side and (B) OM plane display the 3 β-barrel 
monomers arranged into a trimer of OmpE35. (C) Each monomer is a 16 β-stranded barrel 
(rainbow) forming a salt-bridged N- and C-terminus. (D) The constriction region is formed by the 
charged residues of loop L3 (Asp108 and Glu112) and the barrel wall (Arg37, Arg77 and 
Arg127).  
 
The crystal of OmpE35 reveals one trimer in the AU (Figure 4.6 A). Like OmpE36, 16 
antiparallel β-strands of each OmpE35 monomer form 8 extracellular loops (L1-L8) and short 
periplasmic turns (T1-T8) (Figure 4.6 C). The negative charged loop L2 latchs over from one 
monomer to the positive charged groove of the adjacent monomer and stabilises the OmpE35 
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trimer. The β-16 strand shows N- and C- termini linked through a salt bridge. The asymmetric 
charge distribution across the channel is mediated by the loop L3 folded inside causing the 
constriction of OmpE35 pore. The negative charged residues Asp108 and Glu112 of loop L3 are 
faced opposite the positive ladder of Arg37, Arg77 and Arg127 in the β-barrel wall (Figure 4.6 
D).  
 
4.6. Crystallographic structure of OmpK36 
The best crystal of OmpK36 diffracted to ~ 1.65 Å resolution at the synchrotron and the 
phase problem was solved using the low-resolution structure of previous deposited OmpK36 
(with PDB code 1OSM) as the molecular replacement model. The crystallographic data and 
refinement statistics are summarised in Table 4.5.  
Table 4.5. X-ray diffraction and refinement statistics for OmpK36.  
Values in the parentheses refer to the highest resolution shell. 
*Rfree was computed as for Rwork using a test set (~5%) of randomly selected reflections that were omitted from the 
refinement. 
 
With the space group of C2, the OmpK36 structure shows the arrangement of three β 
barrel monomers arranged into a homotrimer in the AU of the crystal (Figure 4.7 A, B). OmpK36 
Data collection Refinement statistics 
Beamline DLS I04 Resolution (Å) 107.57-1.65 
Wavelength (Å) 0.9793 Reflections (n) 161366 
Space group C2 Rwork/Rfree (%)* 14.6/18.9 
Cell dimensions 
(a,b,c), (α,β,ϒ) 
232.31, 74.51, 90.81 
90.00, 112.17, 90.00 
Atoms (n) 
Protein/solvent 
ligand/detergent 
8032/635 
-/54 
Molecules/AU 3 
B factors (Å
2
) 
Protein/solvent 
ligand/detergent 
28.8/39.2 
-/49.6 
Solvent content (%) 63 Rmsd bond lengths (Å) 
bond angles (ᴼ) 
0.0136 
1.5878 
Resolution (Å) 45.4-1.65 
Ramachandran plot 
(%) Most 
favoured/outliers 
95.5-0.6 
Completeness 98.5 (97.3) 
Redundancy 3.8 (3.9) 
I/ σ 11.6 (1.6) 
Rpim (%) 3.9 (60) 
CC (1/2) 0.99 (0.68) 
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monomer displays a similar protein fold as seen for its orthologs (OmpE35/E36 and OmpF/C). 
Each monomer is a 16-stranded β-barrel formed by 8 long flexible loops (L1-L8) in the 
extracellular space and 8 short periplasmic turns (T1-T8). The OmpK36 barrel also shows N- and 
C-terminal ends linked through a salt bridge, another typical feature of general porins. Loop L3 is 
folded inside to constrict the barrel and loop L2 latchs over to the grooves of adjacent monomer 
to stabilise the trimer (Figure 4.7 A). Like other porins, the constriction region (CR) of OmpK36 
comprises five charged residues Asp106, Glu110, Arg37, Arg75 and Arg125 (Figure 4.7 D). 
 
 
Figure 4.7. Structure of K. pneumoniae OmpK36.  
The cartoon views from the (A) extracellular side and (B) OM plane display the 3 β-barrels 
arranged into a trimer of OmpK36. (C) Each 16 β-stranded monomer (rainbow) forms a salt-
bridged N- and C-terminus and (D) is constricted in the middle by the positive charged residues 
of loop L3 (Asp106 and Glu110) and negative charged residues of the barrel wall (Arg37, Arg75 
and Arg125). (E) Structural superposition of OmpK36 (in rainbow) and 1OSM (in gray). 
 
The structural superposition of 1OSM (OmpK36, Dutzler et al., 1999) and OmpK36 from 
our study (Figure 4.7 E), exhibit similar lengths and orientations of the β-strands as well as 
extracellular loops and periplasmic turns (except turn T4). Unexpectedly however, OmpK36 
when superposed on 1OSM gives a Cα core rmsd of 0.7 Å, which is slightly higher than expected 
considering both are the same proteins. This can be explained by the fact that the proteins are 
derived from two different strains of K. pneumoniae and have a sequence identity of 94% (Figure 
4.8). OmpK36 (1OSM), published earlier was obtained from the K. pneumoniae strain KT793 
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(Dutzler et al., 1999) while the protein used in our study is from the K. pneumoniae strain ATCC 
43816 (GenBank Assembly GCA_000742755.1). Thus, 1OSM and OmpK36 have the same 
protein fold but the difference in the two proteins sequences accounts for the somewhat high core 
r.m.s.d. value after superposition (Figure 4.7 E). 
 
 
Figure 4.8. Sequence alignment of 1OSM and OmpK36 from the present study.  
The differences in the two aligned sequences are coloured in red and these residues are mostly 
correspond to the extracellular loops (except few located in the β-strand regions and are indictaed 
by black dots in the figure). 
 
4.7. Structural comparison of porin orthologs 
 
The sequence homology studies have classified porins OmpE36/OmpK36 and OmpE35 
as orthologs of E. coli OmpC and OmpF respectively. Thus, in this section we draw a structural 
comparison between the three ortholog pairs; OmpE36/OmpC, OmpK36/OmpC and 
OmpE35/OmpF (OmpC PDB code 2J1N and OmpF PDB code 2ZFG). The low Cα core r.m.s.d. 
values obtained for the superposition (Table 4.6) imply strong resemblance between the 
structures of OmpF/C and their respective ortholog (s) that extends from adopting a similar β-
barrel fold to displaying a striking similarity in the orientations of the charged residues of the 
constriction region (CR).  
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Table 4.6. Structural comparison of OmpF/C orthologs.  
The structural superimpositions (using COOT; Emsley and Cowtan 2004) of OmpE35, OmpE36 
and OmpK36 on OmpF and OmpC reveal the backbone core Cα r.m.s.d values (in Å) with the 
sequence identities mentioned in parenthesis (for alignment of  ≥ 320 Cα-atoms) .  
 
 
  
 
 
Figure 4.9. Structural superposition of OmpF/C orthologs.   
The structures of (A) OmpE36 (magenta), and (B) OmpK36 (orange) are superposed on OmpC 
(gray in A and B), whereas in (C) the OmpE35 structure (light blue) is superposed on OmpF 
(gray in C). The left and middle panels show side and extracellular views respectively. The right 
panels display the charged residues in the CR of OmpE35/E36/K36 to compare their positions 
with the corresponding CR residues of OmpF/C. 
Protein OmpF OmpC OmpE35 OmpE36 OmpK36 
OmpE35 0.6 (80%) 0.8 (66%) - 0.8 (67%) 1.0 (66%) 
OmpE36 0.8 (65%) 0.5 (89%) 0.8 (67%) - 0.6 (82%) 
OmpK36 1.0 (63%) 0.7 (80%) 0.9 (65%) 0.6 (82%) - 
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In Figure 4.9, the charged CR residues of OmpC (Arg37, Arg74, Arg124, Asp105 and 
Glu109) and OmpF (Arg42, Arg82, Arg132, Asp113 and Glu117) are displayed for comparison 
with their counterparts in OmpE36/K36 and OmpE35 respectively. OmpE36 (Arg37, Arg74, 
Arg124, Asp05 and Glu105) and OmpK36 (Arg37, Arg75, Arg125, Asp106 and Glu110) exhibit 
almost identical orientations of the CR residues in comparison to those of OmpC (Figure 4.9 A, 
B). Likewise, OmpE35 (Asp108, Glu112, Arg37, Arg77 and Arg127) displays similar 
orientations of the charged residues in the CR as observed for its ortholog OmpF (Figure 4.9 C).  
 
 
Figure 4.10. Pore-lining residues of OmpF/C orthologs.  
(A) Surface view of OmpF from the side to show the pore (boxed in red) and illustrate the 
structural differences between the ionisable residues lining the pores of (B) OmpE36/OmpC 
(pink/gray), (C) OmpK36/OmpC (orange/gray) and (D) OmpE35/OmpF (blue/gray). The labelled 
residues are colour-coded for each protein and residues in black correspond to OmpF/C.   
 
The channels (of OmpE35/E36/K36) display the archetypical strong segregation of 
positive and negative charges of porins. Although the ionisable residues lining the pore 
constriction are identical for each ortholog pair, the residues at the vestibule opening at the 
extracellular surface reveal subtle variations (Figure 4.10). The lysine residue of OmpE36 
(Lys313) and OmpK36 (Lys315) show similar orientations but differ from Lys317 of OmpC 
(marked with arrows in Figure 4.10 A, B). The aspartate residues of OmpE36 (Asp26) and 
OmpK36 (Asp26) at the vestibule top are located in a different position than the corresponding 
residue in OmpC (Asp28). In comparison to OmpF, OmpE35 has Asp27 (instead of Glu28 in 
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OmpF) and has an additional Lys33 oriented towards the vestibule region (marked with arrows in 
Figure 4.10 C). The counterpart for Y32 of OmpF is missing in OmpE35 and is replaced by 
Y283, located just above loop L3.  
 
In spite of the significant similarity between the orthologs and OmpF/C, a marked 
difference is revealed on the comparison of their electrostatic surfaces (Figure 4.11). Asp171 of 
OmpC does not have a counterpart in OmpE36 and OmpK36 that accounts for an increased 
positive charged region in their grooves compared to OmpC.  This may affect the electrostatics 
involved between L2 loop-groove interfaces to stabilise the oligomerisation state of porins.  In 
addition, the extracellular view of OmpE36 electrostatics exhibit high negative charged region 
due to the presence of acidic residues Glu159 (in loop L4) and Asp205 (in loop L5) (Figure 4.11 
C). Quite contrary, OmpK36 displays a dominant positive-charged region on its extracellular 
surface which is owed to the presence of Arg285 (in loop L7) and Arg326 (in loop L8) (Figure 
4.11 E). Likewise, OmpE35 shows a pre-dominant negatively charged region in its extracellular 
surface as compared to OmpF, that arises due to the two subsequent aspartates of loop L8, 
Asp309 and Asp310 (Figure 4.11 D). 
Figure 4.11. Electrostatics of OmpF/C orthologs.  
The extracelluar views for the electrostatic surfaces of (A) OmpC (-67.4 kT/e to +67.4 kT/e), (B) 
OmpF (-62.5 kT/e to +62.5 kT/e), (C) OmpE36 (-72.1 kT/e to +72.1 kT/e), (D) OmpE35 (-67.6 
kT/e to +67.6 kT/e) and (E) OmpK36 (-68.1 kT/e to +68.1 kT/e). Arrows indicate the positive or 
negative charge regions in comparison to the surfaces of OmpF/C. The figures for the 
electrostatic surface potentials were made using PymoL (Schrödinger 2010).  
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One of the main goals to determine these porin structures (OmpE35/E36/K36) is not only 
to analyse the structural differences but understand the effect of these differences on the uptake of 
different types of compounds. We are working on a paper that describes permeability prediction 
of different molecules through Gram-negative bacterial porins. The paper is under final stages of 
completion for submission (also see section 5.1) and is a collaboration of 3-4 labs from the 
European Innovative Medicines Initiative (IMI) consortium. 
 
4.8. Crystal structure of OmpU shows an N terminal constriction element 
The structure of OmpU was solved via molecular replacement using data to 1.55 Å 
resolution (Table 4.7), with the structure of the Salmonella typhi OmpC loop deletion mutant as 
the search model (PDB accession code 3UPG; sequence identity ~ 26%).  
 
Table 4.7. X-ray data collection and refinement statistics for OmpU  
Values in the parentheses refer to the highest resolution shell. 
*Rfree was computed as for Rwork using a test set (~5%) of randomly selected reflections that were omitted from the 
refinement. 
 
The OmpU structure showed a trimer in the AU and each monomer with 16-stranded β-
barrel displays typical features of the porin (Figure 4.12 A). Like other porins, the L2 loop latches 
into the groove of the adjacent monomer and forms hydrogen bonding as well as electrostatic 
interactions that stabilise the trimer, while the long L3 loop is folded inwards and constricts the 
Data collection Refinement statistics 
Beamline DLS I03 Resolution (Å) 49.49 – 1.55 
Wavelength (Å) 0.97949 Reflections (n) 171689 
Space group P21 Rwork/Rfree (%)* 17/19.9 
Cell dimensions 
(a,b,c), (α,β,ϒ) 
62.7, 153.8, 66.2 
90, 102, 90 
Atoms (n) Protein/solvent 
ligand/detergent 
7325/674 
0/99 
Molecules/AU 3 
B factors (Å
2
) Protein/solvent 
ligand/detergent 
23.0/32.2 
-/38.4 
Solvent content 
(%) 
58.3 
Rmsd bond lengths (Å) 
bond angles (ᴼ) 
0.023 
2.14 
Resolution (Å) 49.49 – 1.55 
Ramachandran plot (%) Most 
favoured/outliers 
94.55/0.64 
Completeness 97 (95) 
Redundancy 3.9 (4.0) 
I/ σ 9.8 (1.4) 
Rpim (%) 3.7 (55.5) 
CC (1/2) 0.9 (0.5) 
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channel (Figure 4.12 A, B). An unusual feature is observed in the structure of OmpU 
distinguishing it from other typical porins. In OmpU, the α-amino group does not interact with 
the C-terminus; instead, the first ~11 residues of the N-terminus fold inwards to constrict the 
lumen of the channel (Figure 4.12 C). Ser12 takes over the role of the N-terminus in OmpF/C, 
with its side chain hydroxyl interacting with the C-terminal carboxyl group (Figure 4.12 B).  
 
Figure 4.12. Structure of V. cholerae OmpU.  
(A) Extracellular view of OmpU trimer with one monomer presented as a rainbow cartoon and 
adjacent two monomers shown in gray. (B) Side view of the monomer in rainbow shows the 16 
β-strands of the barrel with loop L4 in extracellular space. (C) Side-cut view displays the N-
terminal constriction of OmpU just below loop L3.  
 
The N-terminus forms several interactions with the OmpU residues from the barrel wall 
and loop L3 (Figure 4.13). The side chain of Asp8 interacts with the side chains of Arg27 and 
Arg46 in the barrel wall, whereas Asn4 forms a strong hydrogen bond with the backbone of 
Asp113 and Asp116 in loop L3. The N-terminus masks three basic residues Arg288, Arg317 and 
Arg27 and one acidic residue Asp319 from the periplasmic space to the inside of the OmpU 
channel. The presence of the N-terminus and the occurrence of a basic residue in loop L3 
(Lys128) makes the archetypal asymmetric charge distribution across the pore seen in OmpF and 
OmpC orthologs (loop L3 negative, barrel wall positive) less pronounced in OmpU. This 
probably suggests that the electric field across the pore will be less strong in OmpU compared to 
Enterobacterial porins. In terms of pore size, the OmpU constriction has a diameter of ~ 5.5 Å, 
comparable to that of E. coli OmpC. To our knowledge, the presence of N-terminus inside the 
lumen of OmpU marks a novel feature that is observed for the first time in the structure of 
general diffusion porins.  
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Figure 4.13. Interactions of N-terminus with OmpU residues in the CR.  
The residues of the N-terminus (in gray sticks) form hydrogen bonds with the residues of OmpU 
in loop L3 (D113 and D116) and the barrel wall (R27, R46, T280, Y282 and R317).  
 
The DALI (Holm and Laakso 2016) comparison of OmpU with the PDB structures 
mapped three proteins with top Z-scores of ~30 and r.m.s.d values of 2.0 Å over ~280 residues. 
These three proteins are porin 2 from Providencia stuartii (PDB code 4D65), phosphoporin PhoE 
of E. coli (PDB code 1PHO) and OmpE36 from E. cloacae (PDB code 5FVN). These proteins 
therefore show more similarity to OmpU than E. coli OmpF and OmpC (Table 4.8).  
 
Table 4.8. DALI structural alignment of OmpU.  
The table lists the top three proteins of PDB with greatest structural similarity to OmpU, as 
revealed by DALI, followed by the comparison with the porins OmpF/C and OmpT.  
 
 
 
 
 
 
 
 
 
Proteins aligned against OmpU PDB Z-
score 
rmsd Sequence 
identity (%) 
Aligned 
residues 
Omp-Pst2 (P. stuartii) 4D65 30.1 2 28 279 
Phosphoporin (E. coli) 1PHO 30.1 2.1 25 283 
OmpE36 (Enterobacter cloacae) 5FVN 30 2.4 25 283 
OmpC (E. coli) 2J1N 29.6 2.6 24 288 
OmpF (E. coli) 2ZFG 29.5 2.4 25 281 
OmpT (V. cholerae) 6EHd 26.5 2.1 19 267 
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4.9. Crystal structure of OmpT shows that loop L8 constricts the pore 
The diffraction datasets of 2.0 Å from the crystals of IB-expressed OmpT (see section 
3.5.4) were unsuccessful in generating a good solution during molecular replacement (MR) 
because of the unavailability of a good MR search model. The attempts with different search 
models (with PDB accession codes 3UPG, 3VYS, 3PRM, 3RPK etc.) including OmpU by using 
automated MR pipelines like BALBES (Long et al., 2008) and Mr. BUMP (Keegan and Winn 
2007) were not successful to solve the phase problem. However later, one crystal of OmpT (IB-
expressed) diffracted to a higher resolution yielding a dataset in space group C2 with one 
molecule in the AU. For this dataset the phase problem was solved via molecular replacement 
with OmpU and the OmpT structure was refined using data to 1.66 Å (Table 4.9). In addition, yet 
another crystal of OmpT from a different condition (0.05 M calcium chloride dihydrate, 0.05 M 
barium chloride, 0.1 M tris, 32% PEG 400, pH 8.2) yielded one molecule in the AU with space 
group I432 and the data was refined to 2.7 Å resolution (MR was performed with OmpT as the 
search model; Table 4.9).  
 
The models generated from both datasets were very similar with one notable difference. 
Only the I432 crystals showed a trimeric arrangement of OmpT (generated by crystallographic 
symmetry), with gross features consistent with that of OmpU and other porins (Figure 4.14 A). 
The monomer of OmpT is a 16-stranded β-barrel (Figure 4.14 B) with the typical porin 
architecture of the negatively charged L3 loop folded inside the pore and arranged opposite the 
positively charged residues of the β-barrel wall. The loop L2 is disordered in the crystal structure 
of OmpT and hence is missing a few residues in the cartoon (Figure 4.14 B). The α-amino group 
of OmpT interacts with the C-terminal carboxyl group, showing another typical feature of 
Enterobacterial porins (Figure 4.14 B). However similar to OmpU, the OmpT structure reveals an 
additional constriction besides loop L3 inside the lumen of its channel. This constriction is caused 
by extracellular loop L8 that forms a sharp bend in the extracellular space, bringing its tip into the 
constriction region to interact with and pack against the tip of loop L3 (Figure 4.14 C).  
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Table 4.9. X-ray data collection and refinement statistics for OmpT (OM and IB expressed).  
 
monomeric OmpT 
(IB-expressed) 
OmpT 
(OM-expressed) 
trimeric OmpT 
(IB-expressed) 
Data collection 
Beamline DLS I04 DLS I02 DLS I04 
Wavelength (Å) 0.9282 0.979 0.9762 
Space group C2 C2 I432 
Cell dimensions 
(a,b,c), (α,β,ϒ) 
143.8, 75.8, 49.6 
90, 92.06, 90 
144.6, 74.3, 62.3 
90, 96.74, 90 
200.91, 200.91, 
200.91 
90, 90, 90 
Molecules/AU 1 1 1 
Solvent content (%) 64.8 72.2 72.3 
Resolution (Å) 49.64 - 1.66 46.41 – 3.2 71.03 - 2.72 
Completeness 99 (98) 98 (96) 99 (98) 
Redundancy 3.4 (2.5) 3.6 (3.5) 42.2 (43.7) 
I/ σ 14.5 (1.1) 5.0 (1.5) 22.1 (1.2) 
Rpim (%) 2.2 (61) 8.8 (84.7) 2.5 (67.9) 
CC (1/2) 0.9 (0.5) 0.9 (0.5) 1.0 (0.6) 
Refinement 
Resolution (Å) 49.64 – 1.66 46.41 – 3.2 71.03 – 2.72 
Reflections (n) 62456 6527 18714 
Rwork/Rfree (%)* 18.6/ 21.4 21.2/24.4 23.9/28.3 
Atoms (n) 
Protein/solvent 
ligand/detergent 
2521/141 
12/137 
2479/0 
0/0 
2453/12 
0/0 
B factors (Å
2
) 
Protein/solvent 
ligand/detergent 
38.7/45.5 
60.0/57.7 
64.2/22.3 
-/- 
99.1/84.8 
-/- 
Rmsd 
bond lengths (Å) 
bond angles (ᴼ) 
0.024 
2.185 
0.011 
1.528 
0.016 
1.881 
Ramachandran plot (%) 
Most favoured/ 
outliers 
 
94.87/1.28 
 
84.8/2.2 
 
89.5/2.2 
 Values in the parentheses refer to the highest resolution shell.  
*Rfree was computed as for Rwork using a test set (~5%) of randomly selected reflections that were omitted from the 
refinement. 
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Figure 4.14. 3D cartoon for OmpT structure.  
(A) Extracellular and (B) side views of 16 stranded β-barrel of OmpT monomer (in rainbow), 
constricted in the lumen by loops L3 and L8. (C) The slabbed side view of monomer presents a 
better illustration for the L8 constriction of OmpT channel.  
 
The loop L8 makes several interactions with the neighbouring residues lining the barrel 
wall and loop L3 (Figure 4.15).  Gly301 in L8 interacts strongly with two arginines (Arg18 and 
Arg322) in the barrel wall while Asn299 in L8 forms interactions with multiple residues of L3; 
Asp98, Ser100, Phe102 and Phe103. The constriction is lined by Arg69 in the barrel wall, Trp88, 
Asp92 and Asp115 in loop L3, and Thr298, Lys300, Asp303 and Glu305 in L8. This 
configuration of residues is clearly non-typical, and especially the presence of Trp88 (and to a 
lesser extent Thr298) will likely make the OmpT constriction region much less polar than that of 
other porins. The presence of L8 makes the channel constriction very small, with a diameter of ~ 
4 Å. As a result to date, OmpT has probably the narrowest pore size among the other porins of 
Gram-negative bacteria.  
 
The DALI (Holm and Laakso 2016) analysis for OmpT protein revealed its greatest 
structural similarity to the anion-selective porin Omp32 from Comamonas acidovorans (Z = 26, 
2.1 Å r.m.s.d. over 270 residues), but with a sequence identity of only 15% (Table 4.10) followed 
by PorB from Neisseria Meningitidis (PDB code 3VZT) and OmpE36 from E. cloacae (PDB 
code 5FVN). Similarly to OmpU, these proteins showed higher structural similarity to OmpT 
than OmpF/C from E. coli (Table 4.10).   
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Figure 4.15. Interactions of loop L8 with OmpT residues.  
The residues of loop L8 (in gray sticks) form multiple H-bonds and salt bridges with the OmpT 
residues of the barrel wall (R69, R322, R18) and loop L3 (D115, D92, D98, S100, F103 and 
F102). 
 
 
Table 4.10. DALI structural alignments of OmpT.  
The table lists the top three proteins of PDB with greater structural similarity to OmpT, as 
revealed by DALI, followed by the comparison with the porins OmpF/C and OmpU.  
 
 
 
 
 
 
 
 
An interesting feature in the OmpT structure is the presence of clear density for a bound 
ligand at the pore constriction (Figure 4.16). The density fitted well with 2-(N-
morpholino)ethanesulfonic acid (MES), used at a concentration of 100 mM in the crystallisation 
condition. The morpholine ring of MES is pointed towards the extracellular side and sandwiched 
between Asp 92 (of L3 loop) and Asp 303 (of L8 loop) in one direction and between the side 
chain of Trp88 and Lys300 in the other. The sulphonate group of MES is oriented towards the 
periplasmic side and interacts with Arg 37 and Arg 69 in the barrel wall, with Trp88 in L3 and 
Proteins aligned against OmpT PDB 
Z-
sco
re 
rmsd 
Sequence 
identity (%) 
Aligned 
residues 
Omp32 (Comamonas acidovorans) 1E54 27.3 2.1 14 283 
PorB (Neisseria Meningitidis) 3VZT 25.6 2.4 14 280 
OmpE36 (Enterobacter cloacae) 5FVN 25.5 2.7 16 280 
OmpC (E. coli) 2J1N 25.5 2.8 16 282 
OmpF (E. coli) 2ZFG 25.2 2.8 14 279 
OmpU (V. cholerae) 6EHB 26.5 2.1 19 267 
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with Asp303 in loop L8 (Figure 4.16). The antibiotic binding sites in OmpF pore, published 
earlier (Ziervogel and Roux 2013), were compared with MES binding site inside the OmpT pore. 
While ampicillin and carbenicillin bound more closely to the extracellular and periplasmic 
regions respectively of the OmpF pore (Ziervogel and Roux 2013), the binding site of MES was 
located nearly in the mid-region of the OmpT pore.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16. MES bound in OmpT constriction region.  
2Fo-Fc electron density map (contoured at 2σ) for MES bound in the CR. MES forms multiple 
interactions through its morpholine ring and the sulphonate group with the surrounding pore 
constriction residues of OmpT (R69 and R37 from barrel wall; W88 and D92 from loop L3; 
D303 from loop L8).  
 
Crystal structure from membrane-expressed OmpT 
The crystal obtained for OM-expressed OmpT (see section 3.5.2) diffracted to a low 
resolution of 3.2 Å. Due to the absence of the good molecular replacement model initially, the 
phase problem for the data could not be solved. But after obtaining the structure of in vitro-folded 
OmpT, we re-analysed the diffraction data obtained from OM-expressed OmpT to exclude the 
possibility that the unusual conformation of the L8 loop is caused by the in vitro folding of the 
protein. Molecular replacement with in vitro folded OmpT gave a clear solution with PHASER 
(McCoy et al., 2007) yielding LLG and TFZ scores of 1393 and 26.3 respectively and the AU 
showed one molecule with the space group C2 (Table 4.9). As expected, the protein fold of OM-
expressed OmpT is very similar to the one obtained from in vitro folding. In addition, subsequent 
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refinement clearly shows the electron density supporting a similar conformation of the L8 loop as 
observed for in vitro folded OmpT, making it likely that the conformation of loop L8 is 
physiological. Figure 4.17 shows the 2Fo-Fc electron density map as well as the 2Fo-Fc omit 
electron map including simulated annealing for loop L8 of the final refined model of OmpT.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17. Electron density for loop L8 in OM-expressed OmpT.  
(A) Cartoon showing side-cut view of OM-expressed OmpT with L8 in gray. (B)  Final 2Fo-Fc 
electron density map contoured at 2σ, for loop L8 residues (gray sticks). (C) Simulated annealing 
omit Fo-Fc map contoured at 1.5σ, for loop L8 residues. 
 
4.10. Anomalous diffraction of OmpT crystals  
Prior to solving the OmpT structure (also discussed in section 4.8), the in vitro folded 
protein was used to produce crystals of selenomethionine substituted (SeMet) OmpT or crystals 
incorporated with a heavy atom (HA). 
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For HA incorporation (see section 2.6.2.4), the OmpT crystals (from the condition 0.5 M 
CaCl2, 0.05 M BaCl2, 0.1 M Tris, 32% w/v PEG400 and pH 8.2) were soaked for few hours or 
overnight (depending on crystal stability) in solutions of 4 different heavy atoms (see section 
2.6.2.4): Platinum (Pt, K2PtO4), Lead (Pb), Iridium (Ir) and Osmium (Os). A total of 70 crystals, 
soaked in different HA solutions, were analysed for X-ray diffraction. Of these, two crystals, Ir-
OmpT and Pt-OmpT diffracted to ~ 3.5 Å. A complete set of 360° data was collected for an Ir-
OmpT crystal while two sets of 360° data was collected for a Pt-OmpT crystal. The two OmpT 
crystals (Pt- and Ir- derived) yielded datasets in space group I432 with almost identical unit cell 
dimensions (Pt-derived crystal a=201.07, b=201.70, c=201.70, α=90, β=90, γ=90; Ir-derived 
crystal a=200.30, b=200.30, c=200.30, α=90, β=90, γ =90). The scaled reflections for both 
datasets were analysed using AutoSol (Terwilliger et al., 2009), an automated experimental 
phasing pipeline in PHENIX (Adams et al., 2010). Due to the high symmetry space group (P63) 
obtained for the OmpT crystals (Pt- and Ir- derived), the high redundancy (70) of the data aided 
in generating a solution. Interestingly, after density modification in RESOLVE, the map revealed 
clear electron density for a porin trimer (Figure 4.18) but the FOM (figure of merit) was 
somewhat low (~ 0.28). As a result of the low resolution, AutoSol failed to build an acceptable 
model.  
 
 
 
 
 
 
 
 
Figure 4.18. Electron density map of in-vitro folded OmpT from SAD data.  
The anomalous diffraction data from Ir-derived crystal generated a density-modified map by 
RESOLVE, showing the density for 3 β-barrel monomers arranged into a porin trimer. 
 
The best SeMet OmpT crystal diffracted to a resolution of 2.4 Å (C2 space group, 1 
molecule in the AU) and 7 datasets were collected for the same crystal. In PHENIX, 7 
isomorphous datasets were merged using AutoSol that yielded a good FOM scoring value (~ 0.5) 
for 6 substructure HA sites but the experimental electron maps obtained were of poor quality. 
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This could be either due to the poor data quality or because OmpT contains only two methionines 
in its sequence (insufficient HA atoms for successful phasing).  
 
4.11.  Crystal structures of OmpUΔN and OmpTΔL8 
The structure of the truncation mutant of OmpU with the first 10 N-terminal residues 
removed (OmpUΔN) was solved using data to 2.0 Å resolution (Table 4.11).   
Table 4.11. X-ray diffraction and refinement statistics for OmpUΔN. 
Values in the parentheses refer to the highest resolution shell. 
*Rfree was computed as for Rwork using a test set (~5%) of randomly selected reflections that were omitted from the 
refinement. 
The OmpUΔN crystal shows a trimer of 16 antiparallel β-stranded monomeric barrels, as 
seen for other porins (Figure 4.19 A). The structure of OmpUΔN and its Cα r.m.s.d. of 0.6 Å with 
native OmpU suggests that the deletion of the N-terminal 10 residues did not affect the protein 
fold. The remaining segment of the N-terminus (residues 11-19) extends into the periplasmic 
space in OmpUΔN (Figure 4.19 B). As a result, the C-terminal carboxyl group does not interact 
with any other residue in the OmpUΔN barrel. In addition and as expected, the comparison of 
CRs between OmpU and OmpUΔN showed large differences (Figure 4.19 D, E). The pore 
dimension of OmpUΔN (~ 10 × 15 Å) was considerably larger than that of WT OmpU (~ 9 × 10 
Å).  
 
Data collection Refinement statistics 
Beamline DLS I04-1 Resolution (Å) 66.17 – 2.02 
Wavelength (Å) 0.9282 Reflections (n) 48646 
Space group P63 Rwork/Rfree (%)* 19.7/ 24.9 
Cell dimensions 
(a,b,c), (α,β,ϒ) 
81.3, 81.3, 198.5 
90, 90, 120 
Atoms (n) Protein/solvent 
ligand/detergent 
4714/248 
0/24 
Molecules/AU 2 
B factors (Å
2
) Protein/solvent 
ligand/detergent 
40.4/46.6 
-/57.1 
Solvent content 
(%) 
54.5 
Rmsd bond lengths (Å) 
bond angles (ᴼ) 
0.017 
1.64 
Resolution (Å) 66.17 – 2.02 
Ramachandran plot (%) Most 
favoured/outliers 
94.88/0.33 
Completeness 100 (100) 
Redundancy 11.5 (11.4) 
I/ σ 12.3 (1.3) 
Rpim (%) 4.4 (62.8) 
CC (1/2) 0.9 (0.6) 
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Figure 4.19. Structure of OmpUΔN.  
(A) Extracellular side and (B) OM plane views for the monomer cartoon of OmpUΔN. (C) HOLE 
(Smart et al., 1993) comparison between OmpU, OmpUΔN, OmpF and OmpC (OmpU-MD 
corresponds to the pore size calculated from MD simulations)*. The surface views from the OM 
plane (D) and extracellular side (E) show the difference in pore sizes for OmpU (cyan) and 
OmpUΔN (orange). 
*The HOLE figure was obtained from Matteo Ceccarelli (Univeristy of Cagliari). 
 The structure of the loop deletion mutant OmpTΔL8 was solved using data to 2.3 Å 
resolution (Table 4.12). Similar to OmpUΔN, the structure of OmpTΔL8 displayed a 16-stranded 
β-barrel protein fold with only one molecule in the AU (Figure 4.20 A, B), as observed for the 
structure of (IB-expressed) OmpT. 
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Table 4.12. X-ray diffraction and refinement statistics for OmpTΔL8. 
Values in the parentheses refer to the highest resolution shell. 
*Rfree was computed as for Rwork using a test set (~5%) of randomly selected reflections that were omitted from the 
refinement. 
 
 The superposition of OmpTΔL8 on OmpT gave a Cα r.m.s.d. of ~ 1.0 Å demonstrating 
that both structures are similar and that L8 deletion did not affect the protein fold. The pore sizes 
of OmpT and OmpTΔL8 were also compared to evaluate the difference in the constriction zones 
resulting from removal of loop L8 (Figure 4.20 D, E). The OmpTΔL8 channel was very large, 
with pore size dimensions of ~ 7.4 × 10 Å but in OmpT due to the L8 loop, the pore size 
decreases substantially to ~ 4 × 5 Å (Figure 4.20 C).  
 
 Quite recently, we submitted a paper (to Structure; Pathania et al., 2017) that reports the 
3D X-ray structures of V. cholerae porins, OmpU and OmpT (and their deletion mutants) and is 
currently under revision. The paper describes the effect of the constriction elements on the size 
and electrostatics of these porins. In addition, the paper discusses the electrophysiology and 
molecular dynamics simulations that were used to analyse the functional aspects of OmpU/T 
porins. 
Data collection Refinement statistics 
Beamline DLS I24 Resolution (Å) 85.84 – 2.3 
Wavelength (Å) 0.96861 Reflections (n) 18688 
Space group I222 Rwork/Rfree (%)* 22.4/27.3 
Cell dimensions 
(a,b,c), (α,β,ϒ) 
43.4, 128.4,171.6 
90, 90, 90 
Atoms (n) Protein/solvent 
ligand/detergent 
2343/39 
0/77 
Molecules/AU 1 
B factors (Å
2
) Protein/solvent 
ligand/detergent 
47.10/44.61 
-/55.04 
Solvent content 
(%) 
60.5 
Rmsd bond lengths (Å) 
bond angles (ᴼ) 
0.011 
1.113 
Resolution (Å) 85.84 – 2.3 
Ramachandran plot (%) Most 
favoured/outliers 
95.9/1.7 
Completeness 99 (98) 
Redundancy 6.9 (5.1) 
I/ σ 13.1 (1.5) 
Rpim (%) 3.4 (51) 
CC (1/2) 0.9 (0.6) 
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Figure 4.20. Structure of OmpTΔL8.  
Monomer cartoon of OmpTΔL8 shows the 16-stranded β-barrel from the OM plane (A) and from 
the extracellular side (B) with loop L3 constriction inside the lumen (N- terminus being 
disordered could not be build in the structure). (C) HOLE (Smart et al., 1993) comparison of 
constriction zones for OmpT, OmpTΔL8, OmpF and OmpC (OmpT-MD corresponds to the pore 
size calculated from MD-simulations)*. The surface views from the OM plane (D) and 
extracellular side (E) compare the constriction zones of OmpT (green) and OmpTΔL8 (purple).  
*The HOLE figure was obtained from Matteo Ceccarelli (Univeristy of Cagliari). 
 
4.12. Co-crystallisation trials with antibiotics and OmpT/OmpTΔL8 
In vitro antibiotic permeation assays and electrophysiology experiments with V. cholerae 
porins revealed interactions with meropenem and imipenem (discussed in Chapter 5). Based on 
this information, we tried to obtain the co-crystal structures of these antibiotics with OmpU/T 
porins (and OmpUΔN/OmpTΔL8) to probe the protein residues that interact with the substrate 
(see section 2.6.2.3). Due to limited solubilities [meropenem (HMDB0014898) - 5.63 g/L; 
imipenem (HMDB0015536) - 0.78 g/L], the maximum concentration used to prepare stock 
solutions for co-crystallisation was 0.4 M for meropenem and 0.25 M for imipenem.  
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The antibiotic-soaked crystals of OmpU, OmpUΔN and OmpTΔL8 did not reveal the 
presence of the substrate inside the channel. However, one of the meropenem-soaked OmpTΔL8 
crystals diffracted to a resolution of 2.4 Å with one molecule in the AU in I222 space group and 
showed electron density for a bound ligand at the constriction region (Figure 4.21). The 
components like MES from the crystal condition or HEPES from the purification buffer were 
ruled out based on the output of negative electron density after refinement. The β-lactam ring-
opened hydrolysed form (MER-1; Figure 4.22) of meropenem was fitted manually into the ligand 
density using COOT. On inspection of the 2Fo-Fc electron map, post-refinement, the hydrolysed 
meropenem proved to be a poor fit because of the inadequate density obtained for its pyrrolidine 
moiety (Figure 4.21 C). Since meropenem has a natural tendency to degrade at room-temperature 
owing to its low stability (Joseph and Rodvold 2008), the ligand density was fitted with the 
thiazolidine ring (bearing a hydroxyethyl side chain) of degraded meropenem (MER-2; Figure 
4.22). However post-refinement, the 2Fo-Fc electron map was still not fully consistent with the 
fitted ligand (Figure 4.21 D). A ligand-fitting approach in PHENIX, LigandFit, resulted in CC 
values of 0.63 (ideal fit requires CC value of ≥ 0.7), implying meropenem is not a good fit for the 
density.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.21. Electron density evident for meropenem bound to the CR of OmpTΔL8.  
(A) The boxed region shown in the side cut view of OmpTΔL8 (in gray) is zoomed in the next 
panels. (B) The Fo-Fc difference map (green) contoured at 1.5σ (carve = 1.6), displays electron 
density for a ligand bound at the CR. (C, D) The 2Fo-Fc maps contoured at 1.5σ show the 
electron density for meropenem. 
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Figure 4.22. Meropenem structure.  
The figure shows the chemical representations of (A) intact meropenem, (B) hydrolysed β-lactam 
ring opened form of meropenem (MER-1) and (C) degraded meropenem containing the 
thiazolidine ring (MER-2).  
 
4.13. Discussion  
The general diffusion porins of E. cloacae (OmpE35/E36) and K. pneumoniae (OmpK36) 
not only share high percentage of sequence identities with OmpF/C orthologs of E. coli but our 
structural studies show that these channels are also very similar in the architecture of the β-barrel 
folds. The β-barrels of OmpE35/E36/K36 display the characteristic pattern of charge segregation 
across the pore with charged residues of the constriction zone overlapping with the identical 
residues of OmpF/C channels. Recent studies have shown that the charged residues of the 
constriction region (CR) apart from creating a transversal electric field across the eyelet also 
involve electrostatics that play a crucial role in facilitating the permeation of solute (Im and Roux 
2002a, b, Bajaj et al., 2017 and Acosta-Gutierrez et al., 2015). Thus the similarity of the charged 
residues in the CR of the orthologs suggests that OmpE35 and OmpE36/K36 channels might 
involve electric fields of similar strengths as in OmpF and OmpC respectively, to facilitate the 
translocation of solute. Moreover, the conservation between the pore-lining ionisable residues of 
the orthologs and OmpF/C porins imply that the channels may employ similar electrostatic forces 
for the transport of solute from the vestibule opening to the periplasmic end.  
 
The determination of the OmpE36–LPS structure is the first porin with attached 
lipopolysaccharide and this allowed us to make the comparison with FhuA–LPS complex 
(Ferguson et al., 1998). For FhuA (with 11 coordinate files present in the PDB showing one LPS 
molecule bound to the same site), basic residues dominate the polar interactions with the bound 
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LPS but in OmpE36, the dominance of basic residues in LPS binding is much less pronounced. 
Moreover, the calcium-mediated interaction in OmpE36–LPS was not present in the FhuA–LPS 
structure. The original FhuA–LPS complex structure [PDB ID code 2FCP (Ferguson et al., 
1998)] contained a putative nickel metal ion bound to one of the phosphates of LPS that did not 
contribute to the binding to FhuA. The major difference in LPS binding between the two OMPs 
lies in the role of the KdoII moieties. In FhuA–LPS, KdoII points away from the protein and 
contributes just one interaction to the binding to FhuA (a salt bridge between Arg384 and the 
KdoII carboxylate). In sharp contrast, the KdoII forms the interaction hub (metal-mediated and 
direct interactions) with OmpE36 in both LPS A and LPS B (Figure 4.4). It is therefore clear that 
OMPs can interact with LPS in different ways, and an expanded database incorporating the LPS–
OmpE36 data should enable a better prediction of LPS binding sites on OMPs (Arunmanee et al., 
2016).  
 
The structures of V. cholerae porins OmpU and OmpT, despite being OmpF/C orthologs, 
exhibit an unusual feature inside their channels. Both channels reveal additional constriction 
elements (other than loop L3) that have not been reported before for any general diffusion porin 
of Gram-negative bacteria. The channels of OmpU and OmpT are constricted inside by the 
folding of N-terminus and L8 loop, respectively. We suspect these additional constrictions might 
be caused due to the external conditions like osmolarity, temperature or pH that are faced by the 
bacterium in aquatic or marine environments. These constrictions of OmpU/T porins cause a 
further reduction in the pore sizes of the channels as compared to OmpF/C porins (Figure 4.23). 
A HOLE comparison (Figure 4.19 C and 4.20 C) illustrates the differences of the pore sizes 
between OmpU/T and OmpF/C structures along the length of the diffusion axis. In addition to the 
differences in the pore constrictions of OmpU and OmpF/C porins, the channels exhibit some 
variations in the regions exposed to the hydrophilic environments in vivo. In contrast to the loops 
of OmpF/C porins, OmpU extracellular loops are comparatively short except loop L4 which 
comprises ~30 residues (Figure 4.23 A, B). As a result, the OmpU channel exhibits an increased 
surface area in the vestibule opening in comparison to OmpF/C channels (Figure 4.23 D). 
However in OmpT, L8 constricts the channel in such a way that the pore is absolutely occluded 
when viewed in a direction perpendicular to the diffusion axis (Figure 4.23 E). The OmpT pore 
becomes visible after tilted at an angle (~10°) with respect to the membrane normal (Figure 4.20 
D) and is restricted at the extracellular surface by loop L5 (~20 residues; Figure 4.20 E). 
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Figure 4.23. Structural comparison of OmpU/T channels with OmpF.  
The side views for the channels of OmpU (A; cyan) and OmpT (B; green) superposed on OmpF 
(in gray). Extracellular surface and cartoon views of OmpU (C), OmpT (D) and OmpF (E) 
porins.   
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Chapter 5. In vitro antibiotic uptake assays and single channel 
electrophysiology 
5.1 Introduction 
The lack of new drug development since 1987 and misuse of the drugs/medicines has led 
to the rapid emergence of multi-drug resistant (MDR) bacteria worldwide. One of the three main 
factors (see section 1.5) that are attributed to the cause of MDR is the inability of antibiotics to 
cross the OM interface of Gram-negative bacteria. The water-filled porin channels provide a 
porin-mediated pathway (detailed in section 1.5.1) for the transport of hydrophilic drug 
molecules (≤ 600 Da).  
 
In vitro liposome swelling assays (LSA; see Figure 1.6) and electrophysiology 
experiments have demonstrated the permeation of β-lactams like penicllins and cephalosporins, 
and fluoroquinolones through the channels of E. coli OmpF/C porins (section 1.5.1). In 
comparison, antibiotic-related studies with the diffusion porins of E. cloacae (OmpE35/E36) and 
K. pneumoniae (OmpK35/K36) and V. cholerae (OmpU/T) have been relatively limited (also 
discussed in sections 1.6.1 and 1.6.2).  
 
This chapter describes the in vitro antibiotics uptake assays with OmpE35/E36 and 
OmpK35/K36 proteins to assess the permeation of different hydrophilic molecules. OmpK35 was 
expressed (in E. coli) and purified by a colleague in the lab for structure determination whilst I 
performed the in vitro antibiotic uptake assays with the isolated pure fractions of the protein.  In 
addition to in vitro uptake assays, electrophysiology can reveal information about the kinetic 
features of the porin channels and helps in gaining a precise knowledge of the functional 
characteristics of the channel such as conductance and selectivity. We performed functional 
characterisation of V. cholerae porins OmpU/T as well as the deletion mutants (OmpUΔN and 
OmpTΔL8) using lipid-bilayer electrophysiology experiments. In addition, the single channel 
electrophysiology and LSA experiments that were performed to study the effect of antibiotics 
with OmpU/T porins are also discussed in this chapter. The statistical analysis of the data, used 
for different assays and experiments, has been decribed in the section 2.12 of chapter 2 (also 
mentioned wherever required).  
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5.2. Disc diffusion assays 
Keeping in mind the size exclusion limit (600 Da) of non-specific porins, we tested the 
uptake of a wide range of antibiotics with different molecular weights using the disc diffusion 
assay (see section 2.9.1). The substrates with low molecular weight compounds like fosfomycin 
(138 Da), trimethoprim (290 Da), ciprofloxacin (331 Da), meropenem (383 Da), gentamycin (477 
Da), chlortetracycline (478 Da), ceftazidime (546 Da) and high molecular weights like 
erythromycin (733 Da), rifampicin (822 Da) were selected for the assay. The proteins OmpE36 
(of E. cloacae), OmpK36 (of K. pneumoniae) and OmpU (of V. cholerae) were used for the assay 
(at 8 mg/ml). E. coli cells of omp8 (Bl21) strain were transformed with an "empty" pBAD24 
plasmid and used as a negative control for the assay (referred to as pBAD; Kan
r
). The data in 
figure 5.1 displays the cumulative result of the radii of the lytic zones obtained for each 
antibiotic, averaged from three different experiments (n=3, also described in section 2.12).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Disc diffusion assay of selected antibiotics with porins.  
The plot depicts the radii of lytic zones (in centimetres) caused by the diffusion of selected 
antibiotic (8 mg/ml) through the porin channels of OmpE36, OmpK36 and OmpU. The averaged 
data is obtained from three separate experiments (n=3; also see section 2.12). * represents no data 
detected.  
 
Overall, trimethoprim showed maximum diffusion for the three proteins, even higher than 
the smallest antibiotic fosfomycin. Surprisingly, small-sized ciprofloxacin did not permeate 
through any of the porins but the high molecular weight compounds like erythromycin and 
rifampicin (larger than 600 Da) also showed significant uptake through OmpK36 and OmpU 
113 
 
porins. Among the three porins, OmpE36 was the least permeable channel and showed (almost) 
zero uptake of all antibiotics (except for meropenem and trimethoprim). However apparently, the 
data displayed an odd behaviour for the negative control (pBAD) by showing significant 
diffusion for majority of the compounds (Figure 5.2). This suggests that the omp8 (Bl21) cells, 
despite being devoid of major porins (OmpF/C), expressed some another porin (or porins such as 
OmpN) that might have allowed the permeation of the substrates. As a result, the results of the 
disc diffusion data could not be considered reliable.  
 
 
 
 
   
 
 
 
 
 
 
 
 
  
 
Figure 5.2. Antibiotic lytic zones by porins and negative control.  
LB agar plates (Kan
r
; supplemented with 0.1% arabinose) display the zones of lysis for 
gentamycin (1),  chlorotetracycline (2) and ceftazidime (3) caused by the cells expressing porin 
channels of (A) OmpK36, (B) OmpE36, (C) OmpU and (D) negative control omp8 cells. 
 
5.3. Growth assays 
The growth assays (see section 2.9.2) were carried out with E. cloacae porins 
OmpE35/E36 and V. cholerae OmpU. The two compounds, meropenem (383 Da) and 
ceftazidime (546 Da) that showed high diffusion rates in the disc diffusion assay (section 5.2) 
were chosen for the assay. The omp8 (Bl21) cells (Kan
r
) were used to express the target proteins 
and functioned as the negative control in the assay. The growth curves in Figure 5.3 display the 
effect observed in the cell OD expressed with the target proteins after the addition of meropenem 
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(0.02/0.04 µg/ml) or ceftazidime (0.08/0.10/0.12 µg/ml). However yet again, the negative control 
omp8 cells interfered with the cumulative result by showing the same pattern for the growth 
curves as observed for others (Figure 5.3). As a result, the results of the growth assays remained 
inconclusive. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Growth assay of OmpE35/E36 and OmpU in presence of antibiotics.  
(A) The standard growth rates of cells expressed with OmpE35/E36 and OmpU proteins without 
the addition of antibiotic. The growth rate of the cells upon addition of (B) 0.02 µg/ml 
meropenem, (C) 0.04 µg/ml meropenem, (D) 0.08 µg/ml ceftazidime, (E) 0.1 µg/ml ceftazidime 
and (F) 0.12 µg/ml ceftazidime are also shown. The figure is a representative result of the assay.  
 
5.4. Liposome swelling assay for OMPs of E. cloacae and K. pneumoniae 
Since the in vivo assays (sections 5.2 and 5.3) were inconclusive because of the lack of a 
proper negative background we decided to conduct in vitro experiments for testing the antibiotic 
uptake. To compare the uptake rates of different classes of antibiotics between the OMPs of E. 
cloacae and K. pneumoniae, the purified samples of OmpE35, OmpE36, OmpK35 and OmpK36 
proteins were used for the preparation of liposomes for the liposome swelling assay (LSA; see 
section 2.9.3). The proteins of E. cloacae (OmpE35/E36) and K. pneumoniae (OmpK35/K36) 
were reconstituted into proteoliposomes along with E. coli OmpF (used as positive control) to 
compare and analyse the relative permeation rates of small hydrophilic solutes. The substrates 
employed for LSA included glucose, amino acids (glycine, glutamate, arginine) and different 
antibiotics (ampicillin, meropenem, imipenem, ceftazidime, ertapenem, cefepime, cefotaxime, 
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ticarcillin and piperacillin) (also see Appendix Figure 4). For analysis, the uptake rate of glycine 
through each protein was normalised to 100% and used as a reference to calculate the permeation 
rates for the rest of the substrates through the same protein (also described in section 2.12). The 
protein levels in the proteoliposome mixtures of OmpF, OmpE35, OmpE36, OmpK35 and 
OmpK36 were assessed through SDS-PAGE (Figure 5.4). The SDS-PAGE gel depicts almost 
identical band intensities for the target proteins (Figure 5.4) implying equimolar protein amounts 
used for the LSA.  
 
 
  
 
 
 
 
   
 
Figure 5.4. SDS-PAGE of proteins from liposome preparations.  
Coomassie-stained gel shows the proteins bands (indicated by the boxes in black) for OmpF 
(Lane 1), OmpE35 (Lane 2), OmpE36 (Lane 3), OmpK35 (Lane 4) and OmpK36 (Lane 5). An 
equal volume (~10 µl) of proteoliposome mixtures was loaded on the SDS-PAGE. L represents 
the molecular weight marker.   
 
The LSA data in Figure 5.5 (also see section 2.12) shows faster uptake of glutamate (147 
Da) than arginine (174 Da) through OmpF which is expected considering the weak cation-
selective nature of the channel. Accordingly, OmpE35 and OmpK35 (OmpF orthologs) are 
assumed to be less cation selective than OmpE36 and OmpK36 (OmpC orthologs) respectively, 
and are expected to reproduce OmpF-like uptake patterns for the charged amino acids. However, 
the uptake of charged molecules through the target porins was slightly different than expected. 
OmpE35 showed slightly higher uptake of glutamate (~78%) than arginine (~72%) but OmpE36 
allowed almost equal uptake of both substrates (~ 61%). Likewise, OmpK36 showed higher 
uptake of arginine (~ 87%) than glutamate (~ 82%) but OmpK35 showed no particular preference 
(~ 86% for both glutamate and arginine). 
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Among the zwitterionic carbapenems, each antibiotic showed similar permeation profile 
through all proteins except for ertapenem. Ertapenem (475 Da) diffused more rapidly through 
OmpF orthologs (71% through OmpK35 and 30% through OmpE35) than OmpC counterparts 
(16% through OmpK36 and none through OmpE36). In contrast, other carbapenems like 
imipenem and meropenem, showed faster permeation rates than other zwitterionic compounds 
through all porin channels. The uptake of imipenem (299 Da, ~ 50%) was less than meropenem 
(~383 Da) and each channel showed more than 70% translocation efficiency for meropenem 
(highest among the antibiotics and comparable to the amino acids).  
 
A large variation was observed for the uptake of anionic compounds. The only di-anionic 
compound, ticarcillin (384 Da), failed to permeate through any porin (except for OmpK35). 
Among the mono-anionic compounds, ceftazidime (546 Da) showed a significant permeation rate 
of ~ 20% through all the proteins while cefotaxime and piperacillin showed extremely low uptake 
(≤ 10%). The zwitterions of ampicillin (349 Da) permeated more swiftly through OmpF 
orthologs than the OmpC orthologs. The maximum uptake of ampicillin (~ 47%) was noted for 
OmpE35 channel. However, another zwitterionic compound, cefepime (480 Da), showed faster 
permeation through OmpC orthologs than OmpF orthologs. The highest uptake of cefepime was 
observed for OmpE36 (66%).  
 
Very recently, after a comprehensive analysis on a large number of compounds, a report 
suggested certain factors like presence of an amine group, rigidity and low globularity of a small 
molecule contribute towards its accumulation inside the cells of Gram-negative bacteria (Richter 
et al., 2017).  The compounds containing ionisable nitrogen atoms (amine group) are more likely 
to pass through cation-selective channels of porins (like OmpF/C) than the molecules with 
carboxylate-groups. Other factors like rigidity and globularity, contributing towards the molecule 
conformation, are crucial to overcome the energy barrier at the CR of porins.  According to these 
criteria, the low uptake of piperacillin can be explained due its globular shape while the rest of 
the molecules adopt linear conformation (Appendix Figure 4). In comparison, despite the linear 
shape, the low uptake for cefotaxime (8 rotating bonds) is probably because of its lower rigidity 
than piperacillin (6 rotating bonds). Among the zwitterions, cefepime possesses two additional 
ionisable nitrogen atoms than ampicillin which may explain its higher translocation rate through 
all the porins (Richter et al., 2017). 
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Figure 5.5. Liposome swelling data for OMPs of E. cloacae and K. pneumoniae.   
The figure depicts the permeation rates of various substrates through the proteoliposomes of OmpF, OmpE35/E36 and 
OmpK35/K36.  The substrates include a sugar (glucose), 3 amino acids (glycine, arginine and glutamate) and 9 antibiotics 
(ampicillin, meropenem, imipenem, ceftazidime, ertapenem, cefepime, cefotaxime, ticarcillin and piperacillin). The substrate 
uptake rates were averaged from triplicates measured from three different liposome samples prepared on different days. The 
values shown correspond to averages and their standard deviations (n = 9, also see section 2.12). For each protein, the uptake rate 
of glycine (0.83) was set to 100% and used as a reference for calculating the permeation of other substrates.   
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5.5. Single channel electrophysiology studies of OmpU and OmpT proteins 
Single channel electrophysiology was used to investigate the channel properties of V. 
cholerae porins OmpU and OmpT (see section 2.10). 
 
5.5.1.  Single channel properties of OmpU and OmpUΔN 
The conductance values for OmpU and OmpUΔN in 1 M KCl (solubilised in 10 mM 
HEPES, pH 7.5) were recorded as 1.0 ± 0.04 nS and 1.4 ± 0.03 nS respectively (n=3). The higher 
conductance of OmpUΔN is explained qualitatively by its shorter constriction and larger pore 
diameter, facilitating higher flow of ions than OmpU. A main point to be noted here is under the 
conditions of high salt (1 M KCl), the current traces of OmpU and OmpUΔN showed no 
evidence of trimeric states (evident in the form of trimeric gating). Another notable feature 
apparent from the current traces of OmpU was the pronounced gating of the channel at positive 
voltages. As a result, the ion-fluctuation created a subconductance state resulting in a small peak 
of current obtained for the histogram plot of OmpU channel, in addition to the main current peak 
(as indicated with an arrow in Figure 5.6 A). However, the ion-current fluctuations were much 
less pronounced in the traces of OmpUΔN (Figure 5.6 B), which may implicate the role of N-
terminus in causing the gating behaviour of OmpU.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6. Characterisation of V. cholerae porin channels.  
Single channel current traces for (A) OmpU, (B) OmpUΔN, (C) OmpT and (D) OmpTΔL8. All-
point histograms shown on the right side of the traces correspond to the positive voltages only 
(time period of 5 seconds). Traces were recorded in 1 M KCl (10 mM Hepes pH 7.5) with a 
potential of 150 mV.  
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5.5.2.  Single channel properties of OmpT and OmpTΔL8  
The single channel conductances recorded for OmpT and OmpTΔL8 were 2.0 ± 0.17 nS 
and 2.0 ± 0.11 nS respectively, in 1M KCl (in buffer 10 mM HEPES, pH 7.5). Like OmpU (or 
OmpUΔN), both OmpT and OmpTΔL8 showed no trimeric traces in 1M KCl, suggesting only 
monomeric channels are inserted into the lipid bilayer under high ionic strength conditions. The 
similar conductance values for OmpT and the L8 deletion mutant are surprising, given the much 
larger pore in the crystal structure of the deletion mutant. The single channel traces of OmpTΔL8 
showed 2-3 subconductance states, which were absent in OmpT, suggesting that the lack of L8 
causes other extracellular loops to move and partially block the ion current. Frequent gating in 
the form of transient current blockages was observed for OmpT at positive voltages (Figure 5.6 
C). As for OmpU, the traces of the loop deletion mutant OmpTΔL8 showed less pronounced 
gating behaviour (Figure 5.6 D), and the data therefore suggest that the gating in WT OmpT 
results from movements of loop L8 within the pore constriction. 
  
5.5.3.  Trimeric traces of OmpU and OmpT at low ionic strength 
We also made the single channel measurements for OmpU and OmpT in low salt buffer 
(150 mM KCl, 10 mM HEPES, pH 7.5). In contrast to the high salt data, the low salt recordings 
showed clear evidence for trimerisation. The trimeric conductances for OmpU and OmpT were 
determined to be 0.7 nS and 1.1 nS respectively (Figure 5.7 A). These values are similar to earlier 
published data from proteins purified from V. cholerae (Delcour 2003) where trimeric 
conductances of OmpU and OmpT were reported to be 0.9 nS and 1.3 nS respectively.  The 
comparison of OmpU and OmpT traces in 1 M and 150 mM KCl demonstrates that the trimeric 
states of these proteins are destabilised in detergent in the presence of high salt concentrations.  
Such behaviour contrasts with the porins of Enterobacteria, which form stable trimers 
independent of ionic strength. Analysis of OmpU and OmpT in blue-native PAGE confirms the 
relatively low stability of the V. cholerae porins (Figure 5.7 B), since both proteins produced 
three bands corresponding to their monomeric, dimeric and trimeric states. A closer look at the 
gel shows the intensity of trimeric band for OmpT is very weak, implying that the trimer of 
OmpT is less stable than that of OmpU.  
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Figure 5.7. Oligomerisation of V. cholerae porins OmpU and OmpT.  
(A) Single channel traces obtained in 150 mM NaCl (10 mM Hepes pH 7.5; 150 mV), showing 
trimerisation for both OmpU and OmpT. (B) Blue native-PAGE of OmpU and OmpT. As a 
control, the OmpF ortholog of Enterobacter cloacae (OmpE36) is included as a stable trimer. 
Molecular weight marker positions are indicated.  
 
5.6. Multichannel electrophysiology studies of OmpU and OmpT 
Multiple porin channels of OmpU (and OmpUΔN) and OmpT (and OmpTΔL8) were 
allowed to insert in a black lipid membrane to corroborate the conductance properties of these 
channels as revealed from the single channel analysis. As shown in figure 5.8, the conductance 
values recorded from multichannel bilayer experiments for OmpU, OmpUΔN, OmpT and 
OmpTΔL8 in 1 M KCl buffer solution (10 mM HEPES, pH 7.0) are in good agreement with the 
single channel recordings. The maximum number of channels for OmpU and OmpUΔN in 1 M 
KCl recorded the conductances of 800 pS and 1200 pS respectively. For OmpT and OmpTΔL8, 
the conductance recorded for maximum number of channels approximated to 1700 pS and 1400 
pS respectively. These values are in accordance with the conductances derived from single 
channel studies except for OmpTΔL8. The deviation of multi-channel conductance of OmpTΔL8 
(~ 1.4 nS) from its single channel conductance (2.0 nS) is unusual and may be explained by the 
fact that the multi-channel measurement is a crude method to estimate the conductance and 
cannot be considered a robust tool for determining ion-channel properties.  
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Figure 5.8. Multichannel data for OmpU (/OmpUΔN) and OmpT (/OmpTΔL8). 
Conductance values (in Siemens) recorded from multichannel (80-100) insertions of (A) OmpU, 
(B) OmpUΔN, (C) OmpT and (D) OmpTΔL8 in 1 M KCl buffer (10 mM Hepes, pH 7.0.). The 
data is a mean of three independent measurements (also described in section 2.12). 
 
 
5.7. Ion-selectivity of OmpU and OmpT 
To probe the ion selectivity of the channels, multichannel lipid bilayer experiments for 
OmpU and OmpT were conducted in three different salt buffers (KCl, LiCl and K
+
-acetate) at 
high ionic strength. The resting membrane potentials recorded in KCl buffer (and in LiCl and K
+
-
acetate buffers) showed a cation-selective nature for both channels. The electrophoretic 
mobilities of the charged ions of KCl solution are equal (K
+
 = Cl
-
) but are different for the ions of 
LiCl and K
+
-acetate solutions. As a result and in comparison to the selectivity data in KCl 
solution, the selectivity for cations is reduced in the LiCl solution because of lower mobility of  
Li
+ 
compared to Cl
-
 ions, but is increased in the K
+
-acetate solution because of the higher 
mobility of K
+
 compared to CH3COO
-
  ions (Figure 5.9).  
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Figure 5.9. Cation selectivity revealed for V. cholerae porins.   
The multichannel data of (A) OmpU, (B) OmpUΔN, (C) OmpT and (D) OmpTΔL8 show the 
resting membrane potentials achieved in KCl, LiCl and CH3COOK solutions. The data shown is 
a mean of three independent measurements (also described in section 2.12). Some of the error 
bars are too small to be visible and are hidden behind the data labels.  
 
The ion selectivity measurements of OmpU and OmpT were also conducted under low 
ionic strength conditions (0.01 M to 0.1 M KCl) for comparison with those done in high ionic 
strength (0.1 M to 1 M KCl). With ion-selectivity being strongly dependent on the salt 
concentrations, the cation selectivity difference between OmpU and OmpT was more evident 
under conditions of low ionic strength (Figure 5.10). The zero-current membrane potentials at 10-
fold salt gradient were used to derive the cation to anion permeability ratios (Pk/Pcl) via the 
Goldman–Hodgkin–Katz voltage equation (Hodgkin and Katz, 1949). The permeability ratios 
were calculated as ~3.8 (OmpU) and ~2.8 (OmpT) and are comparable to OmpF (~3.9) in similar 
salt conditions (Benz et al., 1985). Contrary to the present study, an earlier paper (Simonet et al., 
2003) reported comparatively high Pk/Pcl values for OmpU (~14) and OmpT (~4), showing much 
higher cation selectivity for OmpU for reasons that are unclear. 
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Figure 5.10. Cation selectivity of OmpU and OmpT channels in high vs low salt buffers.  
The porin channels of OmpU and OmpT show higher resting membrane potential (Vm) in 10-fold 
salt gradient of low salt solution (0.01 M – 0.1 M KCl) than for the same gradient of high salt 
solution (0.1 M – 1 M KCl). The data shown is a mean of three independent measurements (also 
see section 2.12).  
 
5.8. Single channel analysis of OmpU(/UΔN) and OmpT(/TΔL8) with substrates   
Cholera infection is treated most commonly with antibiotics from the tetracycline family 
(e.g. tetracycline, doxycycline). Unfortunately, the addition of tetracycline or doxycycline did not 
affect the single channel traces of OmpU/T, which is mostly explained by the limited solubility of 
those compounds in aqueous buffers (~ 1-2 mM). Moreover, the addition of other, water-soluble 
β-lactam antibiotics (ampicillin, piperacillin and ticarcillin) showed no effects, even at 
concentrations of up to 20 mM. However, the addition of two carbapenem antibiotics (imipenem 
and meropenem), generated interesting features in the single channel current traces that are 
discussed in the following sections (Figure 5.11). Using proteins purified from V. cholerae, it was 
previously reported that the physiologically important bile component deoxycholate interacts 
with OmpT and not with OmpU (Duret and Delcour, 2006 and Duret and Delcour 2010). We 
repeated these experiments with our E. coli-expressed proteins to verify those results by testing 
the effect of deoxycholic acid on OmpU and OmpT traces (Figure 5.11). 
 
 
 
124 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11. Chemical structures of substrates.  
Chemical representations of different substrates, (A) meropenem (383 Da), (B) imipenem (299 
Da) and (C) deoxycholate (392 Da) which were studied with the single channels of V. cholerae 
porins.  
 
5.8.1.  Imipenem effect on OmpU/T traces 
Imipenem addition to the single channels of OmpU, OmpUΔN, OmpT and OmpTΔL8 
generated the following features: increase in the ion-current noise, decrease in the average current 
and most importantly, transient current blockage events (Figures 5.12 and 5.13). These reversible 
blockages of current are caused by the entry of a single substrate molecule into the channel. The 
single step downward transitions of complete closures in the current traces illustrate that 
monomers of OmpU (and OmpT) are blocked by the antibiotic molecule, further supporting our 
notion that only monomeric insertions of these porins occur in 1 M KCl. Since, similar effects of 
imipenem were observed with the traces of the deletion mutants, OmpUΔN and OmpTΔL8, it 
may indicate that these constriction elements might not be directly (but indirectly) involved in the 
substrate binding. The measurements for all four channels were performed with cis and trans 
addition of imipenem (to be noted that the ground and live states of the single channel are 
referred to as cis and trans states respectively). For OmpU and OmpUΔN, both cis and trans 
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addition of imipenem generated binding events and hence two association rate constants can be 
calculated (kon
cis
 and kon
trans
; M
-1
s
-1
) for 2.5 mM imipenem at 75 mV along with the dissociation 
rate constant (koff, s
-1
) (Table 5.1). The data show that both binding constants of OmpU are 
similar and very low, indicating that the interaction of imipenem with the OmpU is inefficient. In 
comparison to OmpU, the binding constants of imipenem with OmpUΔN are slightly higher for 
both cis and trans sides (Table 5.1). The difference between the two channels caused by 
meropenem is further illuminated by the current traces and histograms presented in Figure 5.12. 
An equal concentration of meropenem (2.5 mM) induces less current blockages in OmpU than 
OmpUΔN resulting in reduced current flow through OmpUΔN channel. This suggests that the 
deletion of N-terminus in OmpUΔN, by providing a larger pore diameter, may allow better access 
of imipenem as compared to OmpU.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12. Imipenem effect on current traces of OmpU and OmpUΔN channels.  
Current traces of (A) OmpU and (C) OmpUΔN without imipenem (left panels), display current 
blockages upon addition of 2.5 mM imipenem (right panels). (B, D) Current histograms 
(recorded for 10 seconds interval) of (B) OmpU and (B) OmpUΔN with 2.5 mM imipenem 
(gray) as compared to the current flow without imipenem (black as control). The data shown was 
recorded at 75 mV in 1 M KCl solution (10 mM HEPES, pH 7.0). 
 
For OmpT, since the channel showed spontaneous gating events at positive voltages 
(Figure 5.6 C) it became difficult to differentiate the interaction of imipenem from the trans side. 
Thus, for comparison with OmpU, the kon and koff values for OmpT were calculated only for the 
cis side with 2.5 mM imipenem at 75 mV (Table 5.1). 
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Table 5.1. Association (kon) and dissociation (koff) rate constants of imipenem.  
The single channels recordings of OmpU/T and their mutants in 1 M KCl, 10 mM Hepes, pH 7.0 
with 2.5 mM imipenem at 75 mV. The calculated data is a mean of three independent 
measurements.  
 Protein 
kon
cis
 (10
3
) 
(M
-1
 s
-1
) 
kon
trans 
(10
3
)
 
(M
-1
 s
-1
) 
koff 
(s
-1
) 
Imipenem OmpU 72 ± 20 122 ± 30 18180 
 OmpUΔN 90 ± 13 272 ± 40 25000 
 OmpT 320 ± 90 - 10000 
 OmpTΔL8 411 ± 78 - 9500 
- The events for OmpT were not calculated for trans side due to spontaneous gating of the channel.  
For OmpTΔL8, the kon and koff values were also calculated for only cis side with 2.5 mM 
imipenem at 75 mV (Table 5.1). The data shows a ~10-fold higher binding affinity of imipenem 
for OmpT as evident from the higher association rate (kon
cis
 = 320 × 10
3
 M
-1
s
-1
) compared to 
OmpU (kon
trans
 = 122 × 10
3
 M
-1
s
-1
).  This is further supported by the dissociation rate constants of 
imipenem, which for OmpT are almost 2-fold lower than those for OmpU (Table 5.1.). Moreover, 
as compared to OmpU (or OmpUΔN in Figure 5.12), OmpT (or OmpTΔL8) current traces 
(Figure 5.13) showed higher numbers of blocking events upon addition of 2.5 mM imipenem.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13. Imipenem effect on current traces of OmpT and OmpTΔL8 channels.  
The current traces of (A) OmpT and (C) OmpTΔL8 without imipenem (left panels), display 
current blockages upon addition of 2.5 mM imipenem (right panels). (B,D) Current histograms 
(recorded for 10 seconds interval) of (B) OmpT and (D) OmpTΔL8 (D) with 2.5 mM imipenem 
(gray) and without imipenem (black as control). The data shown was recorded at 75 mV in 1 M 
KCl solution (10 mM HEPES, pH 7.0). 
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The addition of imipenem causes almost 50% reduction in the current flow through the 
channels of OmpT and OmpTΔL8 than the control traces without the antibiotic (Figure 5.13 B 
and D). Like OmpU and OmpUΔN, the deletion mutant of OmpT also showed a higher binding 
affinity for imipenem than OmpT (Table 5.1).  
 
5.8.2.  Meropenem effect on OmpU/T traces 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14. Meropenem effect on current traces of OmpU and OmpUΔN channels.  
(A) The current traces (5 seconds) of OmpU without meropenem (left panel), with 5 mM 
meropenem (middle panel) and 15 mM meropenem (right panel). The boxed regions show 
zoomed in 5 ms traces of each OmpU trace. (B) The ion-current traces of OmpUΔN without 
antibiotic (left panel) and upon addition of 5 mM meropenem (right panel). (C) Histogram 
representation (recorded for 10 seconds interval) of current for OmpUΔN without meropenem 
(control in black) and with the addition of 5 mM meropenem (gray). The data shown was 
recorded at 75 mV in 1 M KCl solution (10 mM HEPES, pH 7.0). 
 
The addition of another carbapenem, meropenem, did not show binding events in the 
single channel traces of OmpU nor did it lead to a decrease in current (Figure 5.14 A). This could 
be explained by two extreme possibilities: (i) either meropenem does not permeate through 
OmpU or (ii) permeation is extremely fast (< 50 µs) and cannot be recorded by the amplifier. 
However, meropenem reduced the current flow in the traces of OmpUΔN. Although no binding 
events were observed for OmpUΔN, meropenem addition increased the ion-current noise as well 
as very slight reduction in the average current flow was also observed (Figure 5.14 B and C). 
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However, the association or dissociation rates were not calculated for OmpUΔN since no binding 
events could be recorded upon meropenem addition.  
 
Table 5.2. Association (kon) and dissociation (koff) rate constants of meropenem.  
The single channels recordings of OmpU/T and their mutants in 1 M KCl, 10 mM Hepes, pH 7.0 
with 2.5 mM meropenem at 75 mV. The data shown is averaged (mean) from three independent 
measurements.  
 Protein 
kon
cis
 (10
3
) 
(M
-1
 s
-1
) 
kon
trans 
(10
3
)
 
(M
-1
 s
-1
) 
koff 
(s
-1
) 
Meropenem OmpU ND* ND* ND* 
 OmpUΔN ND* ND* ND* 
 OmpT 43 ± 15 - 28570 
 OmpTΔL8 52 ± 15 - 14285 
*ND Not Detected 
- The events for OmpT were not calculated for trans side due to vigorous flickering of the channel.  
 
 
In contrast to OmpU, meropenem addition to OmpT and OmpTΔL8 showed an increase 
in the ion-current noise accompanied by a reduction in average current. Compared to imipenem 
addition, very few discrete binding events were recorded with meropenem (Figure 5.15), giving a 
binding constant (K= kon/koff) of 1.5 M
-1
 for OmpT and 3.6 M
-1
 for OmpTΔL8 at 75 mV (Table 
5.2). The data suggests lower binding affinity of meropenem for OmpT (or OmpTΔL8) than 
imipenem. However, since binding and permeation are two independent aspects and are not 
necessarily related, the single channel measurements alone do not inform on the permeation rates 
of meropenem and imipenem.  
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Figure 5.15. Meropenem effect on current traces of OmpT and OmpTΔL8 channels.  
A, C) The comparison of the current traces (5 s) of (A) OmpT and (C) OmpTΔL8 without 
antibiotic (left panels) and with 5 mM meropenem (right panels). The boxed regions are zoomed 
in (5 ms) for OmpT traces to show current blockages induced by meropenem. (B, D) The 
histogram (recorded for 10 seconds interval) representation of current flow through (B) OmpT 
and (D) OmpTΔL8 without meropenem (control in black) and with 5 mM meropenem (gray). 
The data presented was recorded at 75 mV in 1 M KCl solution (10 mM HEPES, pH 7.0). 
 
5.8.3.  Deoxycholate effect on OmpU/T traces 
Earlier studies on V. cholerae porins implicated OmpU to play a crucial role in the 
colonisation of the human intestine by bacterial cells by generating resistance to bile (also see 
section 1.6.1.2). Electrophysiological studies on V. cholerae porins demonstrated that the 
addition of deoxycholate causes single step closures in the ion-current traces of OmpT but not 
with OmpU (Duret and Delcour 2006). In our work, we replicated the study to confirm these 
findings for our proteins and obtained data that agree well with the previous results. OmpT traces 
showed single step closures (SSCs) upon the addition of deoxycholate (Figure 5.16). The 
frequency of SSCs increased with the increase in the concentration of added deoxycholate. 
However, addition of substrate beyond 250 µM resulted in rupture of the lipid membrane due to 
the fact that DOC is a detergent.  
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Figure 5.16. Deoxycholate effect on single channel traces of OmpT.  
(A) Standard ion-current traces of OmpT. (B, C) The single step closures in the ion-current traces 
of OmpT with the addition of (B) 100 µM deoxycholate and (C) 200 µM deoxycholate.  
 
 
In contrast to OmpT, the OmpU traces were completely unaffected by deoxycholate 
addition (Figure 5.17). The effect of deoxycholate (if any) on OmpU could only be recorded with 
a maximum concentration of up to 200 µM, since the use of 250 µM or above interfered with the 
membrane stability of the lipid bilayer and resulted in membrane rupture.  
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Figure 5.17. Deoxycholate effect on single channel traces of OmpU.  
(A) Standard ion-current traces of OmpU which remain uneffaected by the addition of (B) 100 
µM deoxycholate and (C) 200 µM deoxycholate. 
 
 
5.9. Liposome swelling assays for OmpU and OmpT  
The electrophysiological studies revealed the interaction of two antibiotics, meropenem 
and imipenem, with the porins of V. cholerae. To corroborate the results of the single channel 
studies, we carried out LSA for an initial characterisation of small-molecule transport through 
OmpU and OmpT (Figure 5.18). For comparison, we assessed uptake by E. coli OmpF as well. 
The uptake of glycine through OmpF channel was set to 100% to be used as a reference for 
calculating the uptake rates of other substrates through OmpF and OmpU/T porins. Overall, 
uptake rates were roughly proportional to the diameter of the channels, with the highest rates 
observed for OmpF and the lowest rates for OmpT. The uptake rates for glutamate were slightly 
higher than those for arginine, despite the cation selectivity of all three channels (Danelon et al., 
2003) Possible reasons for this are the slightly higher substrate concentrations used for glutamate 
(9 mM versus 7 mM for arginine) as well as the higher molecular weight for arginine (174 Da 
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versus 147 Da for glutamate). Interestingly, the data (Figure 5.18) also show that meropenem is 
taken up faster than imipenem by both OmpU and OmpT, despite meropenem being substantially 
larger (383 Da) than imipenem (299 Da). The liposome swelling experiments agree qualitatively 
with the electrophysiological data, in the sense that imipenem showed stronger and more 
pronounced interactions with OmpU and OmpT compared to meropenem, likely making uptake 
of the smaller antibiotic less efficient. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.18. LSA data for V. cholerae porins.  
Liposome swelling data for the substrates glycine (16 mM), glutamate (9 mM), arginine (7 mM), 
imipenem (16 mM) and meropenem (12 mM). Transport of glycine through OmpF is set to 100% 
for standardisation. The values shown correspond to the averages and their standard deviations (n 
= 9, also see section 2.12). 
 
5.10. Discussion 
E. coli porins have been extensively explored to provide a plethora of structural (Lou et 
al., 2011 and Ziervogel and Roux, 2013) and electrophysiological (Hajjar et al., 2010, Mahendran 
et al., 2009 and Cama et al., 2015) information on the interaction of antibiotics with OmpF/C. 
This chapter is aimed to investigate the interaction of other Gram-negative porins with 
antibiotics. The LSA with the porins of E. cloacae and K. pneumoniae have allowed us to 
quantify the uptake rates of different compounds and compare the permeation levels with respect 
to the OmpF channel. Each substrate exhibited similar permeation rates (± 20%) through the 
diffusion porins targeted for LSA, suggesting an analogy between the uptake mechanisms for 
hydrophilic solutes by such non-specific channels. This doesn’t seem surprising given the 
structural knowledge of the porins that the channels of OmpE35/E36, OmpK36 (as discussed in 
section 4.13) and OmpF (Cowan et al., 1992) have equivalent pore sizes. The structure of 
OmpK35 (determined by another member of the lab) revealed similar pore dimensions as 
OmpK36. A few substrates however displayed slightly unexpected uptake patterns through these 
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porins in LSA (Figure 5.5). For instance, the high permeation of ertapenem (zwitterionic; 475 
Da) through OmpF orthologs is probably owed to their larger pore sizes than OmpC orthologs. 
On the other hand, no uptake of small-sized ticarcillin (dianionic; 384 Da) through any porin 
channel, except for OmpK35, certainly suggests that not only size but the charge of a solute also 
plays a crucial role in determining its passage through the porin channel (as discussed in section 
1.3.1.3). Nonetheless, another equally important factor like electrostatics and charged 
environment of the channel also affect the translocation of different substrates (Nestorovich et al., 
2003, Aguilella-Arzo et al., 2007 and Bajaj et al., 2017). This is best exemplified by the channel 
of OmpK35 porin (OmpF ortholog) that allows higher uptake of ticarcillin than the porins of 
OmpF and OmpE35 (another OmpF ortholog). The electrostatics of the three channels differ with 
respect to their surface charges at the extracellular top (Figure 5.19). The net positive charge of 
OmpK35 is higher than OmpE35 and OmpF, which may explain the diffusion of the anionic 
compound (ticarcillin) through OmpK35.    
 
 
 
 
 
 
 
 
Figure 5.19. Surface electrostatics of OmpF ortholgues.  
The figure displays electrostatic surface charges of (A) OmpF, (B) OmpE35 and (C) OmpK35 
from the extracellular side. The arrows indicate the difference in the negative charged regions of 
OmpF and OmpK35.  
 
Single channel electrophysiology experiments show higher single channel conductance of 
OmpUΔN than OmpU, which is expected due to the short constriction and large pore diameter of 
OmpUΔN. However, the similar conductance values for OmpT and the L8 deletion mutant are 
surprising, given the much larger pore in the crystal structure of the deletion mutant (Chapter 4). 
A possible explanation could be that the electrostatic properties of the two channel constrictions 
are quite different, with OmpT being negatively charged and the deletion mutant having a more 
typical "positive-negative" charge distribution due to the lack of loop L8. 
 
V. cholerae porins, to our knowledge, have not yet been scrutinised at the single channel 
level for the effect of antibiotics. The ion current fluctuations observed upon the addition of 
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carbapenems report for the first time on the interaction of an antibiotic with OmpU/T porins at 
the single channel level. The time-resolved current blockages caused by meropenem and 
imipenem in the traces of OmpT and OmpU/T respectively represent the reversible positioning of 
antibiotic at the constriction zone such that the flow of ions is completely obstructed. OmpF has 
been shown previously (Nestorovich et al., 2002) to generate similar current blocking events with 
the addition of ampicillin (zwitterionic penicillin) and subsequent research has suggested that 
such events possibly result in the translocation of drug through the channel (Danelon et al., 
2006).  We anticipated similar behaviour for OmpU/T traces with ampicillin due to the structural 
homology between their structures and OmpF (section 4.13). Unexpectedly however, ampicillin 
addition displayed no visible affects in the ion current traces of OmpU/T. As argued before, this 
does not necessarily reflect an inability to bind or permeate but means that the binding (or 
translocation) of the compound does not alter the ionic flow of current (Danelon et al., 2006 and 
Ziervogel and Roux 2013). The zwitterionic carbapenems were recently investigated at the single 
channel level for their translocation though OmpF (Bodrenko et al., 2015) and OmpC (Bajaj et 
al., 2016). OmpC revealed binding events with imipenem with lower association rate constant 
(kon = 34 × 10
3
 M
-1
) and higher dissociation rate constant (koff = 25000 s
-1
) than we obtain for 
OmpU (kon = 122 × 10
3
 M
-1
; koff = 18180 s
-1
) and OmpT (kon = 322 × 10
3
 M
-1
; koff = 10000 s
-1
) 
channels. The addition of meropenem (10 mM) to OmpF revealed no such binding events but 
showed an average current reduction in the ion current traces (Bodrenko et al., 2015) that are 
similar to the current histograms of OmpT upon addition of 2.5 mM meropenem (Figure 5.15 B). 
Together, the electrophysiology data suggest that imipenem and meropenem have higher 
affinities for OmpU/T than for OmpF/C. However, this does not mean that those compounds 
translocate faster via OmpU/T than via OmpF, as noted above and demonstrated by the liposome 
swelling assays that show faster permeation via OmpF (Figure 5.18). However, given that the 
liposome swelling assay reports indirectly on substrate permeation it remains necessary to 
develop assays that monitor translocation (as opposed to interactions) of small molecules such as 
antibiotics through OM channels in real time.  
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Chapter 6.  Final Discussion 
Multi-drug resistance in Gram-negative bacteria is a consequence of three primary factors 
(Pages et al., 2008), one of which is the inability of the drugs to permeate the asymmetric OM 
interface. The diffusion channels present across the OM provide the porin-mediated pathway for 
the translocation of hydrophilic compounds (≤ 600 Da). An overall aim of the current study is to 
decipher the mechanism for the small molecule transport through water-filled channels of porins 
in order to contribute to drug-discovery strategies. Towards this, the goals achieved in this study 
include the structure determination of V. cholerae major porins (and E. cloacae and K. 
pneumoniae porins) followed by functional characterisation of porins through electrophysiology 
and in vitro antibiotic uptake assays.  
 
6.1. Structure and Function of Enterobacterial porins 
The recombinant OM expression of OmpE35/E36/K36 porins produced more than ~ 5 mg 
of proteins per litre of cells. The proteins withstood multiple rounds of purification and were 
purified as trimers through SEC column (unlike V. cholerae porins that were eluted as 
monomers), indicating the robust nature of their oligomerised states. Furthermore, the 3D 
structures of Enterobacterial porins were crystallised as trimers of 16-stranded β-barrels (Chapter 
4). The sequence alignment of E. cloacae (OmpE35/E36), K. pneumoniae (OmpK35/K36) and E. 
coli (OmpF/C) proteins shows more than 70% sequence identity between the proteins (Appendix 
Figure 1).  In addition, a striking similarity observed on the superposition of the protein folds of 
Enterobacterial porins and the structural differences are interesting (Figure 6.1 and see section 
4.7). The structural superposition shows conservation of more than 50% of the pore-lining 
residues and the porins also match each other with the positions of the critical charged residues in 
the constriction region (Chapter 4).  
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Figure 6.1. Structural superposition of OmpF/C orthologs.  
(A) Side and extracellular views of OmpF (gray) superposed on OmpE35 (blue) and OmpK35* 
(green). (B) Side and extracellular views of OmpC (gray) superposed on OmpE36 (magenta) and 
OmpK36 (orange). 
*Also see Appendix figure 5 for OmpK35 structure. 
 
Small molecule permeation studies with Gram-negative porins have indicated molecular 
weight, polarity, shape, charge and rigidity as the key factors for determining permeation 
(Aguilella et al., 2015, Richter et al., 2017 and see section 1.3.1.3). Nonetheless, the charged 
environment inside a channel is an equally important factor playing a critical role in shaping the 
channel electrostatics to allow or restrict the passage of a molecule (Bajaj et al., 2017 and Acosta-
Gutierrez et al., 2015). For instance, based on the antibiotic flux measurements, the porin 
channels of OmpE35 and OmpK35 show different uptakes for zwitterions of ampicillin and 
cefepime (see section 5.4 and figure 5.5). Since the two channels have similar pore-size 
dimensions, it may be possible that the interior electrostatics of OmpE35 and OmpK35 channels 
affect the permeation of the same molecule in different ways. The current ortholog paper that we 
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are working on defines a molecular mechanism which can be used for the prediction of the 
permeability of compounds through porins. Based on the single channel data and in vitro as well 
as in vivo data, we have devised a scoring function to predict a molecule permeability through a 
specific porin. This in turn depends on avaerge sizes of the molecule and the porin channel, and 
the electrostatic interactions between the molecule (charge and dipole) and porin (electrostatic 
potential and electric field).  
  
6.2. Structure and Function of V. cholerae porins 
The single channel studies under low salt conditions verify the trimeric states of OmpU 
and OmpT, which dissociate into monomers in high salt conditions. Since OmpF/C porins are 
trimeric even in high salt conditions, the trimers of OmpU and OmpT are relatively unstable, a 
finding that is confirmed further by Native-PAGE. Moreover, the two proteins were purified as 
monomers during purification through SEC. The crystal structures aid in explaining the observed 
difference in trimer stability. The OmpU structure shows that the L2 loop (~15 residues) latches 
from one monomer into a groove of the other as observed for OmpF/C porins (Figure 6.2). An 
interaction analysis with PISA (Krissinel and Hendrick, 2007) shows that OmpF has a more 
extensive network of salt bridges compared to OmpU, all mediated by loop L2 (Appendix Table 
1). However, OmpU makes more hydrogen bonds with the neighbouring monomer compared to 
OmpF, making a qualitative explanation for the higher trimer stability of OmpF difficult. For 
OmpT, however, the difference with both OmpF and OmpU is pronounced. The short L2 loop 
doesn't mediate any electrostatic interactions with the adjacent monomer and the number of 
hydrogen bonds is low, compared with both OmpF and OmpU. The OmpT structure therefore 
provides a clear explanation for the low stability of the OmpT trimer in detergent solution. 
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Figure 6.2. Structural comparison of the L2 loop between OmpU, OmpT and OmpF.  
The structural superpositions of rainbow colored cartoons of (A) OmpU and (C) OmpT with 
OmpF (in gray) show the differences in the lengths of loop L2. Electrostatic representations from 
the top and side views of OmpU, OmpT and OmpF are shown in B, D and E respectively. The 
L2-groove interface is indicated by the arrows, showing the positively charged groove (in top 
views) and negatively charged L2 loop (in side views). Surface potentials vary from -69.8 kT/e to 
69.8 kT/e (for OmpU), -76.4 kT/e to 76.4 kT/e (for OmpT) and -63.5 kT/e to 63.5 kT/e (for 
OmpF). 
 
The crystal structures of general porins like E. coli OmpF and OmpC display a classical 
hourglass shape formed by 16-stranded β-barrel in which the inward-folded L3 loop together 
with opposing barrel wall residues forms the constriction eyelet.  Our structures reveal a similar 
porin architecture for V. cholerae OmpU and OmpT. However, a closer inspection of loop L3 for 
both OmpU and OmpT shows that its conformation is different from that in OmpF and OmpC. In 
OmpU and OmpT, the C-terminal part of L3 is located much closer to the barrel wall (Figure 
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6.2), and this would create a much larger pore without the additional constriction elements (i.e. in 
OmpUΔN and OmpTΔL8). Crucially, and contrasting with earlier predictions (Nikaido, 2003), 
L3 is one residue shorter in OmpU and OmpT compared to OmpF/C (Appendix Figures 2 and 3), 
and it is tempting to speculate that the 1-residue deletion is (partly) responsible for the different 
conformation of L3 in the barrel lumen, enlarging the channel. From an evolutionary perspective, 
the deletion may have facilitated subsequent insertion of the additional constriction elements (N-
terminus in OmpU; L8 loop in OmpT) to generate channels with smaller pores. An intriguing 
question is why these structural features have evolved in at least some Vibrio porins. We 
speculate that the environmental conditions in which many Vibrio species are encountered (high 
osmolarity, low pH, presence of bile salts) might necessitate small pores for protection of the cell. 
This notion has precedence, since the expression of the smaller-pore OmpC from Enterobacteria 
is favoured under conditions of high osmolarity (Pratt et al., 1996). 
 
Comparison of V. cholerae porins with OmpU/T orthologs of Vibrionaceae like the 
OmpL/H porins of Photobacterium profundum (Li et al., 2000) and OmpF/C of E. coli show a 
high conservation of several pore-lining charged residues (Appendix Figures 2 and 3). Strikingly, 
the N-terminal extension forming the additional constriction element in OmpU of V. cholerae is 
also present in V. mimicus but not in other OmpU proteins, raising the possibility that the other 
OmpU orthologs have different constriction elements that (like the one in V. cholerae) are not 
obvious from sequence alignment. The OmpT alignment, on the other hand, shows that the L8 
constriction element is likely present in many other OmpT orthologs but not, for example, in P. 
profundum OmpH. Structural analysis of other OmpU/T porins from Vibrionaceae will be 
required to establish whether additional constriction elements as present in the V. cholerae 
channels are widespread. 
 
In addition to decreasing the channel size, the additional constriction elements in OmpU 
and OmpT also affect the internal channel electrostatics. In the case of OmpU, the internal 
electric field is screened by the N-terminus linking two negative residues of the loop L3 and a 
positive residue from the basic ladder. In OmpT, the effect of the L8 loop on the channel 
electrostatics is dramatic. The charge segregation in the constriction region of OmpTΔL8 
resembles that in previously studied general porins, but the L8 insertion neutralises it to the 
extent that the transversal component becomes smaller than the longitudinal one. This unusual 
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characteristic might make the OmpT channel suitable for the uptake of more hydrophobic 
compounds (e.g. deoxycholate) that do not readily permeate through general porins due to the 
strong transversal electric field (Im and Roux 2002a, Im and Roux 2002b). 
 
The N-terminal extension of OmpU was previously implicated to be involved in adhesion 
during the intestinal colonization of V. cholerae (Sperandio et al., 1995), partly based on 
sequence similarities with a region in the adhesins HMW1 and HMW2 of Haemophilus 
influenzae. Another report claiming that the N-terminus of Vibrio mimicus OmpU is a motif 
required for bacterial adhesion (Liu et al., 2015) identified an immunogenic epitope with the 
sequence NQSGDKAGS (4 - 12 residues of the mature protein), which is identical to the 
corresponding sequence in V. cholerae. However, our structural data clearly shows that this 
sequence (residues 4 - 12 residues mature OmpU) is periplasmic and folded into the lumen of the 
channel. Thus, based on our findings, the N-terminus of OmpU in V. cholerae is very unlikely to 
be involved in adhesion. 
 
6.3. Future Work 
 The structures of OmpF/C orthologs in E. clocacae and K. pneumoniae display identical 
protein folds but the presence of unusual constriction elements in the channels of V. cholerae 
porins poses an interesting question on the evolutionary aspect of Gram-negative bacterial porins. 
In comparsion to Enterobacterial porins, it will be interesting to know if the additional 
constriction elements are restricted to Vibrionaceae family by determining the structures of 
porins from other Vibrio species (and other genera of the family). To test if the conformation of 
L8 loop in OmpT is physiological, the experiments can be carried out by crosslinking loop L8 to 
the pore via making a double cysteine mutant and analyse the same through electrophysiology 
experiments. 
 As seen during single channel study, deoxycholate causes SSCs in the OmpT traces but 
not in OmpU. Although this implies that DOC either binds or blocks the OmpT pore but doesn’t 
provide an information on its transport. Electrophysiology experiments like reverse potential can 
be used to analyse if DOC is uptaken by OmpT and not through OmpU. Docking experiments 
with DOC through molecuar simulation studies can also be used to determine its binding to the 
pore.  
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In single channel studies, the reversible blockages indicate that imipenem must have a 
common binding site within the CR (or inside the pore) of OmpU (or OmpT) and its deletion 
mutant OmpUΔN (or OmpTΔL8). The cocrystal structures of imipenem with these porin 
channels using X-ray crystallography may reveal the binding sites of the antibiotic in the pore. 
Alternatively, the construction of single mutants of the charged residues in the CR (of OmpU/T) 
and the subsequent analysis through electrophysiology can provide  some input on imipenem 
binding residues of the porins. In addition, meropenem addition doesn’t affect OmpU single-
channel traces but shows high diffusion rate through OmpU in LSA. Does meropenem get 
translocated at a faster rate through OmpU than OmpT? Besides obtaining co-crystal structures, 
the effects of meropenem on OmpU can also be analysed by performing single-channel 
electrophysiology at low-temperatures (≤ 4°C), which will slow down the diffusion of the 
molecule and enable us to detect the interaction (if any).  
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Appendix Figure 1 
 
Appendix Figure 1. Sequence alignment of OmpF/C orthologs.  
E. coli OmpF and OmpC protein sequences were aligned with the sequences of 
OmpE35/OmpE36 from Enterobacter cloacae and OmpK35/OmpK36 from Klebsiella 
pneumoniae.  The charged residues in the CR are highlighted in cyan. Aligned positive and 
negative charged residues of the protein sequences are colored in orange and green respectively. 
Conservation symbols (* / . / : ) were assigned by Clustal Omega (Sievers et al., 2011). 
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Appendix Figure 2 
 
Appendix Figure 2. Sequence alignment of OmpU.  
OmpU was aligned with the sequences of OmpF/C porins from E. coli and OmpU homologs in 
Photobacterium profundum (OmpL), Vibrio fischeri (OmpU), Vibrio harveyi (OmpU) and Vibrio 
parahaemolyticus (OmpU). The N-terminal constriction element of OmpU is shown in green. 
The amino acids in red are the pore-lining charged residues (except Ser6) of OmpU and 
equivalent identical residues are highlighted in cyan in the other sequences. Conservation 
symbols (* / . / : ) were assigned by Clustal Omega (Sievers et al., 2011). 
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Appendix Figure 3 
 
Appendix Figure 3. Sequence alignment of OmpT.  
OmpT was aligned with the sequences of OmpF/C porins from E. coli and OmpT homologs from 
Photobacterium profundum (OmpH), Vibrio fluvialis (OmpU), Vibrio albensis (OmpU) and 
Grimontia indica (OmpU). The L8 constriction loop region of OmpT is shown in green. The 
amino acids in red are the pore-lining charged residues of OmpT and equivalent identical 
residues are highlighted in cyan in other sequences. Conservation symbols (* / . / : ) were 
assigned by Clustal Omega (Sievers et al., 2011). 
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Appendix Figure 4 
 
Appendix Figure 4. Chemical structures of the compounds used in this study.  
The molecular weights of the compounds are listed in parentheses. 
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  Appendix Figure 5 
 
 
Appendix Figure 5. Structure of K. pneumoniae OmpK35.  
(A) Extracellular side (left panel) and OM plane (right panel) views for the cartoon presentation 
of the superposition of OmpK35 (red) to E. coli OmpF (grey). (B) Surface presentation of OmpF 
(left panel) and OmpK35 (right panel) viewed from the top of the barrel. 
 
 
 
 
 
 
 
147 
 
Appendix Table 1 
 Protein-protein interface interactions in the trimers of OmpF, OmpT and OmpU. Interface 
interactions (by salt bridges and hydrogen-bonds) between the subunits of OmpF, OmpT and OmpU 
trimers, as analysed by PDBePISA (Krissinel and Henrick 2007). L2 loop residues and their 
interactions are indicated in bold for each protein.
Monomer 1 Distance (Å) Monomer 2 
Salt bridges (OmpF) 
Glu71 (OE1) 2.98 Arg132 (NH2) 
Glu71 (OE1) 3.84 Arg132 (NE) 
Glu71 (OE2) 3.52 Arg132 (NE) 
Glu71 (OE2) 2.80 Arg132 (NH2) 
Glu71 (OE2) 3.38 Arg132 (NH2) 
Glu71 (OE2) 2.80 Arg132 (NE) 
Asp74 (OD2) 3.96 Arg163 (NH1) 
Hydrogen bonds (OmpF) 
His21 (ND1) 2.86 Tyr98 (OH) 
Glu 71 (N) 2.77 Asp126 (OD2) 
Gln76 (NE2) 3.07 Asn79 (O) 
Gln76 (NE2) 2.81 Tyr63 (OH) 
Asn304 (ND2) 2.90 Thr49 (OG1) 
Tyr338 (OH) 2.65 Asn9 (OD1) 
Leu20 (O) 3.87 Tyr98 (OH) 
Asp37 (OD1) 2.85 Tyr98 (OH) 
Asn68 (O) 2.82 Arg163 (NH1) 
Asn69 (O) 3.36 Arg100 (NH1) 
Glu71 (OE1) 3.80 Ser125 (OG) 
Glu71 (OE1) 2.98 Arg132 (NH2) 
Glu71 (OE1) 2.80 Arg100 (NH2) 
Glu71 (OE1) 2.80 Arg132 (NE) 
Asn306 (OD1) 3.88 Thr49 (OG1) 
Met307 (SD) 3.72 Tyr58 (N) 
Tyr338 (OH) 3.54 Glu48 (N) 
Monomer 1 Distance (Å) Monomer 2 
Hydrogen bonds (OmpU) 
Asp73 (OD1) 2.80 Lys103 (NZ) 
Asp73 (OD2) 2.77 Asp136 (N) 
Gln74 (OE1) 3.42 Asn180 (ND2) 
Gln74 (O) 3.45 Asn180 (ND2) 
Gly75 (O) 2.93 Gln207 (NE2) 
Asn77 (OD1) 3.58 Arg134 (NH1) 
Asn77 (OD2) 2.86 Lys103 (NZ) 
Ala78 (O) 3.00 Lys103 (NZ) 
Asn80 (O) 2.76 Asn85 (N) 
Ser82 (O) 2.90 Asn85 (ND2) 
Tyr318 (OH) 3.11 Lys52 (N) 
Lys35 (NZ) 3.48 Tyr177 (OH) 
Thr71 (OG1) 2.70 Asp136 (OD2) 
Asp73 (N) 2.87 Asp136 (OD2) 
Gly75 (N) 3.35 Asp158 (OD2) 
Asn77 (ND2) 2.90 Asp133 (OD2) 
Asn80 (N) 2.82 Asp84 (OD1) 
Asn81 (ND2) 3.56 Asn81 (OD1) 
Asn81 (ND2) 3.14 Asn81 (O) 
Asn286 (ND2) 3.40 Thr20 (OG1) 
Tyr318 (OH) 3.68 Ser21 (O) 
Monomer 1 Distance (Å) Monomer 2 
Salt bridges (OmpU) 
Asp73 (OD1) 2.80 Lys103 (NZ) 
Asp73 (OD2) 3.24 Lys103 (NZ) 
Hydrogen bonds (OmpU) 
Ser33 (OG) 3.04  Arg159 (NH1) 
Ser33 (OG) 3.08 Arg159 (NH2) 
Ser33 (O) 3.03 Arg159 (NH1) 
Lys38 (O) 3.00 Arg159 (NH1) 
Ala39 (O) 3.38 Asn137 (ND2) 
Als39 (O) 2.82 Arg159 (N) 
Asp41 (OD2) 2.86 Arg137 (N) 
Thr70 (O) 2.93 Asn85 (ND2) 
Monomer 1 Distance (Å) Monomer 2 
Hydrogen bonds (OmpT) 
Asp28 (N) 3.00 Asp142 (OD1) 
Ile31 (N) 3.16 Glu141 (OE1) 
Met66 (N) 3.13 Met66 (O) 
Ser36 (OG) 2.72 His71 (NE2) 
Asp62 (O) 2.97 Lys86 (NZ) 
Asp28 (OD2) 3.33 Asp142 (N) 
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